| Keywords
|
|
[150]
|
'-omics
|
|
|
| 2024 |
|
2024 AB0064
|
BIOINFORMATICS AND SYSTEMS-BIOLOGY APPROACH TO IDENTIFY COMMON PATHOGENIC MECHANISMS FOR COVID-19 AND SYSTEMIC LUPUS ERYTHEMATOSUS,
Y. Wu, Y. LI, X. Bai, Y. Liu
|
|
2024 AB0267
|
NOVEL INSIGHTS INTO DERMATOMYOSITIS AND MALIGNANCY: TRANSCRIPTOMIC ANALYSIS ON MUSCLE BIOPSIES,
R. Martinez-Canales, M. Montelongo Rojas, S. E. Rojas Gutierrez, C. Elizondo Solis, N. Macias-Segura, M. Salinas Carmona
|
|
2024 AB0346
|
GUT MICROBIOME DYSBIOSIS IN ASIAN PATIENTS WITH KNEE OSTEOARTHRITIS,
T. C. Tan, L. Chandrasekaran, A. Low, R. Purbojati, S. Pettersson, Y. Y. Leung
|
|
2024 AB0649
|
LOWER SHORT CHAIN FATTY ACIDS ADVANCE THE PROGRESSION OF RHEUMATOID ARTHRITIS TO POLYARTHRITIS AND INTERSTITIAL LUNG DISEASE,
N. Wang, Z. Liang, Y. Jia, L. Shang, C. Gao, J. Luo
|
|
2024 AB0731
|
IN-VITRO DRUG SCREENING REVEALS THE POTENTIAL OF EPIGENETIC COMPOUNDS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS,
M. Brinkmann, T. Preglej, A. Tosevska, B. Luckerbauer, G. Steiner, D. Aletaha, L. Göschl, M. Bonelli
|
|
2024 AB0732
|
CELLULAR AND MOLECULAR HALLMARKS OF EARLY METHOTREXATE RESPONSE IN RA,
A. Tosevska, T. Preglej, M. Brinkmann, P. Schatzlmaier, E. Simader, D. Sieghart, D. Aletaha, P. Hofer, L. Göschl, M. Bonelli
|
|
2024 AB0736
|
DEVELOPMENT AND APPLICATION OF EPITOPESCAN, A PYTHON3 TOOLSET FOR MUTATION TRACKING IN SARS-CoV-2 IMMUNOGENIC EPITOPES RESTRICTED BY THE RHEUMATOID ARTHRITIS SUSCEPTIBILITY ALLELE HLA-DRB1*04:01,
A. Kovalenko, S. Viatte
|
|
2024 AB0739
|
INCREASED FREQUENCY AND CYTOTOXICITY OF TERMINALLY DIFFERENTIATED CD4 T CELLS ARE ASSOCIATED WITH CMV POSITIVITY IN ACTIVE RHEUMATOID ARTHRITIS,
S. A. Yeoh, M. Ehrenstein, A. Akbar, D. Mccluskey, L. Chocarro, W. T. MA, D. Janman, J. Evans, E. Hawkins, L. Tomson
|
|
2024 AB0741
|
WHOLE BLOOD-BASED TRANSCRIPTOMIC BIOMARKERS FOR PREDICTING ADALIMUMAB TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS IDENTIFIED THROUGH MACHINE LEARNING,
C. F. Yap, N. Nair, K. Hyrich, A. G. Wilson, J. Isaacs, A. Morgan, A. Barton, D. Plant On Behalf of 3TR
|
|
2024 AB0752
|
CONTRIBUTION OF SECRETED SYNOVIAL TISSUE PROTEINS TO SERUM INFLAMMATORY PROFILES, CLINICAL FEATURES, AND THERAPEUTIC RESPONSES IN RHEUMATOID ARTHRITIS PATIENTS,
C. Lopez-Pedrera, C. Perez-Sanchez, S. Corrales-Díaz Flores, L. Muñoz-Barrera, R. Ortega-Castro, J. Calvo-Gutiérrez, C. Aranda-Valera, M. L. Ladehesa-Pineda, I. Sanchez-Pareja, M. C. Ábalos-Aguilera, D. Ruíz-Vilchez, C. Merlo-Ruiz, M. Á. Aguirre-Zamorano, C. López-Medina, N. Barbarroja, T. Cerdó, M. Alarcon-Riquelme, A. Escudero-Contreras
|
|
2024 AB0806
|
HUMORAL RESPONSES AGAINST HDL ARE LINKED TO UNFAVORABLE LIPOPROTEIN TRAITS AND LIPID SPECIES IN PRIMARY SJÖGREN SYNDROME,
J. Rodríguez-Carrio, S. Suárez, P. López, Á. I. Pérez-Álvarez, L. Caminal-Montero, A. Suárez
|
|
2024 AB0807
|
ANALYSIS OF THE PROTEOME IN MINOR SALIVARY GLANDS FROM SJOEGREN’S SYNDROME PATIENTS,
N. Štucin, K. Perdan Pirkmajer, A. Hočevar, B. Maurer, P. Zigon, S. Čučnik, K. Klein
|
|
2024 AB0809
|
USER-FRIENDLY TOOL FOR EXPLORING RNA-SEQUENCE AND BIOMARKER DISCOVERY IN SJOGREN’S DISEASE: ANALYSE THE TWO BIGGEST DATASETS OF BLOOD AND SALIVARY GLAND RNA-SEQUENCING DATA USING R SHINY APPS,
E. Pontarini, E. Sciacca, G. Cavallaro, D. Galbraith, A. Pulvirenti, L. Y. Hao, K. Sivils, M. Lewis, C. Pitzalis, M. Bombardieri
|
|
2024 AB0884
|
RADIOGENOMIC EXPLORATION OF AXIAL SPONDYLOARTHRITIS THROUGH SACROILIAC JOINT MRI FEATURES,
D. Chen, L. Ye, S. Miao, S. Xie, M. Zheng, G. Zhu, Q. Xiao, S. Lu, T. Lei, C. Ye
|
|
2024 AB0971
|
OXIDATIVE STRESS AND INFLAMMATION IN AXIAL SPONDYLOARTHRITIS: PROFILING OF PERIPHERAL BLOOD MONONUCLEAR CELLS,
G. Lopalco, L. DI Pietro, A. Privitera, P. Bonacci, N. Musso, D. Natuzzi, R. Bizzoca, S. Del Vescovo, G. Caruso, F. Iannone
|
|
2024 AB1110
|
TRANSCRIPTOME ANALYSIS IMPLICATES TOLL-LIKE RECEPTOR 7 RATHER THAN TOLL-LIKE RECEPTOR 8 IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS,
T. Honda, A. Manno, S. Yamada, J. Ishiguro, Y. Tomimori, G. Senaldi, J. Tanaka
|
|
2024 AB1113
|
ALLELE SPECIFIC GENE EXPRESSION DURING TOLERANCE INDUCTION ON DENDRITIC CELLS FROM MEXICAN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
A. L. Hernández-Ledesma, S. Salazar-Magaña, E. L. Coss-Navarrete, K. J. Nuñez-Reza, L. Tinajero Nieto, A. Peña-Ayala, E. Torres-Valdez, G. Felix Rodríguez, G. Frontana-Vázquez, F. Rosetti, S. L. Fernández-Valverde, M. Gutierrez Arcelus, D. Alpizar-Rodriguez, A. Medina-Rivera
|
|
2024 AB1116
|
AGE-ASSOCIATED INCREASE IN CYTOTOXIC T LYMPHOCYTE-ASSOCIATED PROTEIN 4 (CTLA-4) EXPRESSION ON EFFECTOR T CELLS AND ITS ROLE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Cheong, M. Wasser, K. Nay Yaung, A. Law Hui Nee, N. K. H. Khoo, P. Kumar, T. Arkachaisri, S. L. Poh, J. Y. Leong, J. Thumboo, A. Low, S. Albani, J. G. Yeo
|
|
2024 AB1117
|
EXPLORING GENETIC AND IMMUNE CELL DYNAMICS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH EPSTEIN–BARR VIRUS INFECTION VIA COMBINED MICROARRAY AND SINGLE-CELL RNA SEQUENCING ANALYSES,
J. Gui, M. Fang, J. Tu, X. Chen, L. Sun
|
|
2024 AB1132
|
TRANSCRIPTOME-BASED CHARACTERIZATION OF SEX-SPECIFIC PHENOTYPE ON SLE PATIENTS,
A. Banos, M. Grigoriou, S. Papanikolaou, N. Malissovas, A. Filia, C. Nikolaou, G. K. Bertsias, D. Boumpas
|
|
2024 AB1143
|
CHARACTERIZATION OF THE FECAL METABOLOME IN EARLY SYSTEMIC SCLEROSIS,
A. Young, K. Andréasson, N. Matulionis, B. Wilde, J. Jacobs, H. Christofk, E. Volkmann
|
|
2024 AB1145
|
DECIPHERING THE SPATIAL HETEROGENEITY OF SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE BY INTEGRATIVE RADIOMICS AND SINGLE-NUCLEUS TRANSCRIPTOMIC PROFILING,
J. Gote-Schniering, M. Ammeter, Y. Chen, M. Mueller, S. Zhou, L. De Sadeleer, M. Brunner, O. Distler, H. S. Gabrys, S. Tanadini-Lang, M. D. Luecken, S. Verleden, B. Maurer, H. Schiller
|
|
2024 AB1146
|
ALTERNATIVE SPLICING IDENTIFICATION IN SYSTEMIC SCLEROSIS AND THEIR ROLES IN SKIN FIBROSIS,
H. Zhu, S. Xie, D. Bao, Y. Xiao, H. Li, Q. Meng, B. Dai, L. Ding, M. Guo, M. Li, S. Liu, J. Huang, C. Lv, J. Distler, L. Hui
|
|
2024 AB1152
|
BILE ACID INDUCED CELLULAR AND MOLECULAR CHANGES OF OESOPHAGEAL EPITHELIAL CELLS MAY CONTRIBUTE TO THE PATHOGENESIS OF SYSTEMIC SCLEROSIS. A PILOT IN VITRO STUDY,
S. Zahed Mohajerani, J. Ladbury, R. Ross, F. Del Galdo
|
|
2024 AB1156
|
IMMUNOGLOBULINS G FROM SYSTEMIC SCLEROSIS PATIENTS MODIFY THE PROTEOME OF ENDOTHELIAL CELLS DEPENDING ON ANTINUCLEAR ANTIBODIES SPECIFICITY,
A. Chepy, S. Viver, A. Elhannani, F. Bray, C. Chauvet, L. Guilbert, L. Bourel, C. Rolando, E. Hachulla, S. Dubucquoi, D. Launay, V. Sobanski
|
|
2024 AB1282
|
DECIPHERING THE THERAPEUTIC MECHANISMS OF THE PHYTOCHEMICAL GENISTEIN IN TAKAYASU ARTERITIS: A COMPREHENSIVE APPROACH UTILIZING NETWORK PHARMACOLOGY PREDICTION AND MOLECULAR DOCKING STRATEGIES,
T. Qamar, K. Singh, U. Rathore, D. P. Misra
|
|
2024 AB1361
|
PROTEOMIC ANALYSIS OF TEAR FLUID AND AQUEOUS HUMOR OF CHILDREN WITH AND WITHOUT UVEITIS,
I. Maccora, M. Altaye, K. Greis, A. Kaufman, E. Dosunmu, A. Duell, M. E. Gray, W. Haffey, P. Land, W. W. Motley, M. Quinlan-Waters, A. Sood, A. Sproles, S. Thornton, M. B. Yang, S. Angeles-Han
|
|
2024 AB1426
|
RAB19 AND PANCREATIC INJURY IN PATIENTS TAKING AZATHIOPRINE: A GENOME-WIDE ASSOCIATION STUDY,
S. Shah, T. Reese, L. Daniel, P. Nepal, J. Zanussi, A. Dickson, R. Tao, A. Hung, W. Q. Wei, C. M. Stein, Q. Feng, C. Chung
|
|
2024 AB1434
|
CELLULAR RESPONSE TO CHEMICAL STIMULUS AND REACTIVE OXYGEN SPECIES ASSOCIATED PATHWAYS IN THE PATHOGENESIS IN SJÖGREN SYNDROME, SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER AUTOIMMUNE DISEASES: A MOLECULAR PATHWAY ENRICHMENT ANALYSIS,
S. E. Rojas Gutierrez, R. Martinez-Canales, C. Elizondo Solis, M. Gelinas Martin del Campo, M. Montelongo Rojas, G. Banda Morales, A. Montoya Rosales, N. Macias-Segura, M. Salinas Carmona
|
|
2024 AB1453
|
PYROPTOTIC GENES AS PREDICTORS OF BONE RESORPTION AND MINERALIZATION IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS,
Z. Yang, M. MA, Y. Liang, Y. Wen, P. Zhang, R. Huang
|
|
2024 OP0014
|
TRANSCRIPTS EXPRESSED IN TEMPORAL ARTERY BIOPSIES ASSOCIATED WITH RESPONSE TO THERAPY IN PATIENTS WITH GIANT CELL ARTERITIS,
S. Croci, A. Rossi, V. Manicardi, M. Bonacini, F. Torricelli, C. Ascione, A. Ciarrocchi, M. Á. González-Gay, S. Castañeda, G. Guggino, D. Saadoun, P. Lio, S. Fontana, J. Martin, A. Cavazza, A. Zerbini, F. Muratore, N. Pipitone, C. Salvarani
|
|
2024 OP0025
|
GENOME-WIDE DNA METHYLATION STUDY REVEALS SPECIFIC SIGNATURES IN THE AFFECTED ARTERIAL TISSUE OF GIANT CELL ARTERITIS PATIENTS,
G. Borrego-Yaniz, E. Estupiñán-Moreno, L. Ortiz-Fernández, E. Andrés-León, L. C. Terrón-Camero, M. Á. González-Gay, S. Castañeda, G. Guggino, D. Saadoun, P. Lio, S. Fontana, A. Márquez, M. Bonacini, A. Rossi, F. Muratore, C. Salvarani, N. Pipitone, S. Croci, J. Martin
|
|
2024 OP0028
|
ADVANCED PROTEOMIC ANALYSIS IN SJÖGREN’S DISEASE: INSIGHTS INTO PATHOPHYSIOLOGY AND TREATMENT RESPONSE FROM THE RepurpSS-I TRIAL,
V. Baloche, W. Y. Wong, A. Concepcion, M. C. Gaudreau, T. Sornasse, M. D. Catalina, H. Leavis, J. Van Roon
|
|
2024 OP0029
|
GUT-SPECIFIC H3R SIGNALING ORCHESTRATES MICROGLIA-DEPENDENT RESOLUTION OF PERIPHERAL INFLAMMATION,
K. Dürholz, M. Linnerbauer, E. Schmid, H. Danzer, V. Azizov, S. Lucas, L. Lößlein, L. Amend, H. Bootz-Maoz, H. Romano, Y. Reich, A. Gessner, D. Mauro, F. Beyer, R. Beckervordersandforth, W. Xiang, A. Haghikia, C. Akdis, T. Baeuerle, K. Sarter, T. Strowig, F. Ciccia, N. Yissachar, G. Schett, V. Rothhammer, M. M. Zaiss
|
|
2024 OP0040
|
DOSE DEPENDENT MODULATION OF PROTEOMIC SIGNATURES BY IANALUMAB IN PATIENTS WITH SJÖGREN’S DISEASE,
G. M. Verstappen, H. Bootsma, S. Finzel, A. Grioni, B. Fisher, A. Papas, C. Rauld, A. Avrameas, D. Tuckwell, J. Zierer, V. De Luca, E. Ferrero, C. Bonal, A. Da Costa, R. Hillenbrand, I. Isnardi, W. Hueber
|
|
2024 OP0051
|
PREDIAGNOSTIC PROTEOMICS OF GOUT: PROSPECTIVE COHORT STUDY OF 48,898 MEN AND WOMEN,
N. Mccormick, A. Joshi, R. Terkeltaub, T. Merriman, C. Yokose, H. Choi
|
|
2024 OP0062
|
MULTI-MODAL ANALYSIS OF SYNOVIAL TISSUE MACROPHAGES INFORMS ON TREATMENT RESPONSE IN NAIVE TO TREATMENT RHEUMATOID ARTHRITIS,
S. Alivernini, S. Perniola, B. Tolusso, A. Elmesmari, M. Gessi, C. DI Mario, L. A. Coletto, M. R. Gigante, L. Petricca, V. A. Pacucci, D. Bruno, D. Somma, L. Macdonald, R. Benvenuto, L. Bui, M. A. D’agostino, E. Gremese, J. Bacardit, M. Kurowska-Stolarska
|
|
2024 OP0066
|
FIBROBLAST ACTIVATION DEFINES DISEASE PROGRESSION: SYNOVIUM ATLAS IN KNEE OSTEOARTHRITIS,
K. Thavaratnam, E. Gracey, A. Ratneswaran, J. Rockel, S. Vohra, C. Pastrello, I. Jurisica, S. Lively, C. Vlieghe, G. Planckaert, S. Dupont, R. Rampersaud, N. Mahomed, R. Gandhi, D. Elewaut, M. Kapoor
|
|
2024 OP0070
|
IDENTIFICATION OF AUTOREACTIVE CYTOTOXIC T CELLS IN ANCA-ASSOCIATED VASCULITIS,
L. Van Dam, S. Younis, J. S. Moon, S. Parsafar, A. Horomanski, O. Sharpe, J. Van Leeuwen, C. Van Kooten, Y. K. O. Teng, W. Robinson
|
|
2024 OP0073
|
UNRAVELING PATHOPHYSIOLOGY AND HEMATOPOIESIS OF VEXAS SYNDROME BY MULTI-OMICS ANALYSIS AND TARGETED GENE EDITING,
C. Campochiaro, R. Molteni, G. Pacini, M. Fiumara, A. Tomelleri, E. Diral, D. Stefanoni, A. Varesi, A. Weber, R. Alfieri, L. Albano, M. Panigada, E. Cantoni, D. Canarutto, L. Bassoricci, P. Quaranta, A. D’alessandro, M. Matucci-Cerinic, R. DI Micco, A. Aiuti, F. Ciceri, I. Merelli, L. Dagna, S. Scala, S. Cenci, L. Naldini, S. Ferrari, G. Cavalli
|
|
2024 OP0082
|
GENE EXPRESSION PROFILE OF CD4+ T LYMPHOCYTES IS MODIFIED IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA),
R. Ríos-Garcés, N. Farran, S. Naranjo-Suárez, R. Alba-Rovira, S. Prieto-González, I. Tavera-Bahillo, E. Arismendi, R. Solans-Laqué, M. Corbera-Bellalta, F. Kamberovic, N. Visocnik, M. C. Cid, G. Espígol-Frigolé
|
|
2024 OP0088
|
ENTHESEAL TISSUE SIGNATURE IN RESPONSE TO IL-17 BLOCKADE IN PSORIATIC ARTHRITIS - RESULTS FROM THE EBIO ENTHESIAL BIOPSY STUDY,
M. G. Raimondo, H. Mohammadian, S. Alivernini, V. Fedorchenko, S. Rauber, H. Labinsky, M. Angeli, F. Fagni, G. Corte, K. Tascilar, L. Bräuer, M. A. D’Agostino, G. Schett, A. Kleyer, M. Pachowsky, A. Ramming
|
|
2024 OP0109
|
SERUM PROTEOMIC PROFILING IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS (AAV),
A. Singh, L. Rani, A. Saini, R. Walker Minz, G. Naidu, A. Sharma
|
|
2024 OP0111
|
QUIESCENT HUMAN BLOOD MONOCYTE STATES ARE PRE-COMMITTED TO AN INFLAMMATORY SYNOVIAL TRANSCRIPTIONAL PROGRAM,
E. Amies, M. Christofi, B. Mulhearn, L. Marshall, M. Sutcliffe, K. Hyrich, A. Morgan, A. G. Wilson, J. Isaacs, D. Plant, A. Barton, T. Hussell, S. Raychaudhuri, P. Martin, S. Viatte
|
|
2024 OP0128
|
SPATIAL TRANSCRIPTOMICS IMPLICATES GLANDULAR CELL INVOLVEMENT IN PATHOPHYSIOLOGY OF SJÖGREN’S DISEASE,
S. Yao, R. Wilbrink, P. Czarnota, M. C. Marlin, B. Khatri, A. M. Stolarczyk, C. Pritchett Frazee, C. Li, K. Wright, K. L. Tessneer, J. A. James, R. H. Scofield, I. Adrianto, A. Rasmussen, J. M. Guthridge, A. D. Farris, C. J. Lessard
|
|
2024 OP0133
|
INVESTIGATING THE GENETIC BACKGROUND OF THE SEX DIMORPHISM IN SYSTEMIC SCLEROSIS,
I. Rodriguez-Martin, M. Kerick, C. Rosa-Baez, G. Borrego-Yaniz, L. Ortiz-Fernández, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, S. Assassi, I. Ssc Group, S. M. Proudman, M. Nikpour, A. S. Interest Group (Asig), N. Hunzelmann, G. Moroncini, J. K. De Vries-Bouwstra, G. Orozco, A. Barton, A. L. Herrick, Y. Allanore, C. Fonseca, L. Beretta, C. P. Denton, M. D. Mayes, J. Martin, M. Acosta-Herrera
|
|
2024 OP0135
|
MULTI-OMIC STUDY IN PATIENTS WITH SITRAME SYNDROME,
Y. Y. J. Zhu, A. Soria, E. Amsler, A. Barbaud, F. Rahal, Y. Chantran, T. Moreau, M. Cescato, F. Maillet, A. S. Korganow, Y. Dieudonné, G. Boursier, M. Miyara, C. Cretet, A. Haddouche, V. Beziat, C. Deswarte, D. Duffy, S. Georgin-Lavialle, M. P. Rodero
|
|
2024 OP0139
|
THE MOLECULAR LANDSCAPE OF ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS: DISTINCT TRANSCRIPTIONAL PROFILES IN VENOUS VERSUS ARTERIAL EVENTS, WITH POTENTIAL THERAPEUTIC IMPLICATIONS,
D. Nikolopoulos, C. Loukogiannaki, G. Sentis, P. Garantziotis, T. Manolakou, N. Kapsala, M. Nikoloudaki, A. Pieta, S. Flouda, I. Parodis, G. K. Bertsias, A. Fanouriakis, A. Filia, D. Boumpas
|
|
2024 OP0141
|
EXPLORING REGULATORY DYNAMICS: FUNCTIONAL SNPS IN THE PRDM1-ATG5 LOCUS IMPLICATED IN SYSTEMIC LUPUS ERYTHEMATOSUS AND SJÖGREN’S DISEASE,
M. Radziszewski, M. M. Wiley, B. Khatri, A. Rasmussen, K. L. Tessneer, K. Kim, E. M. Vital, N. Dand, C. Gong, D. Morris, P. Tombleson, E. Pontarini, M. Bombardieri, M. Rischmueller, M. Wahren-Herlenius, M. Kvarnström, T. Witte, H. Bootsma, G. M. Verstappen, F. G. M. Kroese, A. Vissink, S. Pringle, A. Tzioufas, C. Mavragani, A. Baer, M. Alarcon-Riquelme, J. Martin, X. Mariette, G. Nocturne, J. O. Pers, J. E. Gottenberg, W. F. Ng, C. Shiboski, K. E. Taylor, L. Criswell, B. M. Warner, A. D. Farris, P. M. Gaffney, J. A. James, R. H. Scofield, J. M. Guthridge, D. J. Wallace, S. Venuturupali, M. T. Brennan, J. Imgenberg-Kreuz, L. Ronnblom, E. Baecklund, M. L. Eloranta, L. A. Aqrawi, Ø. Palm, J. G. Brun, D. Hammenfors, M. V. Jonsson, S. Appel, S. M. Bucher, H. Forsblad-D’elia, T. Mandl, P. Eriksson, S. C. Bae, T. J. Vyse, B. Tsao, G. Nordmark, C. J. Lessard
|
|
2024 OP0144
|
MULTIPLE SPATIAL PROTEOMICS TO DEFINE ENDOTHELIAL CELL PHENOTYPES AND ALTERATIONS OF THE VASCULAR NICHE IN SSc,
J. Distler, M. Liang
|
|
2024 OP0161
|
MULTI-MODAL ANALYSIS OF SYNOVIAL TISSUE INFLAMMATION INFORMS ON TREATMENT RESPONSE IN ACTIVE PSORIATIC ARTHRITIS,
D. Bruno, D. Somma, L. A. Coletto, B. Tolusso, C. DI Mario, S. Perniola, V. Varriano, A. Paglionico, M. Gessi, R. Benvenuto, L. Bui, L. Petricca, M. R. Gigante, L. Macdonald, A. Elmesmari, G. Peluso, M. M. Lizzio, M. A. D’ Agostino, E. Gremese, M. Kurowska-Stolarska, S. Alivernini
|
|
2024 OP0176
|
SINGLE-CELL SPATIAL PROTEOMICS IDENTIFIES INTRAGLOMERULAR MYELOID CELLS IN MEMBRANOUS LUPUS NEPHRITIS,
A. Fava, C. Y. Lee, M. C. Marlin, X. Yang, T. Stephens, A. I. Celia, J. Hodgin, D. Demeke, P. Izmirly, J. Buyon, C. Putterman, J. A. James, M. Petri, J. M. Guthridge, A. Rosenberg on behalf of the Accelerating Medicines Partnership RA/SLE
|
|
2024 OP0178
|
IMAGING MASS CYTOMETRY-BASED CHARACTERIZATION OF FIBROBLASTS SUBSETS, THEIR NETWORKS AND SPATIAL MICROENVIRONMENT IN SYSTEMIC SCLEROSIS,
A. Rius Rigau, M. Liang, T. Filla, V. Devakumar, A. E. Matei, A. H. Györfi, G. Schett, J. Distler, Y. N. Li
|
|
2024 OP0179
|
DISEASE ASSOCIATED AUTOANTIBODIES ARE LINKED TO GRADUAL PROTEOMIC CHANGES IN PRIMARY SJÖGREN’S SYNDROME,
A. Björk, J. Mofors, L. Meneghel, M. Kvarnström, R. Jonsson, R. Omdal, H. Forsblad-D’elia, S. Magnusson Bucher, P. Eriksson, T. Mandl, P. Olsson, J. Imgenberg-Kreuz, G. Nordmark, M. Wahren-Herlenius
|
|
2024 OP0189
|
MOLECULAR MECHANISMS AND IMMUNE CELL PATTERNS IN PERIPHERAL BLOOD ASSOCIATED TO CORONARY ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS,
R. Martinez-Canales, E. Rojas Gutiérrez, C. Elizondo Solis, N. Macias-Segura, M. Salinas Carmona
|
|
2024 OP0192
|
SYNOVITIS IN SYSTEMIC SCLEROSIS IS CHARACTERISED BY AN INTERFERON SIGNATURE,
C. Geiss, M. Houtman, R. Micheroli, Y. Djeffal, M. Frank Bertoncelj, S. G. Edalat, K. Buerki, C. Pauli, M. Bonelli, T. Karonitsch, O. Distler, C. Ospelt, M. Elhai
|
|
2024 OP0193
|
BITEING MULTI-DRUG RESISTANT RHEUMATOID ARTHRITIS WITH CD19-T CELL ENGAGERS,
L. Bucci, M. Hagen, T. Rothe, M. G. Raimondo, F. Fagni, C. Tur, A. Wirsching, J. Wacker, A. Wilhelm, J. P. Auger, M. Eckstein, S. Alivernini, A. Zoli, A. Bozec, M. A. D’agostino, G. Schett, R. Grieshaber-Bouyer
|
|
2024 OP0194
|
COMPUTATIONAL SYSTEMS BIOLOGY APPROACH TO UNVEIL MOLECULAR INTERACTIONS IN SJÖGREN’S SYNDROME PATHOGENESIS,
S. E Silva-Saffar, J. E. Gottenberg, M. Bombardieri, D. Cornec, J. O. Pers, M. Alarcon-Riquelme, P. Moingeon, M. Barnes, S. Ng, W. F. Ng, X. Mariette, G. Nocturne, A. Niarakis
|
|
2024 OP0198
|
COMPARATIVE IMMUNOMICS OF CHILDHOOD AND ADULT-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS REVEALS DISTINCT MECHANISTIC DIFFERENCES WITH THERAGNOSTIC APPLICATIONS,
J. G. Yeo, K. Nay Yaung, A. Law Hui Nee, M. Wasser, S. L. Poh, K. L. Teh, L. Das, Y. X. Book, C. Huang, T. Arkachaisri, J. Thumboo, A. Low, S. Albani
|
|
2024 OP0199
|
SPATIAL INSIGHTS INTO THE SALIVARY GLANDS OF PATIENTS WITH SJOGREN’S DISEASE,
S. Nayar, J. D. Turner, J. Flint, D. H. Gardner, S. Bowman, A. P. Croft, A. Filer, B. Fisher
|
|
2024 OP0204
|
EFFECT OF FT011 TREATMENT ON REVISED CRISS-25 AND GENE EXPRESSION IN SKIN BIOPSIES FROM PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS,
M. Papadimitriou, L. Tsoi, J. Fox, S. Eddy, J. E. Gudjonsson, M. Kretzler, M. Bradney, C. P. Denton, W. Stevens, D. Kelly
|
|
2024 OP0208
|
LYMPHOCYTE, NK CELL AND MITOCHONDRIAL GENE DYSREGULATION PATTERNS SEPARATE PATIENTS WITH NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS INTO DISTINCT SUBGROUPS WITH DIFFERENTIAL ANTICIPATED RESPONSE TO TARGETED THERAPIES,
J. Lindblom, D. Nikolopoulos, D. Toro-Domínguez, E. Carnero-Montoro, M. O. Borghi, J. Castillo, E. Iacobaeus, Y. Enman, C. Mohan, L. Beretta, M. Alarcon-Riquelme, G. Barturen, I. Parodis
|
|
2024 OP0218
|
SYNOVIAL PHOSPHOPROTEOME ANALYSIS OF LATE-STAGE RHEUMATOID ARTHRITIS PATIENTS (R4RA TRIAL) IDENTIFIES SIGNALLING PATHWAYS ASSOCIATED WITH PATHOTYPE AND RESPONSE TO RITUXIMAB AND TOCILIZUMAB,
R. Lau, C. Cubuk, V. Rajeeve, P. Cutillas, R. Hands, L. Fossati-Jimack, A. Surace, M. Lewis, C. Pitzalis on behalf of R4RA investigators
|
|
2024 OP0224
|
INTEGRATION OF DNA METHYLATION INTO MULTI-OMIC ANALYSIS OF SYNOVIAL BIOPSIES FROM THE STRAP RANDOMIZED CLINICAL TRIAL IDENTIFIES PREDICTORS OF RESPONSE TO ANTI-TNF THERAPY IN RHEUMATOID ARTHRITIS,
S. Wang, N. Nair, C. Cubuk, C. F. Yap, R. Lau, G. Giorli, L. Fossati-Jimack, D. Plant, A. Barton, M. Lewis, C. Pitzalis on behalf of STRAP Collaborative Group
|
|
2024 OP0239
|
DECODING THE COMPLEXITY OF CHILDHOOD-ONSET SLE (cSLE) USING A HIGH-DIMENSIONAL APPROACH: ENHANCING THERAGNOSIS WITH AN IMMUNOLOGICAL-BASED DIAGNOSTIC MODEL REVEALING MECHANISTIC INSIGHTS,
K. Nay Yaung, J. G. Yeo, M. Wasser, S. L. Poh, K. L. Teh, L. Das, Y. X. Book, N. K. H. Khoo, Z. M. Y. Tay, R. Cheong, J. J. M. Wong, T. Arkachaisri, S. Albani
|
|
2024 OP0271
|
TRANSCRIPTOME AND REPERTOIRE ANALYSIS REVEALED PLASTICITY OF SYSTEMIC LUPUS ERYTHEMATOSUS REGULATORY T CELLS,
Y. Nagafuchi, M. Nakano, M. Ota, H. Hatano, T. Itamiya, T. Okamura, K. Fujio, K. Ishigaki
|
|
2024 OP0272
|
SINGLE-CELL ANALYSIS OF PERIPHERAL BLOOD MONONUCLEAR CELLS IDENTIFIES IMMUNE SIGNATURES AT DIFFERENT STAGES OF ACTIVE RHEUMATOID ARTHRITIS,
Y. Tan, T. Bhatt, M. Sutcliffe, J. Fitton, P. Emery, A. Aslam, M. Menon, D. Plant, M. Buch
|
|
2024 OP0299
|
DYNAMICS OF THE B CELL RECEPTOR REPERTOIRE DURING THE PRECLINICAL PHASE OF RHEUMATOID ARTHRITIS: LONGITUDINAL STUDIES IN UNTREATED RA-RISK INDIVIDUALS (DOMINO STUDY) AND THE EFFECTS OF RITUXIMAB TREATMENT (PRAIRI STUDY),
A. Musters, A. Al-Soudi, D. Anang, I. Niewold, L. G. M. Van Baarsen, B. Van Schaik, A. Van Kampen, D. Gerlag, P. P. Tak, S. W. Tas, N. De Vries
|
|
2024 OP0302
|
CLONAL SHARING OF CD8+ T-CELLS LINKS SKIN AND JOINT INFLAMMATION IN PSORIATIC ARTHRITIS,
L. Durham, F. Humby, N. Ng, S. Ryan, R. Nuamah, K. Fung, A. Menon, P. Dhami, B. Kirkham, L. Taams
|
|
2024 OP0307
|
CELLULAR PROFILING OF SYNOVIAL FLUID IN INFLAMMATORY ARTHRITIS HIGHLIGHTS SHARED AND DISEASE-SPECIFIC CELL STATES WITH BIOLOGICAL AND DIAGNOSTIC RELEVANCE,
M. Christofi, S. Valma, L. Marshall, B. Mulhearn, T. Hussell, A. Barton, D. Rao, S. Viatte
|
|
2024 OP0308
|
MULTI-OMICS APPROACH TO THE IDENTIFICATION OF BIOMARKERS FOR PROGRESSION FROM PSORIASIS TO PSORIATIC ARTHRITIS,
S. R. Pennington, J. Schwenk, A. Bendes, S. Rischke, R. Gurke, L. Hahnefeld, B. Kirby, L. C. Coates, O. Coleman, J. Waddington, R. Zhou, B. Wundervald, P. Whitfield, G. Blackburn, C. Regnault, A. Barton, J. Bowes, J. Bluett, O. Fitzgerald
|
|
2024 OP0325
|
FARNESYL PYROPHOSPHATE INDUCES NEUTROPHIL HYPERACTIVATION VIA THE TRPM2 CALCIUM CHANNEL IN BEHÇET’S DISEASE,
M. Zhang, N. Kang, X. Yu, W. Liu, W. Zheng
|
|
2024 OP0327
|
MAPPING THE JOINT-NERVE INTERACTOME OF THE KNEE: AN INTEGRATIVE APPROACH FOR IDENTIFYING NEW STRATEGIES FOR THE CONTROL OF JOINT PAIN,
A. M. Malfait, M. Olmer, A. Obeidat, J. Li, H. Swahn, M. Newton, F. Ko, B. Mehta, M. Otero, T. Maerz, D. Orange, R. Miller, R. Miller, M. Lotz
|
|
2024 POS0018
|
UNCOVERING NEW DIAGNOSTIC BIOMARKERS AND MOLECULAR PATTERNS IN PSORIATIC ARTHRITIS BY HIGH-THROUGHPUT PROTEOMIC ANALYSIS OF IMMUNE CELLS,
I. Arias-de la Rosa, L. Cuesta-López, M. L. Ladehesa-Pineda, M. Ruiz-Ponce, A. Barranco, M. Á. Puche-Larrubia, C. Perez-Sanchez, Y. Hanaee, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, P. Ortiz-Buitrago, C. Lopez-Pedrera, A. Escudero-Contreras, E. Collantes-Estevez, C. López-Medina, N. Barbarroja
|
|
2024 POS0021
|
METABOLIC TARGETING BY SODIUM PYRUVATE PREVENT FIBROBLAST-TO-MYOFIBROBLAST TRANSITION AND FIBROTIC REMODELING,
X. Zhou, T. Trinh-Minh, C. Tran-Manh, A. H. Györfi, A. E. Matei, H. Zhu, X. Hong, T. Filla, J. Wang, J. Distler
|
|
2024 POS0040
|
SECRETION OF ENDOPLASMIC RETICULUM CHAPERONE PROTEINS BY SUBINTIMAL SYNOVIOCYTES IS INVOLVED IN SYNOVITIS PATHOGENESIS,
Z. Gendebien, C. Deroyer, C. Poulet, G. Paulissen, G. Cobraiville, A. Mesdagh, C. Daniel, T. Thirion, E. Bianchi, P. Delvenne, C. Ribbens, D. De Seny
|
|
2024 POS0049
|
DETECTION AND CHARACTERIZATION OF CIRCULATING FIBROBLASTS AND FIBROCYTES BY SINGLE-CELL PROTEOMICS IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS,
M. Kyriakidi, E. K. Vetsika, N. I. Vlachogiannis, K. Verrou, M. G. Tektonidou, G. E. Fragoulis, P. P. Sfikakis
|
|
2024 POS0056
|
UNVEILING VASCULAR, PRO-FIBROTIC AND INTERFERON-RELATED ABNORMALITIES THROUGH AN EPIGENOME-WIDE ANALYSIS IN SYSTEMIC SCLEROSIS,
J. Martinez-Lopez, E. Estupiñán-Moreno, L. Ortiz-Fernández, M. Kerick, E. Andrés-León, L. C. Terrón-Camero, E. Carnero-Montoro, G. Barturen, L. Beretta, P. Clinical Consortium, M. Alarcon-Riquelme, M. Acosta-Herrera, E. Ballestar, J. Martin
|
|
2024 POS0130
|
THE USE OF HIGH-THROUGHPUT TECHNOLOGIES FOR MOLECULAR PROFILING IN RHEUMATOID ARTHRITIS ENABLES THE IDENTIFICATION OF PATIENT SUBGROUPS WITH DISTINCTIVE DISEASE ACTIVITY AND THERAPEUTIC RESPONSE,
C. Lopez-Pedrera, I. Sanchez-Pareja, C. Perez-Sanchez, D. Toro-Domínguez, L. Muñoz-Barrera, T. Cerdó, R. Ortega-Castro, J. Calvo-Gutiérrez, M. Rojas-Giménez, M. L. Ladehesa-Pineda, C. Aranda-Valera, M. C. Ábalos-Aguilera, D. Ruíz-Vilchez, C. Merlo-Ruiz, I. Arias-de la Rosa, M. Á. Aguirre-Zamorano, C. López-Medina, N. Barbarroja, M. Alarcon-Riquelme, A. Escudero-Contreras
|
|
2024 POS0138
|
EX VIVO IMAGING-BASED HIGH CONTENT PHENOTYPING OF RHEUMATOID ARTHRITIS PATIENTS,
F. Kartnig, M. Bonelli, U. Goldmann, N. Mészáros, N. Krall, D. Aletaha, L. Heinz, G. Superti-Furga
|
|
2024 POS0143
|
DIFFERENTIAL DIAGNOSTIC SERUM BIOMARKER FOR PSEUDOGOUT AND RHEUMATOID ARTHRITIS IDENTIFIED BY METABOLOMIC ANALYSIS,
S. Takahashi, M. Takahashi, S. Yasui, M. Namiki, Y. Tanimoto, M. Katayama, S. Hatachi, M. Shinohara, S. Kumagai
|
|
2024 POS0144
|
MULTI-MODAL IMMUNE DYNAMICS OF PRE-COVID-19 KAWASAKI DISEASE FOLLOWING INTRAVENOUS IMMUNOGLOBULIN,
G. Olivieri, N. Cotugno, G. Pascucci, D. Amodio, E. Morrocchi, C. Pighi, E. C. Manno, G. A. Rotulo, D. Buonsenso, P. Rossi, A. Marchesi, P. Palma
|
|
2024 POS0154
|
EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS EXHIBIT DISTINCTIVE CIRCULATING INFLAMMATORY SIGNATURES ASSOCIATED WITH RELEVANT BIOLOGIC PATHWAYS,
C. Perez-Sanchez, B. Vellón-García, A. Llamas-Urbano, I. Sanchez-Pareja, L. Muñoz-Barrera, Y. Hanaee, T. Cerdó, C. Merlo-Ruiz, I. Arias-de la Rosa, D. Ruiz-Vilchez, M. D. C. Abalos-Aguilera, M. L. Ladehesa-Pineda, C. Aranda-Valera, M. Rojas-Giménez, J. Calvo-Gutiérrez, E. Collantes-Estevez, N. Barbarroja, C. López-Medina, R. Ortega-Castro, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2024 POS0155
|
PRE-DIAGNOSTIC IMMUNOMODULATORY AMINO ACID METABOLITES AND RISK OF GOUT, ACCOUNTING FOR SERUM URATE: A PROSPECTIVE STUDY OF 249,677 INDIVIDUALS AND MENDELIAN RANDOMIZATION ANALYSES,
N. Mccormick, A. Joshi, C. Yokose, B. Yu, A. Tin, R. Terkeltaub, T. Merriman, O. Zeleznik, A. H. Eliassen, G. Curhan, H. K. Ea, M. Nayor, L. Raffield, H. Choi
|
|
2024 POS0156
|
CD4+HLADR+ T CELLS WITH AUTOIMMUNE REACTIVITY THAT RESIST REGULATORY CONTROL AND PERPETUATE DISEASE INFLAMMATION IN JUVENILE IDIOPATHIC ARTHRITIS,
J. Y. Leong, P. Kumar, S. H. Tay, G. Mijnheer, J. G. Yeo, S. Hazirah, A. J. M. Lim, C. Chua, P. Chen, A. Consolaro, M. Gattorno, T. Arkachaisri, F. Van Wijk, A. Martini, S. Albani
|
|
2024 POS0170
|
CIRCULATING PATHOGENIC LIKE LYMPHOCYTES ARE MECHANISTIC TARGETS FOR THE TOLEROGENIC RE-EDUCATION IN RHEUMATOID ARTHRITIC PATIENTS,
J. Y. Leong, A. Lajam, C. T. Ng, S. Albani
|
|
2024 POS0201
|
PROTEOMIC ANALYSIS OF CIRCULATING NEUTROPHILS FROM OSTEOARTHRITIS PATIENTS SHOWS METABOLIC DYSREGULATION THAT IS ASSOCIATED WITH DECREASED PHYSIOLOGIC APOPTOSIS,
J. Amsler, M. Le Gall, C. Daste, F. Rannou, V. Witko-Sarsat
|
|
2024 POS0213
|
INFRAPATELLAR FAT PAD IN KNEE OSTEOARTHRITIS: CELLULAR AND TRANSCRIPTOMIC ATLAS,
H. Peters, P. Potla, J. Rockel, T. Tockovska, K. Delos Santos, S. Vohra, C. Pastrello, I. Jurisica, S. Lively, K. Perry, A. Perruccio, N. Mahomed, R. Rampersaud, R. Krawetz, M. Buechler, R. Gandhi, M. Kapoor
|
|
2024 POS0238
|
INVESTIGATING PERIPHERAL IMMUNOME DYSREGULATION IN KNEE OSTEOARTHRITIS: IMPLICATIONS FOR DISEASE CLASSIFICATION AND PATHOGENESIS,
A. Chia, A. Lajam, G. Ang, M. Wasser, Y. Y. Leung, S. Albani
|
|
2024 POS0240
|
SINGLE-CELL TRANSCRIPTOMICS OFFERS NEW INSIGHTS INTO SJÖGREN’S DISEASE PATHOGENESIS IN THE SALIVARY GLAND,
B. Khatri, A. M. Stolarczyk, M. C. Marlin, M. Smith, C. Pritchett Frazee, M. Beach, E. Pelayo, Z. Khavandgar, P. Pérez, D. E. Kleiner, S. E. Hewitt, K. Wei, E. M. Theisen, K. L. Tessneer, S. Raychaudhuri, M. B. Brenner, J. E. Gudjonsson, N. Hacohen, J. A. James, R. H. Scofield, S. Shiboski, A. Rasmussen, A. Baer, A. D. Farris, C. Shiboski, B. M. Warner, J. M. Guthridge, C. J. Lessard
|
|
2024 POS0241
|
GENOME-WIDE METHYLATION PROFILES OF PERIPHERAL WHOLE BLOOD IN NEWLY DIAGNOSED GIANT CELL ARTERITIS OR POLYMYALGIA RHEUMATICA,
M. Fröhlich, M. Gernert, O. Gadeholt, H. Einsele, P. P. Strunz, T. Bley, S. E. Serfling, R. A. Werner, K. V. Guggenberger, M. Dittrich, M. Schmalzing, T. Mueller
|
|
2024 POS0256
|
THE FIRST METHYLOME PROFILING STUDY OF B-CELLS IN IGA VASCULITIS REVEALED POTENTIAL BIOMARKERS OF DISEASE SUSCEPTIBILITY,
V. Pulito-Cueto, I. Fernández Rengel, L. C. Terron Camero, J. Batista-Liz, M. Sebastián Mora-Gil, M. T. Leonardo, A. Peñalba, L. Martín-Penagos, L. Belmar-Vega, C. Gomez-Fernandez, L. Gabrie, R. Gálvez-Sánchez, L. Caminal-Montero, A. I. Turrión, P. Quiroga Colina, E. Vicente-Rabaneda, B. Sevilla-Pérez, J. L. Callejas, E. Andrés-León, J. Martin, A. Márquez, S. Castañeda, R. Blanco , R. López-Mejías
|
|
2024 POS0272
|
REDUCED ORAL HAEMOPHILUS PARAINFLUENZAE IN SJÖGREN’S SYNDROME PROMPTS DYSREGULATED T CELL RESPONSE THROUGH ALTERED SALIVARY GLAND EPITHELIAL CELLS,
S. F. Wu, Y. C. Tseng
|
|
2024 POS0286
|
PROTEOMIC INSIGHTS INTO RADIOGRAPHIC PROGRESSION IN AXIAL SPONDYLOARTHRITIS,
N. Barbarroja, I. Arias-de la Rosa, L. Cuesta-López, M. L. Ladehesa-Pineda, M. Ruiz-Ponce, A. Barranco, M. Á. Puche-Larrubia, C. Perez-Sanchez, M. D. C. Abalos-Aguilera, D. Ruiz-Vilchez, P. Ortiz-Buitrago, C. Lopez-Pedrera, A. Escudero-Contreras, E. Collantes-Estevez, C. López-Medina
|
|
2024 POS0327
|
INTERFERON AND B LYMPHOCYTE DYSREGULATION PATTERNS DETERMINE DISTINCT LUPUS NEPHRITIS SUBGROUPS WITH DIFFERENTIAL ANTICIPATED RESPONSE TO TARGETED THERAPIES,
I. Parodis, J. Lindblom, D. Toro-Domínguez, L. Beretta, M. O. Borghi, J. Castillo, E. Carnero-Montoro, Y. Enman, C. Mohan, M. Alarcon-Riquelme, G. Barturen, D. Nikolopoulos
|
|
2024 POS0335
|
DECODING THE T-CELL RECEPTOR REPERTOIRE IN CHRONIC ARTHRITIS ACROSS DIFFERENT AGES, DISEASE GROUPS, AND T-CELL SUBSETS,
M. Ha, V. Van Deuren, J. Dehoorne, T. Renson, E. Geens, N. Aerts, R. Wittoek, K. Heusdens, E. De Wachter, A. Andrzejewski, M. Kuznetsova, E. Bartholomeus, N. De Vrij, I. Maes, A. Suls, E. Lion, S. Vanhee, W. Adriaensen, K. Mullan, R. Joos, K. Laukens, P. Meysman, B. Ogunjimi
|
|
2024 POS0338
|
INTEGRATION OF SINGLE-CELL MULTI-OMICS PROFILING FOR INVESTIGATING TREATMENT RESPONSE TO TUMOR NECROSIS FACTOR ALPHA INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS,
H. S. Cha, S. Lee, J. S. Park, E. Ignatova, J. Lee, S. Kang, H. Kim, E. M. Koh, J. K. Choi
|
|
2024 POS0339
|
FECAL AND BLOOD BIOMARKERS FOR FIBROMYALGIA DIAGNOSIS: CLINICAL TRIAL,
E. Duran Gonzalez, J. A. Ramírez Tejero, A. Martínez Lara, D. Cotan
|
|
2024 POS0343
|
HIGHER ABUNDANCE OF HTRA1 GENERATED FRAGMENTS IN THE DEGRADOME OF MODIC TYPE 1 DISCS,
T. Mengis, B. Roschitzki, I. Heggli, N. Herger, M. Farshad, O. Distler, S. Dudli
|
|
2024 POS0344
|
PAROTID TRANSCRIPTOMIC NETWORKS ASSOCIATED WITH B CELL HYPERACTIVITY, AND VIRUS/IFN ACTIVITY ARE TARGETED BY LEFLUNOMIDE/HYDROXYCHLOROQUINE THERAPY IN SJÖGREN PATIENTS AND ARE CAPTURED BY A CIRCULATING PROTEOME,
V. Baloche, H. Leavis, C. Bekker, P. Soret, S. Nayar, M. Tarozzi, G. Castellani, L. Laigle, J. Van Roon
|
|
2024 POS0356
|
IDENTIFICATION OF PAIN AND INFLAMMATION SPECIFIC GENES IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS THROUGH PERIPHERAL BLOOD MONONUCLEAR CELL TRANSCRIPTOMIC ANALYSIS,
L. Gunkl-Tóth, G. Sütő, G. Kumánovics, J. Kun, P. Urbán, A. Gyenesei, G. Nagy, Z. Helyes
|
|
2024 POS0360
|
INHIBITION OF CERAMIDE METABOLISM POTENTIALLY REDUCES INFLAMMATION AND BONE DESTRUCTION IN RHEUMATOID ARTHRITIS,
Z. Yang, H. Liang, P. Zhang, Q. Liang
|
|
2024 POS0365
|
SERUM METABOLOMIC PROFILING SHOWS THAT PREGNANCY OVERRIDES METABOLIC ALTERATIONS IN RHEUMATOID ARTHRITIS,
C. Raine, I. Sheldon, G. Robinson, J. Peng, C. Ciurtin, J. Manson, D. Williams, E. Jury, I. Giles
|
|
2024 POS0377
|
ASSOCIATION OF COMORBIDITIES, MICROBIOTA AND METABOLOMICS WITH ESTABLISHED AND DEVELOPING RHEUMATOID ARTHRITIS,
J. Schirmer, K. Schlicht, T. Demetrowitsch, N. Rohmann, K. Türk, D. Schulte, K. Hartmann, U. Settgast, A. Franke, K. Schwarz, S. Schreiber, B. F. Hoyer, M. Laudes
|
|
2024 POS0378
|
HETEROZYGOUS LOSS-OF-FUNCTION RELA MUTATIONS LEAD TO SYSTEMIC LUPUS ERYTHEMATOSUS OR AUTOINFLAMMATORY SYNDROME,
Q. Riller, L. Barnabei, M. Rodrigo-Riestra, M. C. Stolzenberg, O. Pelle, L. Delage, T. Becquard, C. Courteille, M. Marchais, C. De Cevins, C. Brunaud, A. Magerus, M. Luka, B. Sorin, C. Boussard, R. Salomon, M. Ménager, M. Hié, B. Neven, V. Baud, J. Skokowa, G. Sogkas, Y. Jamilloux, E. Merlin, A. Belot, C. Picard, G. Boursier, E. Riviere, S. Georgin-Lavialle, P. Quartier, B. Bader-Meunier, A. Fischer, J. J. Miner, F. Rieux-Laucat
|
|
2024 POS0407
|
TYPE I INTERFERON PATHWAY IS UPREGULATED IN GLOMERULAR AND TUBULOINTERSTITIAL KIDNEY COMPARTMENTS OF PATIENTS WITH LUPUS NEPHRITIS AND OTHER RENAL DISEASES,
N. Ferrari, E. Mysler, J. Tumlin, B. H. Rovin, H. J. Anders, E. Csomor, P. G. Gavin, A. Platt, K. Woollard, R. Agren, C. Lindholm
|
|
2024 POS0417
|
PROTEOMIC ANALYSIS OF ANA-POSITIVE AT-RISK INDIVIDUALS REVEALS DISCRETE SETS OF PROTEINS DYSREGULATED IN PROGRESSION TO SLE OR STABLE BENIGN AUTOIMMUNITY,
P. Intapiboon, L. M. Carter, J. Arnold, K. Mahmoud, M. Y. MD Yusof, E. M. Vital
|
|
2024 POS0446
|
INTERFERON SIGNATURE PREDICTS FLARES IN LUPUS PATIENTS ACHIEVING LOW DISEASE ACTIVITY, ACCOMPANIED BY THE ACTIVATION OF OXIDATIVE PHOSPHORYLATION AND CELL CYCLE,
T. Abe, T. Itamiya, Y. Tsuchida, H. Tsuchiya, H. Shoda, T. Okamura, K. Fujio
|
|
2024 POS0455
|
IMMUNOMODULATING TREATMENT IN RHEUMATOID ARTHRITIS IMPACTS THE BRG1-MEDIATED DNA DAMAGE RESPONSE IN CD4+T CELLS,
V. Chandrasekaran, K. M. E. Andersson, M. Erlandsson, E. Malmhäll-Bah, G. Katona, M. I. Bokarewa
|
|
2024 POS0466
|
OBEXELIMAB INHIBITS BCR SIGNALLING AND PATHOGENIC B CELL CHEMOTAXIS IN PATIENTS WITH IGG4-RELATED DISEASE,
T. Guy, H. Liu, V. Mahajan, C. Perugino, Z. S. Wallace, S. Quinn, M. Matijevic, A. Poma, D. Zach, J. H. Stone, S. Pillai
|
|
2024 POS0493
|
RADIOMICS CAN DISCRIMINATE BETWEEN AXIAL SPONDYLOARTHRITIS AND AXIAL PSORIATIC ARTHRITIS: A MACHINE LEARNING ANALYSIS ON MRI RADIOMIC FEATURES OF BONE MARROW OEDEMA,
V. Venerito, S. Del Vescovo, C. Scioscia, M. Giannotta, M. G. Anelli, F. Cacciapaglia, F. Iannone, G. Lopalco
|
|
2024 POS0559
|
DISCOVERING BLOOD-BASED BIOMARKERS FOR SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION,
G. A. Bonazza, C. Bruni, K. Buerki, S. Ulrich, M. Lichtblau, O. Distler, P. Blyszczuk, G. Kania
|
|
2024 POS0713
|
CLONALLY EXPANDED CYTOTOXIC CD8 T CELLS INDICATE THERAPEUTIC RESPONSE IN CHECKPOINT INHIBITOR-ASSOCIATED FULMINANT MYOCARDITIS,
R. Wang, C. Xiang, S. M. Hong, Z. Chen, X. Wang, S. Ye, N. Shen, Q. Fu
|
|
2024 POS0718
|
NEXT GENERATION SEQUENCING IDENTIFIES DIFFERENCES IN THE TRANSCRIPTOMIC PROFILE OF PRETREATMENT EARLY RHEUMATOID ARTHRITIS SYNOVIAL TISSUE FROM RESPONDERS AND NON RESPONDERS TARGETED TO ADALIMUMAB,
K. Lowe, A. Small, S. Wei Wong, H. Weedon, C. Altmann, S. M. Proudman, M. D. Smith, C. Kok, M. Wechalekar
|
|
2024 POS0724
|
SERUM METABOLOMICS PROFILING IDENTIFIES POTENTIAL BIOMARKERS FOR DISEASE ACTIVITY AND RESPONSE TO TREATMENT IN EARLY RHEUMATOID ARTHRITIS - A NORD-STAR SPIN-OFF STUDY,
T. Fatima, G. K. Vasileiadis, R. F. Van Vollenhoven, J. Lampa, B. Gudbjornsson, E. A. Haavardsholm, D. Nordström, G. Grondal, K. Hørslev-Petersen, K. Lend, M. S. Heiberg, M. Lund Hetland, M. Nurmohamed, M. Østergaard, T. Uhlig, T. Sokka-Isler, A. Rudin, Y. Zhang, C. Maglio
|
|
2024 POS0725
|
UNCOVERING NOVEL COMMON AND DISTINCTIVE GENE SIGNATURES IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS THROUGH INTEGRATIVE TRANSCRIPTOMIC ANALYSIS,
C. Lopez-Pedrera, I. Sanchez-Pareja, C. Perez-Sanchez, D. Toro-Domínguez, M. Á. Aguirre-Zamorano, L. Muñoz-Barrera, T. Cerdó, S. Corrales-Díaz Flores, R. Ortega-Castro, C. Aranda-Valera, M. L. Ladehesa-Pineda, J. Calvo-Gutiérrez, F. U. Pilar, M. C. Ábalos-Aguilera, D. Ruíz-Vilchez, C. Merlo-Ruiz, C. López-Medina, N. Barbarroja, A. Escudero-Contreras, M. Alarcon-Riquelme
|
|
2024 POS0731
|
IDENTIFICATION OF AUTOANTIBODY SIGNATURES AND BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) USING HIGH-THROUGHPUT PROTEOMIC MICROARRAYS,
A. Mak, N. Nasir, J. Cho
|
|
2024 POS0766
|
PROTEOMIC ANALYSIS REVEALS SIGNIFICANT FEATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS: A COMPARISON BETWEEN JUVENILE AND ADULT ONSET,
C. Simu, M. Badii, I. Szabo, O. Gaal, C. Pamfil, M. M. Tamas, L. Damian, M. Sparchez, T. Crisan, L. Joosten, S. Rednic
|
|
2024 POS0792
|
IMMUNOLOGICAL PROFILING OF PAIN IN KNEE OSTEOARTHRITIS: TREG CELLS AS POTENTIAL NEW KEY PLAYERS IN SYMPTOMATIC KNEE OSTEOARTHRITIS,
M. Binvignat, J. Dubois, N. Tchitchek, M. Rosenzwajg, M. Barbier, F. Pitoiset, A. Roux, R. Lorenzon, S. Hässler, C. Ribet, A. Courties, H. Vantomme, L. Adda, V. Mhanna, P. Barennes, P. Stys, L. Minssen, Y. Marie, C. Aheng, A. Six, A. Butte, F. Berenbaum, D. Klatzmann, E. Mariotti-Ferrandiz, J. Sellam
|
|
2024 POS0955
|
PROTEOMIC DIFFERENCES BETWEEN TREATMENT NAÏVE AND ESTABLISHED ACTIVE PSORIATIC ARTHRITIS PATIENTS: DISENTANGLING PATIENT, DISEASE AND TREATMENT EFFECTS,
M. Bentvelzen, S. El Bouhaddani, S. C. Mastbergen, J. Spierings, H. E. Vonkeman, S. C. Mooij, L. G. Schipper, A. Herman, F. Lafeber, H. W. Uh, P. M. J. Welsing on behalf of TOFA-PREDICT Author Group: Astrid van Tubergen (Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands); Harald Vonkeman (Department of Rheumatology, Medisch Spectrum Twente Hospital, Enschede, The Netherlands); Shasti Mooij (Department of Rheumatology, Medisch Spectrum Twente Hospital, Enschede, The Netherlands); Arno van Kuijk (Amsterdam Rheumatology and Immunology Center/ Reade, Amsterdam, The Netherlands; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands); Tim Jansen (Department of Rheumatology, VieCuri MC, Venlo, The Netherlands); Antoaneta Comarniceanu (Department of Rheumatology, VieCuri MC, Venlo, The Netherlands); Lydia Schipper (Department of Rheumatology, Elisabeth- TweeSteden Hospital, Tilburg, The Netherlands); Sandra van Bijnen (Department of Rheumatology, Elisabeth- TweeSteden Hospital, Tilburg, The Netherlands); Siska Wijngaarden (Department of Rheumatology, Gelre Hospitals, Apeldoorn, The Netherlands); Amin Herman (Department of Rheumatology, Antonius Hospital, Utrecht, The Netherlands); Nazira Jahangier (Department of Rheumatology, Tergooi Hospital, Hilversum, The Netherlands); Kavish Bhansing (Department of Rheumatology, St. Jansdal Hospital, Harderwijk, The Netherlands); Marc Kok (Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands); Radjesh Bisoendial (Department of Rheumatology and Clinical Immunology, Maasstad Hospital, Rotterdam, The Netherlands); Lenny Geurts – van Bon (Department of Rheumatology and Clinical Immunology, ZGT, Almelo, The Netherlands)
|
|
2024 POS0994
|
PRO-INFLAMMATORY TISSUE-RESIDENT FIBROBLASTS PROMOTE GLANDULAR DISEASE IN SJÖGREN`S SYNDROME,
O. Pastva, M. Brunner, D. Guggisberg, M. Kreuzer, L. Moser, M. Sprecher, M. Elhai, R. Bruggmann, B. Maurer, K. Klein
|
|
2024 POS0995
|
SINGLE CELL RNA-SEQ CHARACTERIZATION OF CIRCULATING IMMUNE CELLS IN SJOGREN’S SYNDROME: COMPARISON TO SLE AND RHEUMATOID ARHTRITIS,
J. L. Andréu Sánchez, A. Gómez-Gómez, Y. Guillen Montalban, P. Vela Casasempere, M. P. Álvarez Hernandez, I. Braña Abascal, M. Fernandez Castro, M. A. López Lasanta, J. M. Pego Reigosa, C. Marras Fernandez Cid, M. J. Garcia-Villanueva, F. Blanco, P. Carreira, C. Perez-Garcia, Í. Rúa-Figueroa, H. F. Avalos Bogado, N. Boix-Martí, E. Kirkegaard_biosca, I. Alvarez Saez, N. Palau Balaña, R. Tortosa Mendez, J. Tornero Molina, A. Fernández-Nebro, J. Calvo Alén, J. D. D. Cañete Crespillo, D. Alvarez Errico, E. Choy, H. Heyn, A. Julià Cano, S. Marsal On Behalf of IMID-Consortium and Doctis-Consortium
|
|
2024 POS0999
|
METABOLOMIC PROFILING OF SALIVA IN PRIMARY SJÖGREN’S SYNDROME PATIENTS: A COMPREHENSIVE ANALYSIS USING HIGH-RESOLUTION 1H 1D NMR SPECTROSCOPY AND MASS SPECTROMETRY,
L. Chatzis, I. Barla, S. Kaltsi, D. Benaki, M. I. Saridaki, A. Mina, K. Tsezou, A. V. Goules, N. Thomaidis, E. Gikas, E. Mikros, A. Tzioufas
|
|
2024 POS1002
|
CONTRIBUTION OF METABOLOMICS AND B LYMPHOCYTE TRANSCRIPTOME IN THE NEW SJÖGREN’S DISEASE MOLECULAR CLASSIFICATION,
C. Iperi, A. Fernández-Ochoa, J. O. Pers, N. Foulquier, G. Barturen, M. Alarcon-Riquelme, D. Cornec, A. Bordron, C. Jamin
|
|
2024 POS1048
|
PATIENTS WITH RHEUMATOID ARTHRITIS HAVE ACCELERATED AGE-RELATED STRUCTURAL CHANGES IN THE BRAIN,
C. Wasén, Z. Dai, M. Erlandsson, K. M. E. Andersson, S. T. Silfverswärd, M. I. Bokarewa, R. A. Heckemann
|
|
2024 POS1063
|
EXPLORING GENETIC AND IMMUNE CELL DYNAMICS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH EPSTEIN–BARR VIRUS INFECTION VIA COMBINED MICROARRAY AND SINGLE-CELL RNA SEQUENCING ANALYSES,
J. Gui, M. Fang, J. Tu, X. Chen, L. Sun
|
|
2024 POS1066
|
SINGLE-CELL MULTI-OMIC EVALUATION OF DIFFERENCES IN T CELL POPULATIONS IN PROGRESSION OF SLE,
A. Bylinska, M. Smith, R. Lu, B. Jones, C. Guthridge, M. C. Marlin, C. Wright, S. Macwana, W. Dejager, M. Beel, C. J. Lessard, C. Arriens, J. Merrill, J. A. James, J. M. Guthridge
|
|
2024 POS1094
|
AUTOANTIBODIES TO 14-3-3Η IN AXIAL SPONDYLOARTHRITIS,
A. Marotta, W. P. Maksymowych, S. Wichuk, N. Sidhu
|
|
2024 POS1136
|
THE NEUTROPHIL-LYMPHOCYTE RATIO (NLR) OF PERIPHERAL BLOOD IS AN INDICATOR OF ESTIMATING INTERFERON SIGNATURE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
Y. Koyama, Y. Sato, Y. Nakai, M. Tokunaga
|
|
2024 POS1148
|
MECHANISMS OF PAIN MODULATION BY JAK INHIBITION: UPADACITINIB REGULATES PAIN-RELATED PATHWAYS AND BDNF EXPRESSION IN MICROGLIAL CELLS,
L. Navarini, M. Vomero, E. Corberi, O. Berardicurti, G. Imperatori, D. Currado, L. Kun, F. Trunfio, F. Saracino, L. Lamberti, A. Marino, L. La Barbera, P. Krashia, M. D’amelio, R. Giacomelli
|
|
2024 POS1166
|
PURSUING THE BEST TYPE I INTERFERON-STIMULATED GENE SIGNATURE SUITABLE FOR EVALUATING SYSTEMIC LUPUS ERYTHEMATOSUS ACTIVITY,
S. Sumitomo, H. Oka, H. Shimizu, T. Iwasaki, M. Kanamori, H. Nishioka, K. Ohmura
|
|
2024 POS1178
|
ASSOCIATIONS BETWEEN ALTERED GUT MICROBIOME, METABOLITES, AND HLA-B27 POSITIVITY IN PATIENT WITH ANKYLOSING SPONDYLITIS,
T. Huang, Y. Chen, X. Wang, H. Yang, L. Zhang, K. Hashimoto, Y. Luo, Y. Pu, Y. Liu
|
|
2024 POS1201
|
CHI3L1 AND CHI3L2 REPRESENT TWO HIGHLY SPECIFIC SYNOVIAL FIBROBLAST-RELATED BIOMARKERS IN SEROPOSITIVE AND –NEGATIVE RHEUMATOID ARTHRITIS,
A. Khmelevskaya, M. Houtman, K. Bürki, C. Pauli, H. Mohammadian, M. Angeli, O. Distler, A. Ciurea, D. Veale, A. Ramming, U. Fearon, C. Ospelt, R. Micheroli
|
|
2024 POS1205
|
CELLULAR AND MOLECULAR MECHANISMS UNDERLYING THE EFFECTS OF BIOLOGIC AND TARGETED SYNTHETIC DMARDS IN RHEUMATOID ARTHRITIS IMMUNE CELLS: EX VIVO STUDIES,
C. Lopez-Pedrera, S. Corrales-Díaz Flores, C. Perez-Sanchez, L. Muñoz-Barrera, R. Ortega-Castro, J. Calvo-Gutiérrez, C. Aranda-Valera, M. L. Ladehesa-Pineda, F. U. Pilar, I. Sanchez-Pareja, M. C. Ábalos-Aguilera, D. Ruíz-Vilchez, C. Merlo-Ruiz, M. Á. Aguirre-Zamorano, T. Cerdó, C. López-Medina, N. Barbarroja, M. Alarcon-Riquelme, A. Escudero-Contreras
|
|
2024 POS1208
|
EXPRESSION OF THE GLUCOCORTICOID RECEPTOR IN SYNOVIAL FIBROBLASTS PARALLELS THEIR ACTIVATION STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS,
N. I. Vlachogiannis, K. M. Verrou, M. P. Yavropoulou, M. G. Tektonidou, G. P. Chrousos, P. P. Sfikakis
|
|
2024 POS1215
|
ACYLCARNITINE ENRICHMENT IS A CHARACTERISTIC OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTE METABOLIC FINGERPRINT,
G. K. Vasileiadis, A. K. H. Ekwall, M. Guma, A. Rudin, Y. Zhang, C. Maglio
|
|
2024 POS1221
|
PROTEIN QUANTITATIVE TRAIT LOCI IDENTIFIES GENETIC BIOMARKERS OF PROTEINS ASSOCIATED WITH MEASURES OF MYOCARDIAL FIBROSIS IN NEW-ONSET, TREATMENT NAÏVE RHEUMATOID ARTHRITIS,
A. I. Mohammed, R. R. Shukla, C. F. Yap, S. Plein, D. Plant, M. Buch
|
|
2024 POS1222
|
COMPUTATIONAL TRANSCRIPTOMIC ANALYSIS REVEALS DYSREGULATION OF THE NAD+ PATHWAY IN CHRONIC INFLAMMATORY RHEUMATIC DISEASES,
B. Vellón-García, M. Pérez-Rodriguez, M. Llamas-López, Á. A. Puerto-Nuñez, L. M. Sánchez-Mendoza, J. A. González-Reyes, J. A. Moreno, M. I. Burón, A. Llamas-Urbano, J. M. Martínez-Moreno, Y. Hanaee, I. Arias-de la Rosa, C. López-Medina, E. Collantes-Estevez, N. Barbarroja, A. Escudero-Contreras, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2024 POS1229
|
DEFICIENT IMMUNOMODULATING EFFECTS OF PLATELETS IN RHEUMATOID ARTHRITIS CONTRIBUTE TO Th17 AXIS REGULATION,
G. Cafaro, M. I. Christodoulou, S. Cipriani, M. Sebastiano, C. Perricone, O. Bistoni, R. Gerli, E. Bartoloni
|
|
2024 POS1230
|
SERUM LIPIDOMIC PROFILES IDENTIFY POTENTIAL DIAGNOSTIC BIOMARKER FOR SERONEGATIVE RHEUMATOID ARTHRITIS VERSUS HAND OSTEOARTHRITIS,
W. U. Kim, J. H. Koh, R. LI, Y. Choi
|
|
2024 POS1319
|
PERSONALIZED LIPIDOMIC AND PROTEOMIC PROFILES IDENTIFY APS PATIENTS WITH DISTINCTIVE ATHEROTHROMBOTIC RISK,
B. Vellón-García, C. Perez-Sanchez, M. Á. Aguirre-Zamorano, S. Corrales-Díaz Flores, I. Sanchez-Pareja, L. Muñoz-Barrera, T. Cerdó, L. Pérez-Sánchez, P. Ortiz-Buitrago, C. Merlo-Ruiz, D. Ruiz-Vilchez, M. D. C. Abalos-Aguilera, M. L. Ladehesa-Pineda, C. López-Medina, N. Barbarroja, A. Escudero-Contreras, R. Ortega-Castro, J. M. Villalba, C. Lopez-Pedrera
|
|
2024 POS1391
|
UTILITY OF MOUSE MODELS OF LUPUS FOR CLINICAL RESEARCH AND DRUG TESTING,
M. Rivas-Torrubia, M. Morell, Z. Makowska, J. Kageyama, A. Buttgereit, J. Lindblom, P. Cytometry Consortium, I. Parodis, L. Beretta, R. Lesche, F. Mcdonald, M. Alarcon-Riquelme, G. Barturen On Behalf of Genetics of Complex Diseases
|
|
2024 POS1393
|
LUPUS PREGNANCIES ARE CHARACTERIZED BY A DISTINCT INFLAMMATORY TRANSCRIPTOMIC SIGNATURE PARTLY DRIVEN BY SPECIFIC MIRNA,
E. Schmauch, P. Georgel, R. Carapito, A. Pichot, G. Alsaleh, N. Paul, A. Molitor, C. Mutter, J. E. Gottenberg, R. Felten, S. Bahram, J. Sibilia, M. Scherlinger
|
|
2024 POS1396
|
ONTOLOGICAL ANALYSIS OF CO-EXPRESSED GENES IN THE PATHOGENESIS OF RENAL FIBROSIS IN THE CONTEXT OF LUPUS NEPHRITIS,
R. Martinez-Canales, M. Montelongo Rojas, S. E. Rojas Gutierrez, C. Elizondo Solis, N. Macias-Segura, M. Salinas Carmona
|
|
2024 POS1400
|
PROTEOMIC ANALYSIS SUGGESTS A TWO-PHASE IMMUNE RESPONSE TO B CELL DEPLETION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
P. Intapiboon, L. M. Carter, J. Arnold, K. Mahmoud, M. Y. Md Yusof, E. M. Vital
|
|
2024 POS1401
|
INTEGRATION OF PROTEOMIC AND METABOLOMIC ANALYSES FOR STRATIFYING SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: UNVEILING SIGNATURES ASSOCIATED WITH CARDIOVASCULAR RISK AND RENAL COMPLICATIONS,
C. Lopez-Pedrera, T. Cerdó, L. Woodridge, C. Perez-Sanchez, M. Á. Aguirre-Zamorano, A. Rahman, F. Farinha, R. Ortega-Castro, P. Seguí Azpilcueta, I. Sanchez-Pareja, L. Muñoz-Barrera, S. Corrales-Díaz Flores, C. Merlo-Ruiz, D. Ruiz-Vilchez, M. C. Ábalos-Aguilera, F. U. Pilar, N. Barbarroja, C. López-Medina, A. Escudero-Contreras, E. Jury
|
|
2024 POS1403
|
IGG AND IGA AUTOANTIBODIES AGAINST NOVEL ANTIGEN SPECIFICITIES IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH DIFFERENTIAL UNDERLYING MECHANISMS HERALDING PROMISE FOR EARLY DIAGNOSIS,
I. Parodis, D. Nikolopoulos, J. Lindblom, L. Beretta, N. Çetrez, J. Peyper, G. Barturen, P. J. Jakobsson, M. Alarcon-Riquelme, H. Idborg
|
|
2024 POS1404
|
NOVEL IGG AND IGA AUTOANTIBODIES DIFFERENTIATING SYSTEMIC LUPUS ERYTHEMATOSUS FROM PRIMARY SJÖGREN’S SYNDROME AND SYSTEMIC SCLEROSIS,
I. Parodis, D. Nikolopoulos, J. Lindblom, L. Beretta, N. Çetrez, J. Peyper, G. Barturen, P. J. Jakobsson, M. Alarcon-Riquelme, H. Idborg
|
|
2024 POS1406
|
MODULAR GENE EXPRESSION CHANGES IN THE SLEEK PHASE 2 STUDY OF UPADACITINIB AND ABBV-599 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
J. Merrill, M. D. Catalina, I. Filip, A. Iyer, P. K. Wung, K. D’silva, M. C. Gaudreau
|
|
2024 POS1411
|
ALTERNATION OF GASTROINTESTINAL TRACT MICROBIAL COMPOSITION IN PATIENTS WITH SYSTEMIC SCLEROSIS AND PREDICTINGTHEIR FUNCTIONAL CAPABILITIES,
S. J. Moon, H. Son
|
|
|
[1]
|
'-omics, Artificial Intelligence
|
|
|
| 2024 |
|
2024 POS0237
|
TRANSCRIPTOMIC LANDSCAPES IN IDIOPATHIC INFLAMMATORY MYOPATHY: DIVERGENT PATHWAYS AND IMMUNE CELLS POTENTIALLY DRIVING MUSCLE DAMAGE.,
S. Izuka, N. Umezawa, T. Komai, Y. Sugimori, N. Kimura, F. Mizoguchi, Y. Fujieda, K. Ninagawa, T. Iwasaki, K. Suzuki, T. Takeuchi, K. Ohmura, T. Mimori, T. Atsumi, E. Kawakami, A. Suzuki, Y. Kochi, K. Yamamoto, S. Yasuda, T. Okamura, M. Ota, K. Fujio on behalf of AMED Practical Research Project for Allergic Diseases and Immunology
|
|
|
[1]
|
'-omics, Biomarkers
|
|
|
|
|
[1]
|
ANCA associated vasculitis
|
|
|
| 2024 |
|
2024 POS0218
|
VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OF TR-VaS COHORT,
H. Kocaayan, E. Durak Ediboglu, T. Demirci Yildirim, B. Özdemir Ulusoy, T. S. Öğüt, B. Firlatan, D. Ozgur, M. Kiziltepe, R. C. Kardaş, D. Sahin, C. Akleylek, Z. Dündar, N. S. Yasar Bilge, E. Erpek, P. Akyüz Dağli, Z. Özsoy, E. Bilgin, E. C. Bolek, G. Ayan, B. Armagan, A. Erden, H. Küçük, L. Kiliç, A. Cefle, A. Babayigit, A. Ates, M. E. Tezcan, F. Erbasan, C. Bes, V. Yazisiz, O. Karadag, F. Onen, A. Omma, S. Akar on behalf of Turkish Vasculitis Study Group (TRVaS)
|
|
|
[176]
|
Adaptive immunity
|
|
|
| 2024 |
|
2024 AB0022
|
SEASONAL DISTRIBUTION IN ADULT ONSET STILL’S DISEASE AND ITS RELATIONSHIP WITH THE DISEASE COURSE,
R. Yildirim, M. Dinler, B. C. Uludogan, N. S. Yasar Bilge, T. Kaşifoğlu
|
|
2024 AB0070
|
DURABILITY OF CELLULAR AND HUMORAL IMMUNITY FOLLOWING A FIFTH SARS-CoV-2 VACCINE IN PATIENTS WITH INFLAMMATORY JOINT DISEASES ON IMMUNOSUPPRESSIVE THERAPIES,
H. S. Ørbo, I. Jyssum, A. T. Tveter, A. Lind, V. P. Dimova-Svetoslavova, I. E. Christensen, J. Sexton, K. H. Bjørlykke, T. K. Kvien, E. A. Haavardsholm, K. K. Jørgensen, S. Aarrestad Provan, S. W. Syversen, G. L. Goll
|
|
2024 AB0077
|
IMMUNOGENICITY AND SAFETY PROSPECTIVE STUDY OF ANTI-SARS-CoV-2 MRNA VACCINATION IN A REAL-LIFE SETTING OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS,
M. Ferraioli, I. Prevete, M. S. Chimenti, L. De Marco, S. Meschi, D. Mariotti, A. Aiello, V. Vanini, G. Cuzzi, A. Salmi, F. Maggi, D. Goletti, G. D. Sebastiani
|
|
2024 AB0172
|
SINGLE-CELL PROFILING IDENTIFIES IL1BHI MACROPHAGES ASSOCIATED WITH INFLAMMATION IN PD-1 INHIBITOR-INDUCED INFLAMMATORY ARTHRITIS,
H. Yang, Z. Zhou, X. Zhou, X. Jiang, M. Wang, X. Zhang
|
|
2024 AB0175
|
ALTERATIONS IN JAK-STAT SIGNALING PATHWAY ARE FOUND IN PERIPHERAL BLOOD LEUKOCYTES FROM UNTREATED EARLY ARTHRITIS PATIENTS,
R. L. Teixeira, A. R. Faísca, C. Tomé, V. C Romão, J. E. Fonseca, I. Alcobia, R. A. Moura
|
|
2024 AB0326
|
ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE,
C. Wang, H. Wang, R. Su, X. Gu
|
|
2024 AB0396
|
MODULATION OF PERIPHERAL BLOOD T AND INNATE LYMPHOCYTES BY APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS AND CLINICAL THERAPEUTIC RESPONSE,
M. De Santis, A. Tonutti, F. Motta, N. Isailovic, A. Ceribelli, G. M. Guidelli, M. Caprioli, D. Renna, N. Luciano, C. Selmi
|
|
2024 AB0529
|
JAK-INHIBITORS PROMOTE INSULIN SENSITIVITY AND ENHANCE IMMUNOSUPPRESSIVE EFFECT OF INSULIN ON CD4+ T CELLS OF PATIENTS WITH RHEUMATOID ARTHRITIS,
M. Erlandsson, M. Tuameh, V. Chandrasekaran, K. M. E. Andersson, M. I. Bokarewa
|
|
2024 AB0655
|
FAMILIAL AGGREGATION OF AUTOIMMUNE DISEASES IN PATIENTS WITH RHEUMATOID ARTHRITIS- A ROMANIAN STUDY,
C. Alexandru, M. Bojinca, S. Bezedica, I. Ancuta, C. Dumitrașcu, C. Cobilinschi, C. C. Iorgus, A. Bobirca
|
|
2024 AB0706
|
CIRCULATING HELPER T AND INNATE LYMPHOID CELLS IN A COHORT OF bDMARDs-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT,
P. Semeraro, F. Angeli, A. Caproli, F. Franceschini, P. Airo’, S. Piantoni
|
|
2024 AB0722
|
EFFICACY, TOXICOLOGY, BIODISTRIBUTION, AND MECHANISTIC INSIGHTS OF APT001 IN COLLAGEN-INDUCED ARTHRITIS – A NOVEL CITRULLINATED PEPTIDE-APTAMER NANOPARTICLE DRUG CANDIDATE FOR RHEUMATOID ARTHRITIS,
K. Astakhova, T. W. Kragstrup, A. H. Bustos, N. B. Pedersen, C. Mahony, A. P. Croft, M. H. Clausen
|
|
2024 AB0723
|
PHARMACOKINETICS OF ADALIMUMAB IN CYNOMOLGUS MONKEYS FOLLOWING DOSING WITH BHV-1300, A FIRST-IN-CLASS MOLECULAR DEGRADER OF IgG,
E. Dierks, P. Ackerman, D. Heller, A. Bunin, F. Engler, B. Gavin, D. Pirman, B. Car, I. Qureshi, V. Coric
|
|
2024 AB0733
|
EPIGENETIC CONTROL OF GENES AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT IN CD4+ T CELLS OF PATIENTS WITH RHEUMATOID ARTHRITIS,
M. I. Bokarewa, K. M. E. Andersson, V. Chandrasekaran, M. Erlandsson, S. T. Silfverswärd
|
|
2024 AB0736
|
DEVELOPMENT AND APPLICATION OF EPITOPESCAN, A PYTHON3 TOOLSET FOR MUTATION TRACKING IN SARS-CoV-2 IMMUNOGENIC EPITOPES RESTRICTED BY THE RHEUMATOID ARTHRITIS SUSCEPTIBILITY ALLELE HLA-DRB1*04:01,
A. Kovalenko, S. Viatte
|
|
2024 AB0739
|
INCREASED FREQUENCY AND CYTOTOXICITY OF TERMINALLY DIFFERENTIATED CD4 T CELLS ARE ASSOCIATED WITH CMV POSITIVITY IN ACTIVE RHEUMATOID ARTHRITIS,
S. A. Yeoh, M. Ehrenstein, A. Akbar, D. Mccluskey, L. Chocarro, W. T. MA, D. Janman, J. Evans, E. Hawkins, L. Tomson
|
|
2024 AB0753
|
VALUE OF T-CELL SUBSETS IN PREDICTING RESPONSE TO MTX AND ANTI-TNF IN EARLY RA,
F. Tastekin, B. Saleem, F. Ponchel, P. Emery
|
|
2024 AB0754
|
ANTI-IL-6 RECEPTOR INTERVENTION STRONGLY ATTENUATES MACROPHAGE AND T-CELL ACTIVITY,
D. Sinkeviciute, S. F. Madsen, M. Bajaj, P. Drobinski, M. Karsdal, A. C. Bay-Jensen
|
|
2024 AB0773
|
POTENTIAL MECHANISMS OF IMPROVEMENT IN RHEUMATOID ARTHRITIS WITH COMBINED MILK ANTIBODY AND PREBIOTIC TREATMENT: ENDOTOXIN MASKING AND ENDOTOXIN TOLERANCE,
K. Kitamura, K. Katayama, H. Shionoya
|
|
2024 AB0782
|
IN VITRO EFFECT OF UPADACITINIB AND TOFACITINIB ON PERIPHERAL BLOOD LEUKOCYTES FROM PATIENTS WITH EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS,
R. L. Teixeira, C. A. Bento, C. Tomé, V. C Romão, J. E. Fonseca, I. Alcobia, R. A. Moura
|
|
2024 AB0784
|
STROMAL B-CELL CROSSTALK PROMOTES THE ESTABLISHMENT OF SYNOVIAL EBV+B-CELL NICHES THROUGH TYPE I INTERFERON SIGNALLING ACTIVATION,
M. Caliste, E. Prediletto, E. Corsiero, L. Jagemann, C. Pitzalis, M. Bombardieri
|
|
2024 AB0796
|
KLRB1 EXPRESSION SIGNIFIES CD4+ T CELL ACTIVATION AND IS HEIGHTENED IN PRIMARY SJÖGREN’S SYNDROME PATIENTS,
C. Liu, Z. Zhang, A. Bahabayi, P. Wang
|
|
2024 AB0801
|
GLYCOLYSIS EXPRESSION IN LYMPHOCYTES INFILTRATING SJOGREN’S DISEASE SALIVARY GLANDS. A PRELIMINARY ANALYSIS ON THE EXPRESSION OF THE GLUCOSE TRANSPORTER GLUT-1,
E. Simoncelli, S. Colafrancesco, E. Pontarini, M. Villa, I. Fischetti, L. Mastromanno, R. Izzo, A. Gattamelata, F. Conti, M. Bombardieri, R. Priori
|
|
2024 AB0805
|
DYSREGULATION OF TREG CELLS IN PATIENTS WITH PRIMARY SJOGREN’S SYNDROME,
M. H. Chen, Y. A. Chang
|
|
2024 AB0806
|
HUMORAL RESPONSES AGAINST HDL ARE LINKED TO UNFAVORABLE LIPOPROTEIN TRAITS AND LIPID SPECIES IN PRIMARY SJÖGREN SYNDROME,
J. Rodríguez-Carrio, S. Suárez, P. López, Á. I. Pérez-Álvarez, L. Caminal-Montero, A. Suárez
|
|
2024 AB0843
|
GUT MICROBIOME DYSBIOSIS PROMOTES THE PROGRESSION OF PRIMARY DRY SYNDROME BY DISRUPTING IMMUNE HOMEOSTASIS,
L. Shang, H. Y. Wen, Z. Liang, N. Wang, C. Gao, J. Luo
|
|
2024 AB0850
|
RITUXIMAB IN CRYOGLOBULINEMIC VASCULITIS SECONDARY TO PRIMARY SJÖGREN’S SYNDROME: THE EARLIER THE BETTER. A SINGLE-CENTER RETROSPECTIVE COHORT STUDY,
S. Longhino, E. Treppo, V. Manfrè, M. T. Rizzo, S. De Vita, L. Quartuccio
|
|
2024 AB0860
|
DESCRIPTION OF THE CLINICAL, HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF PATIENTS WITH SICCA SYNDROME WITH MINOR SALIVARY GLAND BIOPSY AND FOCUS SCORE ≥1,
A. Lamos, S. Rivadeneira, J. P. Castañeda-Gonzalez, A. Escobar, A. M. Arredondo-González, J. Cajamarca-Baron, H. Cubides, J. F. Polo Nieto, C. Ibañez, G. S. Rodríguez-Vargas, R. Parra-Medina, J. J. Capasso, A. Rojas-Villarraga
|
|
2024 AB0876
|
PREVALENCE OF SPONDYLOARTHRITIS-RELATED LESIONS AT SACROILIAC JOINTS IN POSTPARTUM WOMEN AND INFLAMMATORY BOWEL DISEASE PATIENTS,
A. Maroof, S. Nizamaddin, A. Delamy, D. Kiefer, M. Alnimer, X. Baraliakos
|
|
2024 AB0977
|
INVESTIGATING THE EFFECTS OF DISEASE ACTIVITY AND HYPOXIA ON IMMUNE RESPONSES TO GUT BACTERIA IN ANKYLOSING SPONDYLITIS,
E. Peyroux, S. Stebbings
|
|
2024 AB0993
|
LUPUS LOW DISEASE ACTIVITY STATE ATTAINMENT WITH ANIFROLUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND LYMPHOPENIA,
E. Morand, E. M. Vital, S. Manzi, J. Knagenhjelm, C. Lindholm
|
|
2024 AB0995
|
ABNORMALITIES OF CIRCULATING CD4+T CELL SUBPOPULATIONS IN PATIENTS WITH LATE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS AND ITS CLINICAL SIGNIFICANCE,
L. Xue, H. Q. Niu
|
|
2024 AB1072
|
INFECTIOUS EVENTS AND INITIAL SELENA-SLEDAI POSITIVELY CORRELATE WITH AN INCREASED RISK OF FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Borrelli, N. Rashidy, A. Quinternetto, I. Vitali, F. Meli, M. Mazzola, E. Saracco, F. Corradi, I. Badiu, L. Lo Sardo, S. Nicola, L. Brussino
|
|
2024 AB1111
|
GLYCOSYLATION OF γδT CELLS AS AN ESSENTIAL PLAYER IN THE IMMUNOPATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS,
B. Santos-Pereira, I. Alves, A. Campar, A. Marinho, C. Vasconcelos, S. Pinho
|
|
2024 AB1116
|
AGE-ASSOCIATED INCREASE IN CYTOTOXIC T LYMPHOCYTE-ASSOCIATED PROTEIN 4 (CTLA-4) EXPRESSION ON EFFECTOR T CELLS AND ITS ROLE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Cheong, M. Wasser, K. Nay Yaung, A. Law Hui Nee, N. K. H. Khoo, P. Kumar, T. Arkachaisri, S. L. Poh, J. Y. Leong, J. Thumboo, A. Low, S. Albani, J. G. Yeo
|
|
2024 AB1119
|
REPRESSION OF ID3 AGGRAVATES LUPUS PHENOTYPES IN MURINE MODELS VIA ABERRANT B CELL DIFFERENTIATION,
Y. Park, D. S. Kim, M. L. Cho, S. K. Kwok
|
|
2024 AB1126
|
REBAMIPIDE ATTENUATES RENAL MANIFESTATIONS VIA ANTIOXIDANT EFFECTS ON PODOCYTES IN AN ANIMAL MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSUS,
Y. Park, Y. S. Song, D. S. Kim, S. G. Jang, S. K. Kwok
|
|
2024 AB1128
|
SINGLE-CELL RNA SEQUENCING REVEALS CROSS-DISEASE CHARACTERIZATIONS OF TREATMENT-NAÏVE AUTOIMMUNE DISEASES AND DISTINCT INTERFERON SIGNATURES IN SYSTEMIC LUPUS ERYTHEMATOSUS,
Z. Zhang, Y. Fan, Y. Geng, X. Ye, J. Zhao, H. Huang, J. Zhang
|
|
2024 AB1133
|
ASSESSMENT OF RELATIVE IMMUNE CELL POPULATIONS PRESENT IN TUBULOINTERSTITIAL AND GLOMERULAR TISSUE OF PATIENTS WITH LUPUS NEPHRITIS,
R. Martinez-Canales, M. Montelongo Rojas, S. E. Rojas Gutierrez, C. Elizondo Solis, N. Macias-Segura, M. Salinas Carmona
|
|
2024 AB1135
|
FLUCTUATING CHANGES IN T CELLS DURING PREGNANCY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
V. Röhm, J. Henes, R. Klein, A. C. Pecher
|
|
2024 AB1147
|
DIFFERENTIAL RECOGNITION OF TOPOISOMERASE 1 (TOP1)-DNA COMPLEXES MODULATES ACTIVATION OF TOP1-REACTIVE B CELLS IN SYSTEMIC SCLEROSIS,
S. Neppelenbroek, C. Wortel, D. Van Rijswijck, S. Liem, M. Wetzels, A. Heck, C. Fehres, J. K. De Vries-Bouwstra, R. E. M. Toes, H. U. Scherer
|
|
2024 AB1165
|
LAG-3 IS IMMUNE-PROTECTIVE IN SYSTEMIC SCLEROSIS,
M. Aspari, S. R. Greisen, V. Ong, K. Soendergaard, E. Naeser, C. P. Denton, D. Abraham, B. Deleuran on behalf of Bent Deleuran’s Group
|
|
2024 AB1217
|
SYSTEMIC SCLEROSIS UNDER RITUXIMAB: DIGITAL ULCERS AS A POSSIBLE INFECTIOUS RISK FACTOR RATHER THAN IgG LEVELS,
V. De Castro Grotti, A. Pugliesi, G. Vilaça Gutierrez, R. Da Rocha Jorge, R. Suwa Marques, M. Fernanda Zacarin, A. P. Del Rio, M. Paula Souza Dos Santos, Z. Sachetto
|
|
2024 AB1258
|
EFFECTIVENESS OF DUPILUMAB ON REFRACTORY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A CLINICAL AND CYTOLOGICAL STUDY,
F. Davanzo, R. Padoan, L. Iorio, E. Fiorin, M. Codirenzi, A. Doria
|
|
2024 AB1274
|
PROSPECTIVE CELLULAR BIOMARKERS IN ANCA ASSOCIATED VASCULITIS: A PILOT STUDY,
J. Videman, A. Skoumalova, M. Dudkova, M. Skacelova, A. Petrackova, Z. Mikulkova, E. Kriegova, P. Horak
|
|
2024 AB1280
|
SERUM P-GLYCOPROTEIN AND MONOMERIC CRP ARE INCREASED IN TAKAYASU ARTERITIS THAN IN HEALTHY CONTROLS AND MONOMERIC CRP IS A NOVEL MARKER OF DISEASE ACTIVITY IN TAKAYASU ARTERITIS,
D. P. Misra, D. R. Thakare, K. Singh, S. Balakrishnan, U. Rathore, T. Qamar, D. Singh
|
|
2024 AB1296
|
CD8 CELL-DERIVED GRANZYME B MAY BE A PREDICTOR FOR CORONARY ARTERY INVOLVEMENT AND MACE IN TAKAYASU ARTERITIS PATIENTS,
L. Pan, T. LI
|
|
2024 AB1340
|
IMMUNOGENICITY AND SAFETY OF PRIME-BOOST PNEUMOCOCCAL 13-VALENT CONJUGATE PCV13 AND 23-VALENT POLYSACCHARIDE VACCINE PPSV23 IN PATIENTS WITH PSORIATIC ARTHRITIS AND SYSTEMIC SCLEROSIS: A LONGITUDINAL STUDY,
O. Elkayam, V. Furer, I. Litinsky, B. Meek, A. Reiners, S. Pel, Y. Friedlander
|
|
2024 AB1343
|
NO WANING OF PNEUMOCOCCAL VACCINE RESPONSES OVER TIME IN PEOPLE WITH INFLAMMATORY ARTHRITIS: FINDINGS FROM A SINGLE CENTRE COHORT,
K. Bechman, D. Nagra, C. Baldwin, M. A. Adas, M. Russell, I. Karafotias, M. Gibson, S. Patel, R. Shah, Z. Yang, E. Alveyn, S. Norton, J. Galloway
|
|
2024 AB1368
|
UNRAVELLING THE (T)REGULATORY POWER OF GLYCANS IN MYASTHENIA GRAVIS: MECHANISM AND POTENTIAL CLINICAL APPLICATIONS,
Â. Fernandes, M. M. Vicente, P. Carneiro, M. I. Leite, M. E. Santos, S. Pinho on behalf of Immunology, Cancer & GlycoMedicine
|
|
2024 AB1385
|
JAKINIBS EFFECTS ON SUBSETS OF THE INNATE IMMUNE SYSTEM,
J. J. Fernández Cabero, C. Lasa-Teja, A. Comins-Boo, D. San Segundo, M. López Hoyos, R. Blanco
|
|
2024 AB1432
|
DISTINCT IMMUNOLOGICAL SIGNATURES OF AIIRD PATIENTS FROM IMMUNOPHENOTYPING ANALYSIS,
K. J. Park, Y. N. Cho, H. M. Jin, H. J. Jung, H. M. Jeong, S. E. Choi, J. H. Kang, D. J. Park, T. J. Kim, S. S. Lee, Y. W. Park
|
|
2024 AB1434
|
CELLULAR RESPONSE TO CHEMICAL STIMULUS AND REACTIVE OXYGEN SPECIES ASSOCIATED PATHWAYS IN THE PATHOGENESIS IN SJÖGREN SYNDROME, SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER AUTOIMMUNE DISEASES: A MOLECULAR PATHWAY ENRICHMENT ANALYSIS,
S. E. Rojas Gutierrez, R. Martinez-Canales, C. Elizondo Solis, M. Gelinas Martin del Campo, M. Montelongo Rojas, G. Banda Morales, A. Montoya Rosales, N. Macias-Segura, M. Salinas Carmona
|
|
2024 AB1437
|
NON-PDL1 BLOCKING PD1 AGONISTIC ANTIBODIES MAY INDUCE PRO-INFLAMMATORY CYTOKINES PRODUCTION IN VITRO,
Y. Orlovsky, L. Y. Hao, M. Swiecki, S. Cole, S. Dutta, I. White
|
|
2024 AB1537
|
MULTICENTRIC ANALYSIS OF RHEUMATOLOGIC ADVERSE EVENTS RELATED TO CANCER IMMUNOTHERAPY IN TWO SPANISH HOSPITALS,
A. Llobell-Uriel, I. Gonzalez-Mazon, S. Retamozo, C. Secada-Gómez, A. Martín-Gutiérrez, A. García Castaño, E. Gallardo-Diaz, A. Gómez-Centeno, L. Fernandez-Morales, J. Gratacós, R. Blanco
|
|
2024 AB1713
|
FLUCTUATION OF ANTINUCLEAR ANTIBODIES IN PATIENTS WITH JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A MONOCENTRIC LONGITUDINAL STUDY,
M. R. Pellico, I. Suardi, G. Carrea, S. Costi, L. M. Argolini, M. Cornalba, A. Marino, M. Gattinara, R. F. Caporali, M. Gerosa, C. Chighizola
|
|
2024 LBA0007
|
SAFETY AND EFFICACY OF DARATUMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS – A SINGLE-CENTER PHASE 2 OPEN-LABEL TRIAL,
T. Alexander, L. Ostendorf, J. Zernicke, J. Klotsche, U. Schneider, R. Biesen, R. Kempkens, Q. Cheng, L. Khodadadi, F. Heinrich, P. Durek, G. R. Burmester, M. F. Mashreghi, G. Krönke, F. Hiepe
|
|
2024 OP0004
|
AGE-ASSOCIATED B-CELLS ARE EXPANDED IN EARLY RHEUMATOID ARTHRITIS LINKED TO ATHEROSCLEROSIS AND IMMUNE CIRCUITS: A POTENTIAL ROLE AS A BIOMARKER FOR RISK STRATIFICATION,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2024 OP0020
|
IMMUNOGENICITY OF AN ADJUVANT RECOMBINANT ZOSTER VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH UPADACITINIB: 60-WEEK RESULTS FROM A RANDOMIZED SUBSTUDY,
K. L. Winthrop, S. K. Penn, J. Klaff, Y. Liu, C. García, E. Mysler, A. Wells, X. Bu, N. Khan, M. Chen, A. L. Cunningham
|
|
2024 OP0044
|
ANALYSIS OF IMMUNOGLOBULIN REPERTOIRE REVEALS ALTERED PERIPHERAL B CELL TOLERANCE CHECKPOINTS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS,
E. Marasco, A. Aquilani, I. Caiello, R. Nicolai, G. Tarantino, S. Magni-Manzoni, R. Carsetti, F. De Benedetti
|
|
2024 OP0047
|
FASTING MODULATES THE HUMAN GUT MICROBIOME AND REDUCES AN IL-17+/IFNG+ T CELL-INDUCING GUT PATHOBIONT IN PATIENTS WITH RHEUMATOID ARTHRITIS,
M. S. Pereira, K. Stuhlträger, N. Effelsberg, A. Rajput Khokhar, S. Redanz, H. Ebid, B. Hansen, C. C. Laczny, U. Löschberger, S. Bletz, J. G. Schneider, P. Wilmes, C. S. Kessler, A. Michalsen, A. Mellmann, M. A. Kriegel
|
|
2024 OP0070
|
IDENTIFICATION OF AUTOREACTIVE CYTOTOXIC T CELLS IN ANCA-ASSOCIATED VASCULITIS,
L. Van Dam, S. Younis, J. S. Moon, S. Parsafar, A. Horomanski, O. Sharpe, J. Van Leeuwen, C. Van Kooten, Y. K. O. Teng, W. Robinson
|
|
2024 OP0071
|
CX3CR1-POSITIVE CYTOTOXIC T CELLS SPECIFICALLY CONTRIBUTE TO THE PATHOGENESIS OF ELDERLY-ONSET AND DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS,
S. Wakasugi, M. Akiyama, K. Yoshimoto, R. Inukai, Y. Matsuno, S. Ishigaki, W. Alshehri, K. Saito, Y. Kaneko
|
|
2024 OP0082
|
GENE EXPRESSION PROFILE OF CD4+ T LYMPHOCYTES IS MODIFIED IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA),
R. Ríos-Garcés, N. Farran, S. Naranjo-Suárez, R. Alba-Rovira, S. Prieto-González, I. Tavera-Bahillo, E. Arismendi, R. Solans-Laqué, M. Corbera-Bellalta, F. Kamberovic, N. Visocnik, M. C. Cid, G. Espígol-Frigolé
|
|
2024 OP0096
|
ELIMINATION OF CD45RCHIGH T AND B CELLS BY ANTI-CD45RC mAb LEAD TO EFFICIENT CONTROL OF EXPERIMENTAL RHEUMATOID ARTHRITIS,
C. Bergua, M. Besnard, G. Ahmil, L. H. Ouisse, N. Vimond, A. Salama, B. Evrard, E. Brisebard, A. Collette, F. Blanchard, T. Larcher, R. Van Brempt, B. Le Goff, I. Anegon, C. Guillonneau
|
|
2024 OP0110
|
AZD1163 - FIRST-IN-CLASS ANTI-PAD2/4 BI-SPECIFIC ANTIBODY TO INHIBIT AUTOANTIGEN FORMATION IN RHEUMATOID ARTHRITIS,
D. A. Sims, J. Andrews, T. Kuriakose, L. Scaletta, L. Rajasinghe, A. Sigurdardottir, M. Strain, F. Jiang, E. Boger, L. Björsson, G. Douglas, N. White, K. Day, I. B. Mc Innes, J. Neisen, D. Close, C. Huntington, G. P. Sims
|
|
2024 OP0121
|
IMMUNE CELL SIGNATURES OF PATIENTS WITH DIFFERENT SUBTYPES OF BEHCET’S DISEASE,
Q. Fu, H. Yuan, A. Xu on behalf of Professor Chen Dong’s lab
|
|
2024 OP0139
|
THE MOLECULAR LANDSCAPE OF ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS: DISTINCT TRANSCRIPTIONAL PROFILES IN VENOUS VERSUS ARTERIAL EVENTS, WITH POTENTIAL THERAPEUTIC IMPLICATIONS,
D. Nikolopoulos, C. Loukogiannaki, G. Sentis, P. Garantziotis, T. Manolakou, N. Kapsala, M. Nikoloudaki, A. Pieta, S. Flouda, I. Parodis, G. K. Bertsias, A. Fanouriakis, A. Filia, D. Boumpas
|
|
2024 OP0154
|
TLR2 INCREASING CD8+T CELL CYTOTOXICITY BY ACTIVATING MITOPHAGY IN PRIMARY SJOGREN’S SYNDROME,
Z. Zhou, Z. Tan, N. Xiang, L. Wang, X. Li
|
|
2024 OP0171
|
SINGLE-CELL IMMUNE LANDSCAPE OF AFFECTED LUNGS FROM THE PATIENTS WITH ANTI-MDA5-POSITIVE DERMATOMYOSITIS,
Z. Chen, S. Ye, Q. Fu, X. Zhang
|
|
2024 OP0193
|
BITEING MULTI-DRUG RESISTANT RHEUMATOID ARTHRITIS WITH CD19-T CELL ENGAGERS,
L. Bucci, M. Hagen, T. Rothe, M. G. Raimondo, F. Fagni, C. Tur, A. Wirsching, J. Wacker, A. Wilhelm, J. P. Auger, M. Eckstein, S. Alivernini, A. Zoli, A. Bozec, M. A. D’agostino, G. Schett, R. Grieshaber-Bouyer
|
|
2024 OP0198
|
COMPARATIVE IMMUNOMICS OF CHILDHOOD AND ADULT-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS REVEALS DISTINCT MECHANISTIC DIFFERENCES WITH THERAGNOSTIC APPLICATIONS,
J. G. Yeo, K. Nay Yaung, A. Law Hui Nee, M. Wasser, S. L. Poh, K. L. Teh, L. Das, Y. X. Book, C. Huang, T. Arkachaisri, J. Thumboo, A. Low, S. Albani
|
|
2024 OP0221
|
LBL-047, A NOVEL AFUCOSYLATED ANTI-BDCA2/TACI FUSION PROTEIN WITH YTE MUTATION, INHIBITS THE FUNCTIONS OF BOTH pDCs AND B CELLS,
B. Wang, J. Sun, F. Li, Y. Zhu, J. Li, H. Wang, Y. Qin, G. Wu, J. Guan, J. Zhu, S. Lai, X. Kang, X. Huang, H. Ling on behalf of Nanjing Leads Biolabs
|
|
2024 OP0226
|
POTENTIAL VALUE OF THE BLOOD INTERFERON SIGNATURE IN THE DIAGNOSIS OF PEDIATRIC-ONSET SJÖGREN’S DISEASE PATIENTS,
H. Bootsma, E. Legger, A. Visser, W. Maassen, M. E. Van Gijn, W. Armbrust, F. G. M. Kroese, G. M. Verstappen
|
|
2024 OP0242
|
SYNOVIAL TISSUE AND BLOOD DEEP B/T CELL PHENOTYPING EXPLAINS RESPONSE MECHANISMS TO RITUXIMAB IN RHEUMATOID ARTHRITIS IN R4RA,
A. Surace, L. Overend, E. Sciacca, L. Fossati-Jimack, E. Jaworska, E. Pontarini, R. J. M. Bashford-Rogers, C. Pitzalis, M. Lewis
|
|
2024 OP0244
|
INVESTIGATION OF NORMAL ENTHESIS IL-17F CELL SUBSETS, PROTEIN EXPRESSION AND ITS IMPACT ON ENTHESEAL MESENCHYMAL STEM CELL FUNCTION,
N. Mcdermott, M. Harland, C. Wong, A. Altaie, T. Macleod, C. Bridgewood, P. Loughenbury, R. Dunsmuir, A. Khan, A. S. Rao, V. Borse, A. Manghera, S. Shaw, D. Mcgonagle
|
|
2024 OP0255
|
SELECT SOLUBLE MEDIATORS INFORM A REFINED LUPUS DISEASE ACTIVITY IMMUNE INDEX THAT CHARACTERIZES CLINICAL DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
M. E. Munroe, D. Blankenship, D. Defreese, A. Holloway, M. Purushothaman, W. Dejager, S. Macwana, J. M. Guthridge, S. Kamp, N. Redinger, T. Aberle, E. F. Chakravary, C. Arriens, Y. LI, H. Zeng, S. Dezzutti, P. Izmirly, U. Thanarajasingam, D. L. Kamen, J. P. Buyon, J. A. James, E. Jupe
|
|
2024 OP0267
|
REVERSE TRANSCYTOSIS IN ILEUM IS A MECHANISM WHICH COULD EXPLAIN THE HIGH LEVELS OF SERUM SECRETORY IgA IN SpA PATIENTS,
J. De Avila, A. Ramos-Casallas, D. Acero-M, C. Florez, L. Parra, L. Chila, W. Bautista-Molano, A. Beltrán, D. Jaimes, J. M. Bello-Gualtero, C. F. Pacheco Tena, P. Chalem, C. Romero-Sánchez
|
|
2024 OP0271
|
TRANSCRIPTOME AND REPERTOIRE ANALYSIS REVEALED PLASTICITY OF SYSTEMIC LUPUS ERYTHEMATOSUS REGULATORY T CELLS,
Y. Nagafuchi, M. Nakano, M. Ota, H. Hatano, T. Itamiya, T. Okamura, K. Fujio, K. Ishigaki
|
|
2024 OP0280
|
DEEP CELLULAR IMMUNE PROFILING IN PSORIATIC ARTHRITIS CORRELATES WITH IMAGING PHENOTYPES AND RESPONSE TO TARGETED ADVANCED THERAPY,
L. Eder, X. Li, S. Thib, D. Ganatra, L. Diao, V. Chandran
|
|
2024 OP0299
|
DYNAMICS OF THE B CELL RECEPTOR REPERTOIRE DURING THE PRECLINICAL PHASE OF RHEUMATOID ARTHRITIS: LONGITUDINAL STUDIES IN UNTREATED RA-RISK INDIVIDUALS (DOMINO STUDY) AND THE EFFECTS OF RITUXIMAB TREATMENT (PRAIRI STUDY),
A. Musters, A. Al-Soudi, D. Anang, I. Niewold, L. G. M. Van Baarsen, B. Van Schaik, A. Van Kampen, D. Gerlag, P. P. Tak, S. W. Tas, N. De Vries
|
|
2024 OP0302
|
CLONAL SHARING OF CD8+ T-CELLS LINKS SKIN AND JOINT INFLAMMATION IN PSORIATIC ARTHRITIS,
L. Durham, F. Humby, N. Ng, S. Ryan, R. Nuamah, K. Fung, A. Menon, P. Dhami, B. Kirkham, L. Taams
|
|
2024 OP0307
|
CELLULAR PROFILING OF SYNOVIAL FLUID IN INFLAMMATORY ARTHRITIS HIGHLIGHTS SHARED AND DISEASE-SPECIFIC CELL STATES WITH BIOLOGICAL AND DIAGNOSTIC RELEVANCE,
M. Christofi, S. Valma, L. Marshall, B. Mulhearn, T. Hussell, A. Barton, D. Rao, S. Viatte
|
|
2024 OP0313
|
THE ADAPTOR PROTEIN 3BP2 DEVELOPS SYSTEMIC LUPUS ERYTHEMATOSUS THROUGH ACTIVATION OF THE PATHOGENIC B CELLS,
S. Nawachi, T. Katsuyama, N. Kubota, Y. Terajima, K. Matsumoto, K. Hirose, K. Shidahara, T. Nakadoi, Y. Katayama, Y. Miyawaki, E. Katsuyama, M. Narazaki, Y. Matsumoto, J. Wada
|
|
2024 OP0328
|
HEALTHY AND PATHOLOGIC T-CELL AUTOREACTIVITY IN RA,
J. Stanway, A. E. Anderson, A. Pratt, J. Isaacs
|
|
2024 POS0032
|
UTILIZING HIGH-DIMENSIONALITY MASS CYTOMETRY TO DECODE COMPLEX IMMUNOPATHOGENIC NETWORK FOR POTENTIAL THERAGNOSTIC APPLICATIONS IN EARLY SYSTEMIC SCLEROSIS,
M. Noviani, P. Kumar, V. R. Chellamuthu, A. Lajam, A. Chia, K. Nay Yaung, M. Wasser, J. G. Yeo, A. Low, S. Albani
|
|
2024 POS0049
|
DETECTION AND CHARACTERIZATION OF CIRCULATING FIBROBLASTS AND FIBROCYTES BY SINGLE-CELL PROTEOMICS IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS,
M. Kyriakidi, E. K. Vetsika, N. I. Vlachogiannis, K. Verrou, M. G. Tektonidou, G. E. Fragoulis, P. P. Sfikakis
|
|
2024 POS0054
|
AN OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY TO EVALUATE RELMACABTAGENE AUTOLEUCEL, THE CD-19 DIRECTED CAR-T CELL THERAPY, FOR ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS IN CHINA,
Y. Hu, M. Heng, W. Xie, C. Mei, D. Liao, J. Shu, Z. Chen, M. MA, Z. Zhou, W. Huang on behalf of Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
|
|
2024 POS0057
|
KPG-818, A NOVEL CEREBLON MODULATOR IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RANDOMIZE, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A STUDY,
Y. Wang, R. Levin, L. Martinez, J. Pinero, R. Gupta, K. Ayesu, V. Chindalore, I. Acosta, A. Ocampo, A. Maiquez, J. Amaya, L. Reyes, C. Martinez, K. Hao, B. Liao
|
|
2024 POS0090
|
CELLULAR AND HUMORAL RESPONSES RESTORED BY UPDATED SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY,
H. S. Ørbo, A. S. Wolf, T. M. Kasahara, K. H. Bjørlykke, I. Jyssum, J. Sexton, A. T. Tveter, G. Solum, I. Fadum Kjønstad, I. E. Christensen, T. K. Kvien, G. B. Kro, J. Jahnsen, E. A. Haavardsholm, L. A. Munthe, S. Aarrestad Provan, J. T. Vaage, K. K. Jørgensen, G. Grødeland, S. Mjaaland, S. W. Syversen, G. L. Goll
|
|
2024 POS0111
|
BENEFICIAL EFFECT OF TEMPORARY METHOTREXATE WITHDRAWAL ON B AND T CELL RESPONSES UPON SARS-CoV-2 VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIATIC ARTHRITIS,
S. Castañeda, E. Vicente-Rabaneda, P. Martínez-Fleta, A. Triguero-Martinez, M. Uriarte-Ecenarro, F. Gutiérrez-Rodríguez, P. Quiroga Colina, A. Romero, N. García Castañeda, J. A. García-Vadillo, C. Valero, I. Llorente, A. Ortiz, E. Tomero Muriel, M. A. Alfranca, R. Garcia-Vicuña, F. Sánchez-Madrid, I. González-Álvaro
|
|
2024 POS0141
|
DISTINCT PROFILES OF SERUM CYTOKINES AND PERIPHERAL BLOOD IMMUNOPHENOTYPING BETWEEN LATE-ONSET AND YOUNG-ONSET RHEUMATOID ARTHRITIS.,
S. Takanashi, N. Seki, H. Tsujimoto, K. Chiba, Y. Kaneko
|
|
2024 POS0144
|
MULTI-MODAL IMMUNE DYNAMICS OF PRE-COVID-19 KAWASAKI DISEASE FOLLOWING INTRAVENOUS IMMUNOGLOBULIN,
G. Olivieri, N. Cotugno, G. Pascucci, D. Amodio, E. Morrocchi, C. Pighi, E. C. Manno, G. A. Rotulo, D. Buonsenso, P. Rossi, A. Marchesi, P. Palma
|
|
2024 POS0156
|
CD4+HLADR+ T CELLS WITH AUTOIMMUNE REACTIVITY THAT RESIST REGULATORY CONTROL AND PERPETUATE DISEASE INFLAMMATION IN JUVENILE IDIOPATHIC ARTHRITIS,
J. Y. Leong, P. Kumar, S. H. Tay, G. Mijnheer, J. G. Yeo, S. Hazirah, A. J. M. Lim, C. Chua, P. Chen, A. Consolaro, M. Gattorno, T. Arkachaisri, F. Van Wijk, A. Martini, S. Albani
|
|
2024 POS0161
|
INSUFFICIENT PD-1 EXPRESSION DURING ACTIVE AUTOIMMUNE RESPONSES: A DEEP SINGLE-CELL PROTEOMICS ANALYSIS IN CHRONIC INFLAMMATORY ARTHRITIS,
E. K. Vetsika, G. E. Fragoulis, M. Kyriakidi, K. Verrou, M. G. Tektonidou, T. Alissafi, P. P. Sfikakis
|
|
2024 POS0170
|
CIRCULATING PATHOGENIC LIKE LYMPHOCYTES ARE MECHANISTIC TARGETS FOR THE TOLEROGENIC RE-EDUCATION IN RHEUMATOID ARTHRITIC PATIENTS,
J. Y. Leong, A. Lajam, C. T. Ng, S. Albani
|
|
2024 POS0191
|
A LUPUS FLARE RISK INDEX INFORMED BY SELECT ADAPTIVE AND TNF SUPERFAMILY IMMUNE MEDIATORS: VALIDATION IN A CONFIRMATORY COHORT,
M. E. Munroe, D. Blankenship, D. Defreese, A. Holloway, M. Purushothaman, W. Dejager, S. Macwana, J. M. Guthridge, S. Kamp, N. Redinger, T. Aberle, E. F. Chakravary, C. Arriens, Y. LI, H. Zeng, S. Dezzutti, P. Izmirly, U. Thanarajasingam, D. L. Kamen, J. P. Buyon, J. A. James, E. Jupe
|
|
2024 POS0192
|
LUPUS PATIENTS CAN BE CATEGORIZED INTO FOUR GROUPS BASED ON IMMUNOPHENOTYPE, EACH EXHIBITING DISTINCT RELAPSE RATES,
S. Kubo, S. Nakayamada, Y. Miyazaki, Y. Todoroki, M. Ueno, K. Kusaka, S. Matsunaga, H. Tanaka, N. Ohkubo, H. Sakai, I. Miyagawa, K. Hanami, Y. Tanaka
|
|
2024 POS0208
|
IMMUNOPHENOTYPING PROFILES OF PERIPHERAL B CELLS IN ANTI-Jo-1 ANTIBODY-POSITIVE IDIOPATHIC INFLAMMATORY MYOPATHIES,
M. Nakazawa, C. De Vries, K. Lodin, I. E. Lundberg, V. Malmström, C. Grönwall
|
|
2024 POS0212
|
UNRAVELING JAK/STAT3 ACTIVATION PATTERNS IN DERMATOMYOSITIS: IMPLICATIONS FOR UNDERSTANDING THE IFN-I SIGNALING PATHWAYS,
S. Del Vescovo, F. Cacciapaglia, M. Fornaro, S. Stano, A. Napoletano, G. G. Dipietrangelo, R. Bizzoca, D. Natuzzi, F. Iannone
|
|
2024 POS0237
|
TRANSCRIPTOMIC LANDSCAPES IN IDIOPATHIC INFLAMMATORY MYOPATHY: DIVERGENT PATHWAYS AND IMMUNE CELLS POTENTIALLY DRIVING MUSCLE DAMAGE.,
S. Izuka, N. Umezawa, T. Komai, Y. Sugimori, N. Kimura, F. Mizoguchi, Y. Fujieda, K. Ninagawa, T. Iwasaki, K. Suzuki, T. Takeuchi, K. Ohmura, T. Mimori, T. Atsumi, E. Kawakami, A. Suzuki, Y. Kochi, K. Yamamoto, S. Yasuda, T. Okamura, M. Ota, K. Fujio on behalf of AMED Practical Research Project for Allergic Diseases and Immunology
|
|
2024 POS0238
|
INVESTIGATING PERIPHERAL IMMUNOME DYSREGULATION IN KNEE OSTEOARTHRITIS: IMPLICATIONS FOR DISEASE CLASSIFICATION AND PATHOGENESIS,
A. Chia, A. Lajam, G. Ang, M. Wasser, Y. Y. Leung, S. Albani
|
|
2024 POS0241
|
GENOME-WIDE METHYLATION PROFILES OF PERIPHERAL WHOLE BLOOD IN NEWLY DIAGNOSED GIANT CELL ARTERITIS OR POLYMYALGIA RHEUMATICA,
M. Fröhlich, M. Gernert, O. Gadeholt, H. Einsele, P. P. Strunz, T. Bley, S. E. Serfling, R. A. Werner, K. V. Guggenberger, M. Dittrich, M. Schmalzing, T. Mueller
|
|
2024 POS0247
|
CIRCULATING CD4+CXCR5-PD-1hiICOS+ CELLS ARE ELEVATED INPATIENTS WITH NEWLY DIAGNOSED GIANT CELL ARTERITIS AND ASSOCIATE WITH THE CLINICAL OUTCOME,
M. E. Miranda-Carus, B. Nieto-Carvalhal, I. Monjo-Henry, M. D. C. Uyaguari Morocho, I. Casado-Juárez, A. Balsa, E. De Miguel
|
|
2024 POS0256
|
THE FIRST METHYLOME PROFILING STUDY OF B-CELLS IN IGA VASCULITIS REVEALED POTENTIAL BIOMARKERS OF DISEASE SUSCEPTIBILITY,
V. Pulito-Cueto, I. Fernández Rengel, L. C. Terron Camero, J. Batista-Liz, M. Sebastián Mora-Gil, M. T. Leonardo, A. Peñalba, L. Martín-Penagos, L. Belmar-Vega, C. Gomez-Fernandez, L. Gabrie, R. Gálvez-Sánchez, L. Caminal-Montero, A. I. Turrión, P. Quiroga Colina, E. Vicente-Rabaneda, B. Sevilla-Pérez, J. L. Callejas, E. Andrés-León, J. Martin, A. Márquez, S. Castañeda, R. Blanco , R. López-Mejías
|
|
2024 POS0257
|
MOLECULAR CLASSIFICATION OF SALIVARY GLANDS IN PRIMARY SJOGREN’S SYNDROME,
H. Xu, X. Wang, L. Jing, S. Ying, J. Hong, H. Cheng, P. Wang, Y. He, J. Zhang, W. Ye, X. Zhu, C. Zhu, L. Yang, Z. LI, S. Lin, D. Chen, X. Wu, Z. Xie, J. Wu
|
|
2024 POS0272
|
REDUCED ORAL HAEMOPHILUS PARAINFLUENZAE IN SJÖGREN’S SYNDROME PROMPTS DYSREGULATED T CELL RESPONSE THROUGH ALTERED SALIVARY GLAND EPITHELIAL CELLS,
S. F. Wu, Y. C. Tseng
|
|
2024 POS0274
|
PLASMA EXTRACELLULAR VESICLES PROMOTE FOLLICULAR T HELPER CELL EXPANSION IN PRIMARY SJÖGREN’S SYNDROME,
S. Liu, C. Luo, C. He, J. Sun, Z. Chen, T. Lyu, F. Zhang, H. Chen
|
|
2024 POS0275
|
IMPAIRED BONE MARROW B CELL DEVELOPMENT AND PERIPHERAL B CELL MATURATION IN ANCA-ASSOCIATED VASCULITIS,
M. Rizzi, J. Thiel, F. M. Schmidt, R. Lorenzetti, A. Troilo, I. Janowska, L. Nießen, S. Pfeiffer, J. Staniek, B. Benassini Orozco, A. K. Dufner, M. T. Bott, J. Korzhenevich, L. Konstantinidis, F. Burgbacher, N. Frede, R. Voll, J. Stuchly, M. Bakardjieva, T. Kalina, C. Smulski, N. Venhoff
|
|
2024 POS0282
|
THE IMBALANCE BETWEEN Th17 AND REGULATORY T CELLS IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,
R. Su, B. C. LI, L. Cheng, X. Zi, H. Wang, C. Wang
|
|
2024 POS0283
|
DISEASE - CHARACTERISTIC CHANGES CAN ALREADY BE FOUND IN INDIVIDUALS AT RISK OF SJÖGREN’S SYNDROME – RESULTS OF THE preSStige STUDY,
D. Pietsch, P. Javorova, S. Zenz, B. Dreo, F. Sarocchi, K. Pagotto- Betzler, A. Lackner, J. Thiel, D. Cornec, M. Stradner
|
|
2024 POS0313
|
INTESTINAL NEUROINFLAMMATION IN SPA IS CORRELATED WITH DYSBIOSIS,
G. Forte, D. Mauro, A. S. Bergot, A. Cameron, A. Ciancio, G. Scalise, A. Salzillo, I. Pantano, I. Panarese, G. Vespere, L. De Luca, G. Desena, V. Napolitano, R. Franco, V. Provitera, R. Thomas, F. Ciccia
|
|
2024 POS0315
|
EXPLORING THE DTX1 GENE EXPRESSION IN HLA-B27 TRANSGENIC RATS AND SPA PATIENTS,
E. Cela, M. Lauraine, B. Cherqaoui, M. Breban, L. M. Araujo
|
|
2024 POS0328
|
MUCOSAL-ASSOCIATED INVARIANT T CELLS ACTIVATION AND IL-17 EXPRESSION CHARACTERIZE THE SYNOVIAL FLUID AND PERIPHERAL BLOOD OF PATIENTS WITH PSORIATIC ARTHRITIS AND ARE MODULATED BY TOFACITINIB,
M. De Santis, A. Tonutti, F. Motta, N. Isailovic, A. Ceribelli, G. M. Guidelli, D. Renna, N. Luciano, C. Selmi
|
|
2024 POS0335
|
DECODING THE T-CELL RECEPTOR REPERTOIRE IN CHRONIC ARTHRITIS ACROSS DIFFERENT AGES, DISEASE GROUPS, AND T-CELL SUBSETS,
M. Ha, V. Van Deuren, J. Dehoorne, T. Renson, E. Geens, N. Aerts, R. Wittoek, K. Heusdens, E. De Wachter, A. Andrzejewski, M. Kuznetsova, E. Bartholomeus, N. De Vrij, I. Maes, A. Suls, E. Lion, S. Vanhee, W. Adriaensen, K. Mullan, R. Joos, K. Laukens, P. Meysman, B. Ogunjimi
|
|
2024 POS0338
|
INTEGRATION OF SINGLE-CELL MULTI-OMICS PROFILING FOR INVESTIGATING TREATMENT RESPONSE TO TUMOR NECROSIS FACTOR ALPHA INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS,
H. S. Cha, S. Lee, J. S. Park, E. Ignatova, J. Lee, S. Kang, H. Kim, E. M. Koh, J. K. Choi
|
|
2024 POS0340
|
EFFECTS OF CAR-T CELL TREATMENT ON B CELL IMMUNITY IN SYSTEMIC AUTOIMMUNE DISEASES,
L. Bucci, T. Rothe, F. Müller, J. Taubmann, M. Hagen, C. Bergmann, C. Tur, L. Munoz, A. Wilhelm, R. Gerlach, S. Schäfer, S. Völkl, M. Aigner, R. Grieshaber-Bouyer, G. Krönke, A. Bozec, T. Winkler, A. Mackensen, G. Schett
|
|
2024 POS0342
|
ANGIOGENIC T-CELL DEPLETION IS A VERY EARLY EVENT ALONG ARTHRITIS DEVELOPMENT LINKED TO IMPAIRED VASCULAR REPAIR AND SUBCLINICAL VASCULAR STIFFNESS,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2024 POS0351
|
A POST-HOC ANALYSIS OF THE BIOPSY-DRIVEN, MULTICENTRE, RANDOMISED R4RA CLINICAL TRIAL REVEALS AN INNATE IMMUNE SIGNATURE IN MULTI-DRUG RESISTANT RHEUMATOID ARTHRITIS PATIENTS WITH A LYMPHO-MYELOID PATHOTYPE,
F. S. Iaquinta, E. Sciacca, F. Abatecola, L. Fossati-Jimack, C. Pitzalis, F. Rivellese On Behalf of R4RA Collaborative Group
|
|
2024 POS0369
|
IN RHEUMATOID ARTHRITIS, IgA AUTOANTIBODIES ARE PRESENT IN A POLYMERIC STATE; CLUES FOR A MUCOSAL ORIGIN OF THE AUTOIMMUNE RESPONSE?,
A. G. Van Mourik, S. Reijm, A. Bacon, M. A. M. Van Delft, N. Levarht, R. Tjokrodirijo, P. Van Veelen, L. A. Trouw, R. E. M. Toes, K. A. Van Schie, D. Van der Woude
|
|
2024 POS0375
|
ASSESSMENT OF S95011 (OSE-127, LUSVERTIKIMAB), AN ANTI-INTERLEUKIN 7 RECEPTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: AN INTERNATIONAL MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A STUDY,
B. Fisher, A. Szántó, M. Rischmueller, T. Varga, A. Kleyer, S. Finzel, J. A. Garcia Meijide, J. Sánchez-Bursón, S. Galtier, C. Sandré, X. Mariette
|
|
2024 POS0378
|
HETEROZYGOUS LOSS-OF-FUNCTION RELA MUTATIONS LEAD TO SYSTEMIC LUPUS ERYTHEMATOSUS OR AUTOINFLAMMATORY SYNDROME,
Q. Riller, L. Barnabei, M. Rodrigo-Riestra, M. C. Stolzenberg, O. Pelle, L. Delage, T. Becquard, C. Courteille, M. Marchais, C. De Cevins, C. Brunaud, A. Magerus, M. Luka, B. Sorin, C. Boussard, R. Salomon, M. Ménager, M. Hié, B. Neven, V. Baud, J. Skokowa, G. Sogkas, Y. Jamilloux, E. Merlin, A. Belot, C. Picard, G. Boursier, E. Riviere, S. Georgin-Lavialle, P. Quartier, B. Bader-Meunier, A. Fischer, J. J. Miner, F. Rieux-Laucat
|
|
2024 POS0440
|
EVALUATING THE IMPACT OF CD4+ T-CELL DRIVEN OXIDATIVE STRESS AND PRO-INFLAMMATION IN PATIENTS WITH LUPUS NEPHRITIS,
S. Chatterjee, A. Bagchi, D. Sarkar, S. Saha, M. Chatterjee, A. Ghosh, P. Sinhamahapatra
|
|
2024 POS0452
|
1,25(OH)2D3 REINFORCES IL-10 INDUCTION UNDER DUAL INHIBITION OF TNFα AND IL-17A IN CCR6+ MEMORY Th17 CELLS MEDIATED SYNOVIAL INFLAMMATION,
Y. He, A. M.C. Mus, N. Davelaar, B. Van Heeswijk, E. Lubberts
|
|
2024 POS0453
|
B CELL HYPERACTIVATION AND ENHANCED ANTIGEN RECEPTOR SIGNALING IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS,
E. Marasco, A. Aquilani, M. Trevisan, I. Caiello, G. Tarantino, R. Nicolai, S. Magni-Manzoni, R. Carsetti, F. De Benedetti
|
|
2024 POS0454
|
JANUS-KINASE-INHIBITORS (JAKi) SIGNIFICANTLY IMPAIR SIGNAL-TRANSDUCER-AND-ACTIVATOR-OF-TRANSCRIPTION (STAT) SIGNALING OF VARICELLA-ZOSTER-VIRUS-(VZV)-SPECIFIC T-CELL MEMORY RESPONSES,
G. Almanzar, F. Baum, M. Steimer, L. Jahn, S. Hick, A. Ess, C. Rack, I. Turin, A. Schäfer, P. Arampatzi, T. Bischler, T. Gräfenhan, F. Erhard, T. Hennig, L. Doelken, M. Feuchtenberger, M. Schmalzing, M. Prelog
|
|
2024 POS0455
|
IMMUNOMODULATING TREATMENT IN RHEUMATOID ARTHRITIS IMPACTS THE BRG1-MEDIATED DNA DAMAGE RESPONSE IN CD4+T CELLS,
V. Chandrasekaran, K. M. E. Andersson, M. Erlandsson, E. Malmhäll-Bah, G. Katona, M. I. Bokarewa
|
|
2024 POS0459
|
PANTREG: A CELL-THERAPY, SYSTEM-BIOLOGY - BASED APPROACH FOR THERAPY OF AUTOIMMUNITY,
S. Albani, Y. Zhao, D. Guo, M. Chew
|
|
2024 POS0462
|
PRECLINICAL DEVELOPMENT OF KYV-201, AN INVESTIGATIONAL ALLOGENEIC ANTI-CD19 CAR T CELL FOR THE TREATMENT OF AUTOIMMUNE DISEASE,
A. Mahne, B. Kwong, J. Cheng, J. Wang, J. Banuelos, P. Starokadomskyy, S. Park, C. Gibson, S. Sengupta, S. Sandoval, J. Bravo, J. Flandez, S. Shah, A. Goodsell, Y. Zhang, I. Miller, B. Schultes, T. Van Blarcom
|
|
2024 POS0465
|
A NOVEL THERAPEUTICALLY ACTIVE ANTI-TNFR2 AGONISTIC ANTIBODY PROMOTES TREG PROLIFERATION AND INDUCTION OF TREG FUNCTIONAL MARKERS,
T. Miyazaki, M. Maiti, I. Amit, D. Hamel, Q. Wu, R. Pena, K. Brendza, T. Chang, V. Guo, S. Kivimae, Y. Ofran, J. Zalevsky
|
|
2024 POS0526
|
ACCUMULATION OF STRESS-INDUCED MOLECULES RECOGNIZING T CELLS IN MODIC TYPE 1 CHANGES,
J. Devan, S. Dudli, N. Herger, T. Mengis, I. Heggli, M. Perez Vertti Valdes, M. Farshad, O. Distler on behalf of Center for Experimental Rheumatology
|
|
2024 POS0552
|
CYTOTOXIC CD8+ T CELLS REGULATE PRO-FIBROTIC MYOFIBROBLAST ACTIVITY VIA JAK/STAT3 AND TGFΒ SIGNALING IN AUTO-IMMUNE CONNECTIVE TISSUE DISEASE PATHOLOGY,
T. I. Papadimitriou, D. Dorst, P. Van der Kraan, M. Koenders, R. M. Thurlings, A. Van Caam
|
|
2024 POS0566
|
Th17/Treg IMBALANCE DURING ACTIVE GOUT ATTACK DIFFERS BETWEEN PATIENTS WITH EARLY-ONSET GOUT AND LATE-ONSET GOUT,
C. Wang, X. Zi, R. Su, B. C. Li, X. Li
|
|
2024 POS0573
|
NEUTRALISING ANTIBODY RESPONSES TO BIVALENT SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY,
H. S. Ørbo, T. M. Kasahara, A. S. Wolf, K. H. Bjørlykke, J. Sexton, I. Jyssum, A. T. Tveter, G. Solum, I. Fadum Kjønstad, A. Lind, V. P. Dimova-Svetoslavova, T. K. Kvien, J. Jahnsen, E. A. Haavardsholm, L. A. Munthe, S. Aarrestad Provan, J. T. Vaage, S. Mjaaland, K. K. Jørgensen, G. Grødeland, S. W. Syversen, G. L. Goll
|
|
2024 POS0595
|
FUNCTIONAL DISABILITY IN RHEUMATOID ARTHRITIS IS ASSOCIATED WITH STRUCTURAL CHANGES OF THE BRAIN, WHICH ARE PARTLY REVERTIBLE WITH HAND TRAINING,
Z. Dai, R. A. Heckemann, M. Erlandsson, S. T. Silfverswärd, M. I. Bokarewa, C. Wasén
|
|
2024 POS0613
|
ABERRANT SUBSETS OF REGULATORY T CELLS IN RHEUMATOID ARTHRITIS PATIENTS WITH DIFFERENT DISEASE ACTIVITY,
C. Wang, X. Zi, H. Yan, X. LI, J. Luo
|
|
2024 POS0620
|
IMMUNOGENICITY OF THE RECOMBINANT ZOSTER VACCINE IN PEOPLE WITH RHEUMATOID ARTHRITIS USING ABATACEPT,
K. L. Winthrop, J. A. Hawkins, A. Weinberg, S. A. R. Siegel, J. L. Baxter, K. Garth, J. E. Huffstutter, J. Loveless, D. Ridley, E. Moreta, I. Messaoudi, J. R. Curtis
|
|
2024 POS0700
|
SEVERE ENTEROVIRUS INFECTIONS IN PATIENTS WITH AUTOIMMUNE DISEASES RECEIVING ANTI-CD20 MONOCLONAL ANTIBODIES,
G. Martin de Frémont, H. Chabrolles, A. Mirand, A. S. L’honneur, N. Mele, D. Boutboul, M. Farhat, E. Hachulla, M. Lazrek, V. Rieu, A. Mathian, H. Chaussade, A. Ruet, S. Burrel, F. Coury-Lucas, I. Schuffenecker, A. Lemaignen, K. Stefic, M. Le Besnerais, M. Carrette, L. Mouthon, V. Avettand-Fenoel, B. Terrier, J. Hadjadj
|
|
2024 POS0702
|
HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INTERLEUKIN-6 INHIBITORS AND JANUS KINASE INHIBITORS,
E. Perea, A. Avilés, C. Rodríguez, M. C. López González, P. Vela Casasempere, V. Jovani, A. Martínez-Sanchis, J. Esteve, P. Bernabéu, I. Calabuig, S. Gómez, R. Caño, M. Andrés
|
|
2024 POS0716
|
DEVELOPMENT OF PRECLINICAL MODELS FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ARTHRITIS,
K. Murakami, Y. Hotta, A. Yoshida, H. Tsukamoto, M. Shirakashi, T. Yoshida, A. Morinobu
|
|
2024 POS0734
|
UNSUPERVISED MACHINE LEARNING IDENTIFIES DISTINCT SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT ENDOTYPES BASED ON B CELL PHENOTYPING AND AUTOANTIBODY PROFILES WITH DIFFERENTIAL RESPONSE TO BELIMUMAB,
R. Depascale, N. Cetrez, J. Lindblom, L. Iaccarino, A. Doria, D. Nikoloupolos, M. Gatto, I. Parodis
|
|
2024 POS0763
|
MUSCULOSKELETAL MANIFESTATIONS INDUCED BY SARS-CoV-2 IN PEDIATRIC POPULATION - A PORTUGUESE MULTICENTRIC STUDY,
A. J. Serra Gaspar Silva, B. Correia, H. Sousa, J. Silva-Dinis, M. E. Santos, V. Fraga, A. F. Mourão, S. Sousa, F. Oliveira-Ramos, M. Bernardo, P. Costa Reis, R. Campanilho-Marques
|
|
2024 POS0764
|
IMMUNOGENICITY AND SAFETY OF COVID-19 VACCINES IN PATIENTS WITH JUVENILE AUTOIMMUNE DISEASES: DATA FROM SAFER STUDY,
C. Strauss Estevez Gadelha, Y. Oliveira Gondim Moraes, M. T. Terreri, A. Coelho Moreira Da Fraga, D. Borges Ferreira, A. P. Neves Burian, K. Lysie Libardi Lira Machado, S. Lúcia Euzébio Ribeiro, C. Maria Paiva França Telles, R. Poubel Vieira de Rezende, K. Lino Baptista, V. Schinzel, G. A. Ferreira, R. Machado Xavier, O. A. Monticielo, E. Torres Dos Reis Neto, E. I. Sato, V. Angelina de Souza, G. Clemente, G. Salviato Pileggi, V. Valim on behalf of Safer Study Group
|
|
2024 POS0766
|
PROTEOMIC ANALYSIS REVEALS SIGNIFICANT FEATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS: A COMPARISON BETWEEN JUVENILE AND ADULT ONSET,
C. Simu, M. Badii, I. Szabo, O. Gaal, C. Pamfil, M. M. Tamas, L. Damian, M. Sparchez, T. Crisan, L. Joosten, S. Rednic
|
|
2024 POS0792
|
IMMUNOLOGICAL PROFILING OF PAIN IN KNEE OSTEOARTHRITIS: TREG CELLS AS POTENTIAL NEW KEY PLAYERS IN SYMPTOMATIC KNEE OSTEOARTHRITIS,
M. Binvignat, J. Dubois, N. Tchitchek, M. Rosenzwajg, M. Barbier, F. Pitoiset, A. Roux, R. Lorenzon, S. Hässler, C. Ribet, A. Courties, H. Vantomme, L. Adda, V. Mhanna, P. Barennes, P. Stys, L. Minssen, Y. Marie, C. Aheng, A. Six, A. Butte, F. Berenbaum, D. Klatzmann, E. Mariotti-Ferrandiz, J. Sellam
|
|
2024 POS0852
|
TITERS OF STANDARD VACCINATIONS AND SERUM IMMUNOGLOBULINS IN A TWO-YEAR-TIME-PERIOD AFTER AN AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH SYSTEMIC SCLEROSIS,
S. Endres, A. C. Pecher, R. Klein, J. Henes
|
|
2024 POS0867
|
INFLIXIMAB THERAPY FOR MULTISYSTEM SARCOIDOSIS: A SINGLE CENTRE EXPERIENCE,
D. Nagra, K. Bechman, S. Bukhari, C. Baldwin, E. Alveyn, M. A. Adas, H. K. Molabanti, K. Noorani, K. Tsoi, M. Russell, J. Galloway
|
|
2024 POS0869
|
RISK OF SARCOIDOSIS IN HIV PATIENTS BASED ON ANTIRETROVIRAL THERAPY STATUS. A RETROSPECTIVE COHORT STUDY,
Y. Gonzalez Moret, N. Tsibadze, F. Rodriguez, P. Khandwala
|
|
2024 POS0905
|
IMMUNE CELL-SPECIFIC CHARACTERIZATION OF HIGH-RESOLUTION COMPUTED TOMOGRAPHY (HRCT) PATTERNS IN INFLAMMATORY RHEUMATIC DISEASES WITH LUNG INVOLVEMENT: A STUDY IN NEWLY DIAGNOSED PATIENTS,
T. Hoffmann, M. Förster, P. Oelzner, C. Kroegel, U. Teichgräber, D. Renz, J. Böttcher, P. C. Schulze, G. Wolf, M. Franz, A. Pfeil
|
|
2024 POS0995
|
SINGLE CELL RNA-SEQ CHARACTERIZATION OF CIRCULATING IMMUNE CELLS IN SJOGREN’S SYNDROME: COMPARISON TO SLE AND RHEUMATOID ARHTRITIS,
J. L. Andréu Sánchez, A. Gómez-Gómez, Y. Guillen Montalban, P. Vela Casasempere, M. P. Álvarez Hernandez, I. Braña Abascal, M. Fernandez Castro, M. A. López Lasanta, J. M. Pego Reigosa, C. Marras Fernandez Cid, M. J. Garcia-Villanueva, F. Blanco, P. Carreira, C. Perez-Garcia, Í. Rúa-Figueroa, H. F. Avalos Bogado, N. Boix-Martí, E. Kirkegaard_biosca, I. Alvarez Saez, N. Palau Balaña, R. Tortosa Mendez, J. Tornero Molina, A. Fernández-Nebro, J. Calvo Alén, J. D. D. Cañete Crespillo, D. Alvarez Errico, E. Choy, H. Heyn, A. Julià Cano, S. Marsal On Behalf of IMID-Consortium and Doctis-Consortium
|
|
2024 POS1002
|
CONTRIBUTION OF METABOLOMICS AND B LYMPHOCYTE TRANSCRIPTOME IN THE NEW SJÖGREN’S DISEASE MOLECULAR CLASSIFICATION,
C. Iperi, A. Fernández-Ochoa, J. O. Pers, N. Foulquier, G. Barturen, M. Alarcon-Riquelme, D. Cornec, A. Bordron, C. Jamin
|
|
2024 POS1006
|
PROFILING B AND PLASMA CELLS IN KIDNEY BIOPSIES FROM ANCA-ASSOCIATED VASCULITIS PATIENTS WITH GLOMERULONEPHRITIS AT SINGLE-CELL RESOLUTION,
A. Merino-Vico, Y. Vegting, A. Jongejan, J. P. Van Hamburg, P. D. Moerland, M. L. Hilhorst, S. W. Tas
|
|
2024 POS1009
|
ABCS CELLS WERE INVOLVED IN THE PATHOGENESIS OF POLYMYALGIA RHEUMATICA,
W. Chen, F. Yang, J. Wu, X. MA, Y. He, J. Lin
|
|
2024 POS1010
|
DIFFERENTIAL INVOLVEMENT OF CX3CR1-POSITIVE T CELLS IN GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: INSIGHTS INTO IMMUNOPATHOGENIC MECHANISMS AND CLINICAL CORRELATIONS,
Y. Kaneko, R. Inukai, M. Akiyama, K. Yoshimoto, S. Wakasugi, Y. Matsuno, S. Ishigaki, W. Alshehri, K. Saito
|
|
2024 POS1011
|
ABNORMALITIES IN CIRCULATING POLYMORPHONUCLEAR CELLS IN ANCA-ASSOCIATED VASCULITIS,
L. Iorio, C. Baggio, F. Davanzo, M. Codirenzi, E. Fiorin, F. Oliviero, R. Padoan, A. Doria
|
|
2024 POS1061
|
VORINOSTAT AS A DUAL INHIBITOR OF TYPE I IFN PRODUCTION AND ABERRANT B CELL: A NOVEL THERAPEUTIC CANDIDATE FOR SYSTEMIC LUPUS ERYTHEMATOSUS,
T. Hirayama, H. Takamatsu, A. Kumanogoh
|
|
2024 POS1065
|
PREMATURE IMMUNOSENESCENCE WAS CORRELATED WITH THE PRESENCE AND SEVERITY OF PROLIFERATIVE LUPUS NEPHRITIS,
K. Handono, C. S. Wahono, M. Z. Pratama, H. Kalim On Behalf of LAURA (Lupus-Autoimmune-Rheumatic-Allergy) Study Group Faculty of Medicine Universitas Brawijaya
|
|
2024 POS1066
|
SINGLE-CELL MULTI-OMIC EVALUATION OF DIFFERENCES IN T CELL POPULATIONS IN PROGRESSION OF SLE,
A. Bylinska, M. Smith, R. Lu, B. Jones, C. Guthridge, M. C. Marlin, C. Wright, S. Macwana, W. Dejager, M. Beel, C. J. Lessard, C. Arriens, J. Merrill, J. A. James, J. M. Guthridge
|
|
2024 POS1198
|
EPIDEMIOLOGY OF VEXAS SYNDROME IN ISRAEL – A HIGH PREVALENCE OF UBA1 p.M41V PATHOGENIC VARIANT IN ISRAELI VEXAS PATIENTS,
T. Eviatar, M. Zisapel, N. Feinstein Goren, I. Sagy, S. Kivity, M. Lidar, A. Bieber, O. Tayer-Shifman, H. Peleg, D. Ozeri, J. Shamash, E. Pras, H. Baris-Feldman, Y. Edel, A. Dortort Lazar, O. Wolach, Y. Molad, G. Stremer, M. E. Naffa, T. Porges, O. Elkayam
|
|
2024 POS1200
|
MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, REDUCES JOINT INFLAMMATION, CYTOKINE PRODUCTION, AND AUTOANTIBODY LEVELS IN A COLLAGEN-INDUCED ARTHRITIS DISEASE MODEL,
A. Cartwright, F. Desai, S. Vora, L. Gyger, L. Roditi, S. Nguyen, A. Trouilloud, D. Lam, P. Trenh, X. Lucas, M. Zlotosch, E. Liardo, D. Wible, V. Oleinikovas, I. Lamberto, B. Demarco, C. King, D. Bonenfant, E. Krishnan, S. De Beukelaer, S. Townson, O. Wallace, F. Janku, L. Mcallister, A. Paterson, M. Peluso
|
|
2024 POS1207
|
AMELIORATION OF RHEUMATOID ARTHRITIS IN PREGNANCY IS NOT ASSOCIATED WITH ENHANCED FUNCTION OF REGULATORY T CELLS,
C. Raine, G. Robinson, C. Ciurtin, J. Manson, D. Williams, E. Jury, I. Giles
|
|
2024 POS1219
|
AN IL-17A SECRETING HLA-DR-CCR6+ T REGULATORY SUBPOPULATION SUPPRESSES T CELLS AND INDUCES INFLAMMATORY MEDIATORS IN SYNOVIAL FIBROBLAST,
B. Van Heeswijk, M. Bongenaar, N. Davelaar, P. H. P. De Jong, R. J. E. M. Dolhain, H. Den Braanker, E. Lubberts
|
|
2024 POS1226
|
REDUCED EXPRESSION OF GPR55 ON B-CELLS IN EARLY RHEUMATOID ARTHRITIS PATIENTS: A CANDIDATE MODULATOR OF IMMUNE RESPONSES IN ATHEROSCLEROSIS,
D. Miranda-Prieto, M. Alperi-López, J. Rodríguez-Carrio, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez
|
|
2024 POS1229
|
DEFICIENT IMMUNOMODULATING EFFECTS OF PLATELETS IN RHEUMATOID ARTHRITIS CONTRIBUTE TO Th17 AXIS REGULATION,
G. Cafaro, M. I. Christodoulou, S. Cipriani, M. Sebastiano, C. Perricone, O. Bistoni, R. Gerli, E. Bartoloni
|
|
2024 POS1240
|
A CASE-CONTROL STUDY ON HCV PATIENTS WITH SICCA MANIFESTATIONS BEFORE AND AFTER DIRECT-ACTING ANTIVIRALS AND COMPARISON WITH SJOGREN’S DISEASE; INFECTION VERSUS AUTOIMMUNITY,
M. T. Hegazy, A. Maher, T. Algarf, M. Abdul-Aziz, L. Quartuccio, N. Zoheir, S. De Vita, G. Ragab
|
|
2024 POS1249
|
FACTORS ASSOCIATED WITH PATIENT ACCEPTABLE SYMPTOM STATE (PASS) IN SJÖGREN’S DISEASE: A REAL LIFE SINGLE-CENTRE STUD,
S. Fonzetti, E. Elefante, I. C. Navarro García, C. Porciani, G. Fulvio, G. La Rocca, F. Ferro, M. Mosca, C. Baldini
|
|
2024 POS1260
|
GUT MICROBIOME DYSBIOSIS PROMOTES THE PROGRESSION OF PRIMARY SJOGREN’S SYNDROME BY DISRUPTING IMMUNE HOMEOSTASIS SIS,
L. Shang, H. Y. Wen, Z. Liang, N. Wang, C. Gao, J. Luo
|
|
2024 POS1315
|
IMMUNE CHECKPOINT INHIBITOR-RELATED MYOSITIS. CASE REPORTS AND LITERATURE REVIEW,
D. Prieto-Peña, A. Llobell-Uriel, A. García Castaño, L. Fernandez-Morales, E. Gallardo-Diaz, A. Gómez-Centeno, J. Gratacós, R. Blanco
|
|
2024 POS1318
|
DYSREGULATION OF CIRCULATING T FOLLICULAR CELLS, BUT NOT B CELLS, IS ASSOCIATED WITH ANTIPHOSPHOLIPID ANTIBODIES POSITIVITY IN PATIENTS WITH THROMBOTIC PRIMARY ANTIPHOSPHOLIPID SYNDROME,
P. Gaspar, A. R. Cruz-Machado, F. Ribeiro, S. Pascual-García, V. R. Fonseca, V. C Romão, L. Graca
|
|
2024 POS1321
|
THE EFFECTS OF EVOLUTIONARY DIVERGENCE IN THE HUMAN LEUKOCYTE ANTIGEN REGION IN AUTOIMMUNE DISEASES,
R. Domínguez Rodríguez, M. Martínez Bueno, E. Carnero Montoro, G. Barturen, R. Díaz Peña, M. Alarcon-Riquelme on behalf of Genomics of Complex Diseases
|
|
2024 POS1322
|
IMID PATIENTS SHOW EXPANDED SENESCENT CD8 T-CELLS ASSOCIATED WITH LEVELS OF CIRCULATING INTERFERON GAMMA AND IL-6,
S. Bitoun, M. Naigeon, M. Roulleaux-Dugage, C. DE Oliveira, C. Berthot, X. Mariette, N. Chaput-Gras, G. Nocturne
|
|
2024 POS1327
|
CD19.CAR-T CELL-CONTAINING COMBINATION THERAPY IN SYSTEMIC SCLEROSIS,
W. Merkt, M. Freitag, M. Claus, P. Kolb, M. Röhrich, L. Rodon, I. Andreeva, F. Deicher, N. Blank, C. Watzl, M. Polke, C. Heussel, H. M. Lorenz, M. Schmitt
|
|
2024 POS1345
|
OVERLAP OF SYSTEMIC SCLEROSIS AND ANCA ASSOCIATED GLOMERULONEPHRITIS,
V. Syrmou, T. Simopoulou, I. Alexiou, A. Gkouvi, M. Karapli, N. M. Liapis, F. Karasavvidou, C. Katsiari, D. Bogdanos
|
|
2024 POS1377
|
REFINING AUTOANTIBODY PROFILES IN PATIENTS WITH RHEUMATOID ARTHRITIS – A SCANDINAVIAN STUDY ON 6900 SAMPLES,
J. Askling, C. Grönwall, H. Westerlind, L. Mathsson-Alm, I. Gehring, J. Sexton, S. Lillegraven, E. Haavardsholm, M. Lund Hetland, H. B. Hammer, B. Glintborg
|
|
2024 POS1392
|
HIGHLY INFLAMMATORY IL-7 RECEPTOR ALPHA LOW EFFECTOR MEMORY CD8+ T CELLS PROMOTE NEUTROPHIL EXTRACELLULAR TRAPS AND LUPUS IMMUNE COMPLEX-MEDIATED MONOCYTE ACTIVATION IN HUMANS,
I. Kang, M. S. Shin, J. Yoo, H. J. Park, X. Dong
|
|
2024 POS1399
|
BANK1 SIGNALLING SHAPES THE GUT MICROBIOTA COMPOSITION BY CONTROLLING THE GUT MUCOSAL B CELL RESPONSE IN A TLR7-MEDIATED LUPUS MODEL,
M. Botía Sánchez, G. Galicia, D. Toro-Domínguez, A. López García, J. R. Valera, A. Margolles, N. Varela, M. Morell, M. Alarcon-Riquelme on behalf of Genetics of complex diseases
|
|
2024 POS1410
|
LONG-ACTING DERIVATIVES OF A BACTERIAL IGG PROTEASE WITH REDUCED IMMUNOGENICITY FOR THE RAPID DEGRADATION OF IGG AUTOANTIBODIES,
M. Sauer, B. Dutzar, E. Frazier, K. Chan, D. Farrell, G. Robertson, Y. Song, E. Tarcha, E. Procko
|
|
|
[4]
|
Analgesics
|
|
|
| 2024 |
|
2024 AB0228
|
GABAPENTINOID USE AND THE RISK OF FRACTURES IN PEOPLE WITH INFLAMMATORY ARTHRITIS: NESTED CASE-CONTROL STUDY IN THE CLINICAL PRACTICE RESEARCH DATALINK (CPRD) AURUM,
I. Scott, N. Daud, J. Bailey, H. Twohig, S. Hider, C. Mallen, K. Jordan, S. Muller
|
|
2024 AB0338
|
MELATONIN IS A POTENTIAL NOVEL ANALGESIC AGENT FOR OSTEOARTHRITIS: EVIDENCE FROM COHORT STUDIES IN HUMANS AND PRE-CLINICAL RESEARCH IN RATS,
H. Li, B. Zhou, J. Wu, Y. Zhang, W. Zhang, M. Doherty, X. Deng, N. Wang, D. Xie, Y. Wang, H. Xie, C. Li, J. Wei, G. Lei, C. Zeng
|
|
2024 POS0561
|
THE EFFECT OF HYPERURICAEMIA ON THE USE OF NON-OPIOID AND OPIOID ANALGESICS,
J. Timsans, A. Kerola, J. Kauppi, V. Rantalaiho, M. Paldanius, H. Kautiainen, M. Kauppi
|
|
2024 POS1173
|
COMPARATIVE RISK OF MORTALITY IN NEW USERS OF PRESCRIPTION OPIOIDS FOR NON-CANCER PAIN: RESULTS FROM THE INTERNATIONAL PHARMACOSURVEILLANCE STUDY,
M. Jani, N. Girad, D. Bates, D. Buckeridge, W. Dixon, R. Tamblyn
|
|
|
[82]
|
Animal Models
|
|
|
| 2024 |
|
2024 AB0100
|
PREVENTIVE ANTI-INFLAMMATORY EFFECT OF POLYDATIN IN PYROPHOSPHATE CALCIUM CRYSTAL-INDUCED ARTHRITIS IN MICE,
F. Oliviero, P. Galozzi, C. Baggio, V. Lazzarin, G. Ravagnan, P. Sfriso, R. Ramonda, G. Pennelli, A. Doria, R. Luisetto
|
|
2024 AB0101
|
PRECLINICAL IN VITRO AND IN VIVO EFFICACY STUDIES OF TIGULIXOSTAT, A SELECTIVE NON-PURINE XANTHINE OXIDASE INHIBITOR,
A. Kumar, D. W. Kim, S. Kim
|
|
2024 AB0179
|
IL 33 AND SECUKINUMAB, A LINK IN RHEUMATIC-RELATED GUT ALTERATION,
F. Meyer, H. Martin, P. Totoson, D. Wendling, C. Demougeot, C. Prati, F. Verhoeven
|
|
2024 AB0183
|
CARDIAC EFFECTS OF THE ARTHRITIS/HEART FAILURE COMORBIDITY,
T. C. Tønnessen, M. S. Ahmed, A. O. Melleby, T. Ueland, E. K. S. Espe, L. Zhang, H. Attramadal, I. Sjaastad, L. E. Vinge
|
|
2024 AB0266
|
TARGETING FIBROSIS TO ADDRESS MYOCARDITIS AS COMPLICATION OF RHEUMATIC DISEASE: PROOF OF CONCEPT IN A LARVAL ZEBRAFISH MODEL,
C. Smith, T. Ollewagen
|
|
2024 AB0329
|
MORPHOLOGY OF THE SYNOVIAL SUBINTIMA OF THE INTACT HIP JOINT CAPSULE DURING THE POSTNATAL PERIOD,
A. Fedotchenko
|
|
2024 AB0333
|
DISTRIBUTION OF GALACTOSE-SPECIFIC LECTINS IN THE NORMAL ARTICULAR CARTILAGE OF THE HIP JOINT DURING THE POSTNATAL PERIOD,
A. Fedotchenko
|
|
2024 AB0335
|
DIET ENRICHMENT WITH EXTRA VIRGIN OLIVE OIL INFLUENCES POSTURAL SYMMETRY AND EPIGENETIC REGULATION IN AN OSTEOARTHRITIS MURINE MODEL,
C. Núñez Carro, M. Blanco-Blanco, S. Paniagua-Barro, T. Hermida Gómez, N. Goyanes, M. G. Gaspar Gaspar, A. Centeno, B. Carames, F. J. Blanco, M. C. De Andres on behalf of Grupo de Investigación de Reumatología (GIR)
|
|
2024 AB0352
|
EFFECT OF ORAL VITAMIN K2 USE ON KNEE OSTEOARTHRITIS PROGRESSION IN AN EXPERIMENTALLY CREATED OSTEOARTHRITIS MODEL IN RATS,
E. Uzun, I. Tekeoğlu, Ö. Budak, H. Cakiroglu, E. Şahin, K. Nas, A. Kamanli
|
|
2024 AB0722
|
EFFICACY, TOXICOLOGY, BIODISTRIBUTION, AND MECHANISTIC INSIGHTS OF APT001 IN COLLAGEN-INDUCED ARTHRITIS – A NOVEL CITRULLINATED PEPTIDE-APTAMER NANOPARTICLE DRUG CANDIDATE FOR RHEUMATOID ARTHRITIS,
K. Astakhova, T. W. Kragstrup, A. H. Bustos, N. B. Pedersen, C. Mahony, A. P. Croft, M. H. Clausen
|
|
2024 AB0723
|
PHARMACOKINETICS OF ADALIMUMAB IN CYNOMOLGUS MONKEYS FOLLOWING DOSING WITH BHV-1300, A FIRST-IN-CLASS MOLECULAR DEGRADER OF IgG,
E. Dierks, P. Ackerman, D. Heller, A. Bunin, F. Engler, B. Gavin, D. Pirman, B. Car, I. Qureshi, V. Coric
|
|
2024 AB0725
|
VIMENTIN AND INTEGRIN αvβ3: POTENTIAL TARGETS FOR POSITRON EMISSION TOMOGRAPHY IMAGING OF ANGIOGENESIS IN RHEUMATOID ARTHRITIS,
F. Khodadust, M. M. Steinz, J. Van Beijnum, G. Jansen, S. W. Tas, C. J. Van der Laken
|
|
2024 AB0726
|
CAN DEPLETION OF FAPα SYNOVIAL FIBROBLASTS LEAD TO AMELIORATION OF INFLAMMATORY ARTHRITIS?,
C. I. Hsieh, H. Y. Chen, W. Y. Tseng, Y. J. Jan, Y. J. Huang, C. F. Kuo, K. H. Yu, P. H. Tsai, S. F. Luo
|
|
2024 AB0734
|
PEPTIDYLARGININE DEIMINASE 4 (PAD4) INHIBITOR 4,6-BIS(2,2,2-TRIFLUOROETHOXY)-1,3,5-TRIAZIN-2-AMINE II AMELIORATES COLLAGEN-INDUCED ARTHRITIS IN MICE,
Z. Y. Huang, W. N. Huang, C. C. Lin
|
|
2024 AB0735
|
ALTERED GALECTIN EXPRESSION CORRELATE WITH TNF-MEDIATED INFLAMMATORY CARTILAGE DAMAGE,
S. Hayer, B. Niederreiter, C. Strauß, R. Windhager, D. Aletaha, S. Toegel
|
|
2024 AB0751
|
CHRONOEFFICACY AND CHRONOTOXICITY OF IGURATIMOD AGAINST RHEUMATOID ARTHRITIS IN EXPERIMENTAL RATS,
Y. Jia, Q. Dong, H. Dong, Z. Wang, Z. LI
|
|
2024 AB0755
|
DIFFERENTIAL EFFECTS OF HDL-MODULATING AGENTS IN ARTHRITIS AND HDL PROPERTIES IN MOUSE MODELS OF EXPERIMENTAL ARTHRITIS,
E. Sevdali, E. Neofotistou Themeli, T. Chanis, E. Thymiakou, A. G. Dedemadi, E. Drakos, D. Kardassis, A. Chroni, P. Sidiropoulos
|
|
2024 AB0756
|
RESOLVING INFLAMMATION IN A MURINE MODEL OF ARTHRITIS THROUGH THE DUAL ANTAGONISM OF B-CELL ACTIVATING FACTOR (BAFF) AND IL-17,
P. Faghihi, S. Sidhu, M. Howell
|
|
2024 AB0770
|
WISP1 PROMOTES THE PROGRESSION OF RHEUMATOID ARTHRITIS THROUGH NLRP3 INFLAMMASOME ACTIVATION,
H. Wang, H. Chen, Z. Tang, K. Xie
|
|
2024 AB0772
|
IDENTIFICATION OF CELLULAR TARGETS OF JAK INHIBITORS TO EXERT BONE-PROTECTIVE EFFECTS, OSTEOCLASTS OR OSTEOBLASTS?,
H. Takayanagi, M. Komagamine, N. Komatsu, K. Okamoto, K. Matsuda, T. Takeuchi, Y. Kaneko
|
|
2024 AB0780
|
LOW-DOSE IL-2 AMELIORATED PERIPHERAL ARTHRITIS AND INTESTINAL INFLAMMATION IN COLLAGEN-INDUCED ARTHRITIS (CIA) MICE,
C. Wang, L. Cheng
|
|
2024 AB0783
|
A PRECLINICAL STUDY FOCUSSING ON OXIDATIVE STRESS IN ADJUVANT ARTHRITIS RAT MODEL TO EVALUATE THE EFFECT OF VARIOUS MOLECULAR WEIGHTS OF HYALURONIC ACID IN MONOTHERAPY AND IN COMBINATION WITH METHOTREXATE,
S. Khademnematolahi, K. Bauerova, K. Pružinská, F. Drafi, S. Ponist, K. Švík, J. Muchova On Behalf of Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Bratislava, Slovakia
|
|
2024 AB1034
|
CHARACTERIZATION OF RO7507062, A CD19-TARGETING T-CELL BISPECIFIC ANTIBODY (CD19TCB), AND DESIGN OF A PHASE 1 TRIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS,
F. Kollert, F. Regenass, R. Hallet, J. Neale, C. M. Looney, N. Frances, C. Marban-Doran, S. F. Soehrman, L. Millar, R. Finch, H. Ji, A. Frei, J. Sam, B. Fisher, T. Dörner, C. Klein, F. Schuler
|
|
2024 AB1111
|
GLYCOSYLATION OF γδT CELLS AS AN ESSENTIAL PLAYER IN THE IMMUNOPATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS,
B. Santos-Pereira, I. Alves, A. Campar, A. Marinho, C. Vasconcelos, S. Pinho
|
|
2024 AB1115
|
VITAMIN D SUPPLEMENTATION PRESENTS A POSITIVE EFFECT ON MEMORY BUT NO EFFECT ON ANXIOUS-DEPRESSIVE BEHAVIOR IN A PRISTANE-INDUCED LUPUS MOUSE MODEL,
T. E. Karnopp, G. Flores Chapacais, M. L. Gasparini, N. Garcia Dos Santos, V. Da Silva Freitas, M. Piccoli, A. Leite DI Domenico, L. Denardi Dória, N. M. Pereira de Souza, E. Correa Freitas, A. Rieger, O. A. Monticielo
|
|
2024 AB1119
|
REPRESSION OF ID3 AGGRAVATES LUPUS PHENOTYPES IN MURINE MODELS VIA ABERRANT B CELL DIFFERENTIATION,
Y. Park, D. S. Kim, M. L. Cho, S. K. Kwok
|
|
2024 AB1126
|
REBAMIPIDE ATTENUATES RENAL MANIFESTATIONS VIA ANTIOXIDANT EFFECTS ON PODOCYTES IN AN ANIMAL MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSUS,
Y. Park, Y. S. Song, D. S. Kim, S. G. Jang, S. K. Kwok
|
|
2024 AB1141
|
THERAPEUTIC POTENTIAL OF INHIBITION OF JAK1 AND 2 BY RUXOLITINIB, OF ROCK2 BY BELUMOSUDIL, AND OF BTK BY IBRUTINIB IN SYSTEMIC SCLEROSIS,
X. Hong, Y. Xiao, A. H. Györfi, L. Xu, L. Shen, R. Neelagar, V. Devakumar, T. Filla, T. Trinh-Minh, M. Liang, A. Rius Rigau, J. Distler, A. E. Matei
|
|
2024 AB1153
|
IDENTIFYING THE INVOLVEMENT OF ADROPIN/ENHO IN SYSTEMIC SCLEROSIS (SSc) THROUGH MACHINE LEARNING AND MULTI-MODEL VALIDATION,
J. Distler, M. Liang
|
|
2024 AB1159
|
HIGH FAT DIET AND THE ADIPOCYTE TO MYOFIBROBLAST TRANSITION: IMPLICATIONS FOR SYSTEMIC SCLEROSIS CUTANEOUS FIBROSIS,
A. Young, S. Hernandez, E. Volkmann, H. Christofk
|
|
2024 AB1162
|
A SELECTIVE AND ORALLY BIOAVAILABLE CXCR7 MODULATOR’S IMPACT ON BLEOMYCIN-INDUCED SKIN FIBROSIS IN A MOUSE MODEL,
Y. Kim, Y. Lee, E. Chae
|
|
2024 AB1164
|
ACCUMULATION OF MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES IN SYSTEMIC SCLEROSIS,
A. Manfredi, N. Maugeri, G. A. Ramirez, A. Capobianco, A. Monno, F. Iannone, S. Franchini
|
|
2024 AB1166
|
EXTENDED RELEASE OF INHALED ILOPROST LIPOSOME (L608) FOR TREATMENT OF SYSTEMIC SCLEROSIS-RELATED RAYNAUD PHENOMENA AND DIGITAL ULCER,
K. C. Chen, P. Kan, H. F. Liang
|
|
2024 AB1167
|
MECHANISM OF TOCILIZUMAB TREATMENT TO INHIBIT CD38+ MACROPHAGES IN SKIN FIBROSIS IN SYSTEMIC SCLEROSIS,
H. Zhu, H. Chen, D. Wang
|
|
2024 OP0016
|
INNATE MUCOSAL IMMUNE ACTIVATION AS THE TRIGGER TO PREVOTELLA-INDUCED ARTHRITIS,
Y. Maeda, M. Frech, K. Dürholz, E. Schmid, F. Schälter, I. Miyagawa, A. Kastbom, D. Sjöberg, A. Svärd, G. Schett, T. Strowig, M. M. Zaiss
|
|
2024 OP0030
|
PREDNISONE THERAPEUTIC EFFECT IN MYOSITIS DEPENDS ON Β-ADRENERGIC PATHWAY ACTIVATION INDUCED BY MYOFIBRES,
M. Giannini, D. Rovito, L. Debrut, C. Keime, A. L. Charles, B. Lannes, B. Geny, D. Metzger, G. Laverny, A. Meyer
|
|
2024 OP0038
|
UNRAVELLING THE GUT-JOINT CONNECTION IN RHEUMATOID ARTHRITIS: THE ROLE OF INTESTINAL ACETYLATED PROTEINS,
I. Miyagawa, I. Gimaev, W. Xiang, K. Dürholz, Y. Maeda, E. Schmid, H. Danzer, B. Eggers, S. Gubbi, V. Azizov, F. Schälter, M. Frech, K. Marcus-Alic, K. Sarter, Y. Tanaka, H. Bang, G. Schett, M. M. Zaiss
|
|
2024 OP0073
|
UNRAVELING PATHOPHYSIOLOGY AND HEMATOPOIESIS OF VEXAS SYNDROME BY MULTI-OMICS ANALYSIS AND TARGETED GENE EDITING,
C. Campochiaro, R. Molteni, G. Pacini, M. Fiumara, A. Tomelleri, E. Diral, D. Stefanoni, A. Varesi, A. Weber, R. Alfieri, L. Albano, M. Panigada, E. Cantoni, D. Canarutto, L. Bassoricci, P. Quaranta, A. D’alessandro, M. Matucci-Cerinic, R. DI Micco, A. Aiuti, F. Ciceri, I. Merelli, L. Dagna, S. Scala, S. Cenci, L. Naldini, S. Ferrari, G. Cavalli
|
|
2024 OP0096
|
ELIMINATION OF CD45RCHIGH T AND B CELLS BY ANTI-CD45RC mAb LEAD TO EFFICIENT CONTROL OF EXPERIMENTAL RHEUMATOID ARTHRITIS,
C. Bergua, M. Besnard, G. Ahmil, L. H. Ouisse, N. Vimond, A. Salama, B. Evrard, E. Brisebard, A. Collette, F. Blanchard, T. Larcher, R. Van Brempt, B. Le Goff, I. Anegon, C. Guillonneau
|
|
2024 OP0106
|
ROLES OF JAK-STAT SIGNALING AND GM-CSF FOR THE DEVELOPMENT OF OSTEITIS AND BONE MICROSTRUCTURE CHANGES IN RHEUMATOID ARTHRITIS,
T. Yoshida, Y. Murotani, K. Murata, H. Imai, T. Iwasaki, Y. Nakayama, M. Katsushima, M. Shirakashi, R. Nakashima, R. Watanabe, K. Murakami, H. Yoshifuji, A. Morinobu, M. Hashimoto
|
|
2024 OP0115
|
IDENTIFICATION AND VALIDATION OF ANTI-PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) ANTIBODY AS A NOVEL PROPELLING ANTIBODY FOR SYSTEMIC SCLEROSIS (SSc),
M. Liang
|
|
2024 OP0236
|
TYPE 3 CYTOKINE BLOCKADE IN TRANSLOCATION OF INSTESTINAL BACTERIA IN SPONDYLOARTHROPATHY,
B. Cai, R. Giri, H. Benham, L. Rehaume, G. Strutton, A. S. Bergot, R. Thomas
|
|
2024 OP0282
|
POVETACICEPT (ALPN-303; TACI vTD-Fc), AN ENHANCED, POTENT DUAL INHIBITOR OF BAFF AND APRIL, DEMONSTRATES GREATER TISSUE DISTRIBUTION VERSUS WILD-TYPE TACI-Fc IN ADULT MICE AND IMPROVED EFFICACY VERSUS WILD-TYPE TACI-Fc OR ANTI-CD20 IN THE IFNα-ACCELERATED NZB/W MOUSE MODEL OF SLE,
K. E. Lewis, Z. Maria, E. Repash, T. Blair, A. Enstrom, M. A. Seaberg, N. Wang, S. L. Peng, S. R. Dillon
|
|
2024 OP0313
|
THE ADAPTOR PROTEIN 3BP2 DEVELOPS SYSTEMIC LUPUS ERYTHEMATOSUS THROUGH ACTIVATION OF THE PATHOGENIC B CELLS,
S. Nawachi, T. Katsuyama, N. Kubota, Y. Terajima, K. Matsumoto, K. Hirose, K. Shidahara, T. Nakadoi, Y. Katayama, Y. Miyawaki, E. Katsuyama, M. Narazaki, Y. Matsumoto, J. Wada
|
|
2024 OP0319
|
G PROTEIN-COUPLED RECEPTOR KINASE 5 REGULATES FIBROBLAST ACTIVATION AND FIBROTIC TISSUE REMODELLING IN SYSTEMIC SCLEROSIS,
C. Tran-Manh, T. Trinh-Minh, C. Liebel, C. W. Chen, J. Distler
|
|
2024 OP0327
|
MAPPING THE JOINT-NERVE INTERACTOME OF THE KNEE: AN INTEGRATIVE APPROACH FOR IDENTIFYING NEW STRATEGIES FOR THE CONTROL OF JOINT PAIN,
A. M. Malfait, M. Olmer, A. Obeidat, J. Li, H. Swahn, M. Newton, F. Ko, B. Mehta, M. Otero, T. Maerz, D. Orange, R. Miller, R. Miller, M. Lotz
|
|
2024 POS0012
|
GM-CSF BY NATURAL KILLER CELLS DRIVES INFLAMMATORY ARTHRITIS IN HIV-INFECTED HUMANIZED MICE,
C. Sungur
|
|
2024 POS0014
|
CEMIP EXPRESSION IN SYSTEMIC SCLEROSIS AND ITS ROLE IN SKIN INFLAMMATION AND FIBROSIS,
C. Deroyer, G. Paulissen, Z. Plener, C. Ribbens, D. De Seny
|
|
2024 POS0025
|
ACTIVATION OF NOTCH1 SIGNALING IN FIBROBLASTS IS SUFFICIENT TO INDUCE FIBROSIS AND ACTIVATES A NETWORK OF PROFIBROTIC SIGNALING CASCADES,
C. Dees, A. Kalyva, C. Bergmann, M. Kunz, G. Schett, J. Distler
|
|
2024 POS0180
|
TARGETING OXIDIZED MACROPHAGE MIGRATION INHIBITORY FACTOR (oxMIF) WITH ANTIBODY ON104: A PROMISING THERAPEUTIC APPROACH FOR RHEUMATOID ARTHRITIS,
C. Landlinger, M. Ferhat, G. Rossmüller, K. Mangano, F. Nicoletti, M. Thiele
|
|
2024 POS0198
|
ZDHHC5 LIMITS OSTEOARTHRITIS PROGRESSION BY MEDIATING S-PALMITOYLATION OF NOD2 IN SYNOVIAL MACROPHAGES,
C. LI, T. Liu, J. Chen, S. Lin, J. Xu, Y. Ding
|
|
2024 POS0217
|
AGRIN HAS A DIRECT ANALGESIC EFFECT IN OSTEOARTHRITIS MODELS.,
S. Eldridge, F. Dajas-Bailador, V. Chapman, S. Bharde, S. Sikandar, D. Cici, F. Dell’accio
|
|
2024 POS0315
|
EXPLORING THE DTX1 GENE EXPRESSION IN HLA-B27 TRANSGENIC RATS AND SPA PATIENTS,
E. Cela, M. Lauraine, B. Cherqaoui, M. Breban, L. M. Araujo
|
|
2024 POS0323
|
GUT COMMENSAL TRANSLOCATION AND MOLECULAR MIMICRY FOR AUTOANTIBODY PRODUCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
M. Katsushima, Y. Nakayama, T. Yoshida, Y. Nishida, M. Shirakashi, R. Nakashima, H. Yoshifuji, R. Watanabe, A. Morinobu, M. Hashimoto
|
|
2024 POS0360
|
INHIBITION OF CERAMIDE METABOLISM POTENTIALLY REDUCES INFLAMMATION AND BONE DESTRUCTION IN RHEUMATOID ARTHRITIS,
Z. Yang, H. Liang, P. Zhang, Q. Liang
|
|
2024 POS0370
|
GUT MICROBIOTA DYSBIOSIS IMPACT CARDIAC AUTONOMIC FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS,
R. Audo, J. Thireau, O. Zemb, L. Rauzier, M. Barozet, J. Morel, A. Lacampagne, C. Daien
|
|
2024 POS0459
|
PANTREG: A CELL-THERAPY, SYSTEM-BIOLOGY - BASED APPROACH FOR THERAPY OF AUTOIMMUNITY,
S. Albani, Y. Zhao, D. Guo, M. Chew
|
|
2024 POS0462
|
PRECLINICAL DEVELOPMENT OF KYV-201, AN INVESTIGATIONAL ALLOGENEIC ANTI-CD19 CAR T CELL FOR THE TREATMENT OF AUTOIMMUNE DISEASE,
A. Mahne, B. Kwong, J. Cheng, J. Wang, J. Banuelos, P. Starokadomskyy, S. Park, C. Gibson, S. Sengupta, S. Sandoval, J. Bravo, J. Flandez, S. Shah, A. Goodsell, Y. Zhang, I. Miller, B. Schultes, T. Van Blarcom
|
|
2024 POS0463
|
A NOVEL, ORAL, ALLOSTERIC INHIBITOR OF TYK2 DEMONSTRATES IN VITRO POTENCY, SELECTIVITY, AND IN VIVO EFFICACY IN MOUSE MODELS OF PSORIASIS,
R. Hussein, P. Tsuruda, S. Mortezaei, N. Ferdyan, C. Wegerski, K. Srinivasan, G. Hirst, N. Mozaffarian
|
|
2024 POS0558
|
INTERFERING WITH THE COLLABORATIVE DNA BINDING OF EN1 AMELIORATES FIBROTIC TISSUE REMODELING IN SYSTEMIC SCLEROSIS,
L. Xu, V. Devakumar, A. H. Györfi, X. Hong, Y. Xiao, T. Filla, Y. N. Li, J. Distler, A. E. Matei
|
|
2024 POS0560
|
DYSFUNCTION OF ALVEOLAR EPITHELIAL CELL REPAIR IN HUMANIZED PULMONARY FIBROSIS MOUSE MODEL,
Z. H. LI, R. Mu
|
|
2024 POS0698
|
LYSYL OXIDASE AND LYSYL OXIDASE LIKE 2 CONTRIBUTE TO CARTILAGE CALCIFICATION IN OSTEOARTHRITIS,
S. Nasi, I. Bernabei, E. Faure, J. Wegrzyn, A. So, T. Hügle, N. Busso
|
|
2024 POS0716
|
DEVELOPMENT OF PRECLINICAL MODELS FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ARTHRITIS,
K. Murakami, Y. Hotta, A. Yoshida, H. Tsukamoto, M. Shirakashi, T. Yoshida, A. Morinobu
|
|
2024 POS0721
|
CCN1 IS A NOVEL THERAPEUTIC TARGET FOR REDUCING STRUCTURAL DAMAGE IN RHEUMATOID ARTHRITIS: DEMONSTRATION FROM 2 PRECLINICAL MODELS,
J. Avouac, M. Lesturgie, V. Gonzalez, A. Cauvet, F. Tilotta, Y. Allanore
|
|
2024 POS0786
|
EFFECT OF LORECIVIVINT ON CARTILAGE REPAIR IN A MOUSE MODEL OF JOINT SURFACE INJURY,
A. J. Roelofs, S. M. Clark, J. J. Mcclure, R. A. Symons, I. Cunningham, M. Robertson, A. Richmond, F. L. Collins, S. Kennedy, J. R. S. Tambiah, C. De Bari
|
|
2024 POS0791
|
INHIBITION OF THE GLUCOSE TRANSPORTER GLUT1 WEAKENS CHONDROCYTES AND AGGRAVATES MURINE OSTEOARTHRITIS,
A. Latourte, S. Carrabin, I. Slitine, Z. Bouchemla, H. K. Ea, M. Cohen Solal, P. Richette, E. Hay
|
|
2024 POS0793
|
CD14 CONTRIBUTES TO JOINT PAIN IN A MURINE MODEL OF OSTEOARTHRITIS,
N. Adamczyk, S. Ishihara, A. M. Malfait, C. Scanzello, R. Miller
|
|
2024 POS1093
|
Extl3 INVOLVED IN THE REGULATION OF ENDOCHONDRAL OSSIFICATION IN AXIAL SpA,
S. Hilliquin, O. Fogel, M. Tissier, C. Cherifi, K. Ibrahim, J. Melki, R. Olaso, B. Baroukh, P. Dieudé, L. Rogge, E. Bianchi, M. Do-Cruzeiro, F. M. F. Cornelis, R. Lories, P. Albanese, X. Houard, C. Bardet, C. Miceli Richard
|
|
2024 POS1102
|
ITACONATE IS A METABOLIC REGULATOR OF BONE FORMATION IN HOMEOSTASIS AND ARTHRITIS,
M. Kieler, L. Prammer, G. Heller, M. Hofmann, S. Sperger, D. Hanetseder, B. Niederreiter, A. Komljenovic, A. Miller, K. Klavins, T. Köcher, J. Brunner, I. Stanic, L. Oberbichler, A. Korosec, A. Vogel, M. Kerndl, D. Hromadová, L. Musiejovsky, A. Hajto, T. Piwonka, A. Dobrijevic, A. Haschemi, P. Georgel, D. Marolt Presen, J. Grillari, S. Hayer, J. P. Auger, G. Krönke, O. Sharif, D. Aletaha, G. Schabbauer, S. Blüml
|
|
2024 POS1156
|
THE ANTIRHEUMATIC DRUG IGURATIMOD MITIGATES DISUSE OSTEOPOROSIS IN MICE BY INHIBITING SCLEROSTIN AND RANKL PRODUCTION THROUGH THE ERK/EGR1/TNF-Α PATHWAY IN OSTEOCYTES,
T. Miura, K. Ebina, Y. Etani, T. Noguchi, M. Hirao, K. Takami, A. Goshima, T. Kurihara, Y. Fukuda, N. Ochiai, T. Kanamoto, K. Nakata, S. Okada
|
|
2024 POS1157
|
ROLE OF LECT2 IN THE REGULATION OF BONE METABOLISM IN VITRO AND IN VIVO,
C. H. Lee, C. H. Chung, J. Y. Kim, Y. H. Cheon, S. Y. Eun, G. D. Park, M. S. Lee
|
|
2024 POS1158
|
PEX5 ACTS AS A NEGATIVE REGULATOR OF RANKL-INDUCED OSTEOCLASTOGENESIS IN VITRO AND INFLAMMATORY CALVARIAL BONE DESTRUCTION IN VIVO,
C. H. Chung, C. H. Lee, S. Y. Eun, Y. H. Cheon, G. D. Park, J. Y. Kim, M. S. Lee
|
|
2024 POS1200
|
MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, REDUCES JOINT INFLAMMATION, CYTOKINE PRODUCTION, AND AUTOANTIBODY LEVELS IN A COLLAGEN-INDUCED ARTHRITIS DISEASE MODEL,
A. Cartwright, F. Desai, S. Vora, L. Gyger, L. Roditi, S. Nguyen, A. Trouilloud, D. Lam, P. Trenh, X. Lucas, M. Zlotosch, E. Liardo, D. Wible, V. Oleinikovas, I. Lamberto, B. Demarco, C. King, D. Bonenfant, E. Krishnan, S. De Beukelaer, S. Townson, O. Wallace, F. Janku, L. Mcallister, A. Paterson, M. Peluso
|
|
2024 POS1204
|
ANTI-CITRULLINATED HISTONE ANTIBODY CIT-013 TARGETS NETS IN INFLAMED JOINTS AND HALTS NET-MEDIATED JOINT DETERIORATION IN RA,
S. Kumari, A. Kip, M. Van der Linden, J. Stein, T. Bruurmijn, M. Foster, P. Van Zandvoort, S. Van Dalen, H. Van Es, E. Meldrum, R. Chirivi
|
|
2024 POS1210
|
EXTRACELLULAR DNA IN RHEUMATOID AND COLLAGEN ANTIBODY-INDUCED ARTHRITIS,
K. Macáková, V. Borbelyová, B. M. Schuh, E. Stenova, P. Celec, B. Vlkova
|
|
2024 POS1228
|
CANNABIGEROL IN THE TREATMENT OF COLLAGEN-INDUCED ARTHRITIS,
M. Sklenárová, M. Šteigerová, P. Jelínek, D. Bobek, M. Šoóš, M. Šíma, O. Slanař
|
|
2024 POS1232
|
NEUROINFLAMMATION IN AN EXPERIMENTAL MODEL OF ARTHRITIS: A PILOT STUDY,
N. Garcia Dos Santos, B. Bartikoski, T. E. Karnopp, R. Cavalheiro Do Espírito Santo, V. Da Silva Freitas, G. Flores Chapacais, M. L. Gasparini, S. Pilotti, I. Da Silva Torres, R. Machado Xavier on behalf of Laboratory of Autoimmune Diseases
|
|
2024 POS1391
|
UTILITY OF MOUSE MODELS OF LUPUS FOR CLINICAL RESEARCH AND DRUG TESTING,
M. Rivas-Torrubia, M. Morell, Z. Makowska, J. Kageyama, A. Buttgereit, J. Lindblom, P. Cytometry Consortium, I. Parodis, L. Beretta, R. Lesche, F. Mcdonald, M. Alarcon-Riquelme, G. Barturen On Behalf of Genetics of Complex Diseases
|
|
2024 POS1394
|
VITAMIN D SUPPLEMENTATION REDUCES IMMUNOGLOBULIN DEPOSITS IN THE BRAIN OF PRISTANE-INDUCED LUPUS MICE,
T. E. Karnopp, G. Flores Chapacais, M. L. Gasparini, N. Garcia Dos Santos, V. Da Silva Freitas, M. Piccoli, A. Leite DI Domenico, L. Denardi Dória, N. M. Pereira de Souza, E. Correa Freitas, A. Rieger, O. A. Monticielo On Behalf of Laboratório de Doenças Autoimunes (HCPA)
|
|
2024 POS1399
|
BANK1 SIGNALLING SHAPES THE GUT MICROBIOTA COMPOSITION BY CONTROLLING THE GUT MUCOSAL B CELL RESPONSE IN A TLR7-MEDIATED LUPUS MODEL,
M. Botía Sánchez, G. Galicia, D. Toro-Domínguez, A. López García, J. R. Valera, A. Margolles, N. Varela, M. Morell, M. Alarcon-Riquelme on behalf of Genetics of complex diseases
|
|
2024 POS1402
|
NEUTROPHILS FROM NLRP12 DEFICIENT LUPUS-PRONE MICE EXHIBITED HIGHER LEVEL OF ROS PRODUCTION AND NETS FORMATION AFTER STIMULATION,
Y. P. Tsao, S. T. Chen
|
|
2024 POS1408
|
TARGETING KEY COMPONENTS OF SLE PATHOGENESIS WITH THE MULTIFACETED IMMUNOMODULATORY PROPERTIES OF CENERIMOD, A SELECTIVE S1P1 RECEPTOR MODULATOR,
M. Martinic, T. Hoyler, D. Strasser, O. Berkani, P. Cornelisse, M. Murphy
|
|
|
[42]
|
Anti-Inflammatory Agents
|
|
|
| 2024 |
|
2024 AB0028
|
LONG-TERM TREATMENT PATTERNS OF CANAKINUMAB IN MONOGENIC AUTOINFLAMMATORY DISEASES (FMF, TRAPS, HIDS/MKD) AND SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) – 5-YEARS DATA FROM A BELGIAN REGISTRY,
M. Moutschen, H. Rabijns, C. Wouters
|
|
2024 AB0124
|
FEBUXOSTAT MONOTHERAPY IN GOUT: BEYOND URATE-LOWERING EFFICACY – UNVEILING ANTI-INFLAMMATORY POTENTIAL THROUGH CYTOKINE AND COX-2 MODULATION,
K. Kraev, B. Hristov, P. Uchikov, M. Kraeva, Y. Basheva-Kraeva, S. Popova-Belova, M. Geneva-Popova
|
|
2024 AB0177
|
EUPHORBIA FACTOR L2 ALLEVIATED GOUTY INFLAMMATION BY SPECIFICALLY SUPPRESSING BOTH THE PRIMING AND ACTIVATION PROCEDURE IN NLRP3 INFLAMMASOME,
Y. Li, Y. Zhuang, Y. Chen, G. Wang, Z. Tang, Y. Zhong, Y. Zhang, L. Wu, X. Ji, Q. Zhang, B. Pan, Y. Luo
|
|
2024 AB0190
|
SSGJ-613 RELIEVES PAIN AND REDUCES THE RISK OF ACUTE FLARES IN PATIENTS WITH GOUT: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PHASE II STUDY,
H. Zou, Y. Xue, Q. Zhou, Y. Xu, H. Huang
|
|
2024 AB0191
|
SERUM BIOMARKER CHANGES IN JUVENILE IDIOPATHIC ARTHRITIS TRIAL USING BARICITINIB,
V. Krishnan, J. Sims, C. Y. Chang, S. Keller, R. Wang, M. Hojnik, R. Benschop, S. Ogwu, C. Chew, A. V. Ramanan
|
|
2024 AB0225
|
INCREASED HOMOCYSTEINE LEVELS DURING THE FIRST 3 MONTHS OF BARICITINIB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS,
A. Felis-Giemza, K. Chmurzyńska, M. Ciechomska, P. Klimek, W. Maśliński, M. Massalska
|
|
2024 AB0453
|
APREMILAST FOR PSORIATIC ARTHRITIS IN THE NETHERLANDS: REAL-WORLD DATA FROM THE REWARD STUDY,
M. Vis, T. Jansen, I. Bridges, M. Plantenga, R. Bos
|
|
2024 AB0516
|
A PHARMACOKINETIC (PK) SIMILARITY STUDY BETWEEN AVT05 AND REFERENCE PRODUCT GOLIMUMAB,
C. Wynne, U. Lorch, E. Krantz, R. Katial, T. Ashdown, F. Berti On Behalf of AVT05 Study Team at Alvotech
|
|
2024 AB0700
|
DO RHEUMATOID ARTHRITIS PATIENTS IN REMISSION NEED SYMPTOMATIC TREATMENTS?,
S. Rahmouni, R. Fejji, K. Zouaoui, C. Mekki, M. Abbes, S. Boussaid, S. Rekik, H. Sahli, M. Elleuch
|
|
2024 AB0723
|
PHARMACOKINETICS OF ADALIMUMAB IN CYNOMOLGUS MONKEYS FOLLOWING DOSING WITH BHV-1300, A FIRST-IN-CLASS MOLECULAR DEGRADER OF IgG,
E. Dierks, P. Ackerman, D. Heller, A. Bunin, F. Engler, B. Gavin, D. Pirman, B. Car, I. Qureshi, V. Coric
|
|
2024 AB0738
|
EXPRESSION AND ROLE OF THE LNCRNA RP11-184M15.1 IN THE MYELOID COMPARTMENT DURING INFLAMMATION,
L. Stewart, H. Mackie, S. Kalli, E. Dracos, A. Najm, C. S. Goodyear
|
|
2024 AB0756
|
RESOLVING INFLAMMATION IN A MURINE MODEL OF ARTHRITIS THROUGH THE DUAL ANTAGONISM OF B-CELL ACTIVATING FACTOR (BAFF) AND IL-17,
P. Faghihi, S. Sidhu, M. Howell
|
|
2024 AB0803
|
TOTAL GLUCOSIDES OF PAEONY INHIBITING NLRP3 INFLAMMASOME ACTIVATION OF SUBMANDIBULAR GLAND CELLS IN MICE WITH SJÖGREN’S SYNDROME,
T. Jiang, G. Yao
|
|
2024 AB0910
|
VASCULAR EFFECTS OF ACHIEVING LOW DISEASE ACTIVITY IN AXIAL SPONDYLOARTHRITIS - A 2-YEAR PROSPECTIVE COHORT STUDY,
H. Meng, S. L. Lau, I. T. Cheng, B. P. Yan, A. P. W. Lee, H. So, L. S. Tam
|
|
2024 AB0920
|
BAMBOO SPINE PHENOTYPE ASSOCIATED WITH A HIGHER DISEASE BURDEN IN SPONDYLOARTHRITIS PATIENTS: AN ANCILLARY ANALYSIS OF THE ASAS-COMOSPA STUDY,
S. Hamroun, C. López-Medina, A. Etcheto, K. Oh, M. Dougados, A. Moltó, C. Miceli Richard, O. Fogel
|
|
2024 AB1126
|
REBAMIPIDE ATTENUATES RENAL MANIFESTATIONS VIA ANTIOXIDANT EFFECTS ON PODOCYTES IN AN ANIMAL MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSUS,
Y. Park, Y. S. Song, D. S. Kim, S. G. Jang, S. K. Kwok
|
|
2024 AB1157
|
PTGDS REGULATES PRO-INFLAMMATORY FIBROBLASTS AND CHEMOTAXIS OF MACROPHAGES TO PROMOTE SKIN FIBROSIS IN SYSTEMIC SCLEROSIS,
R. Mu, D. Fang
|
|
2024 AB1185
|
SERIOUS INFECTIONS IN SYSTEMIC SCLEROSIS: A SINGLE CENTRE DATA OF 30 YEARS,
A. G P, S. Ahmed, V. Agarwal
|
|
2024 AB1437
|
NON-PDL1 BLOCKING PD1 AGONISTIC ANTIBODIES MAY INDUCE PRO-INFLAMMATORY CYTOKINES PRODUCTION IN VITRO,
Y. Orlovsky, L. Y. Hao, M. Swiecki, S. Cole, S. Dutta, I. White
|
|
2024 AB1676-PARE
|
GAUDI STUDY: EFFECTS OF SPMS-ENRICHED OIL IN PATIENTS WITH SYMPTOMATIC KNEE OA,
I. Möller, G. Rodés, J. M. Villalón, J. A. Rodas, F. Angulo, N. Martínez Fernández, J. Verges on behalf of TriAnkle
|
|
2024 OP0031
|
COMPARATIVE ANALYSIS OF TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND INTERLEUKIN 17 INHIBITORS IN PSORIATIC ARTHRITIS: EXPLORING CARDIOVASCULAR OUTCOMES,
I. Tskhakaia, R. Ali, Y. González Moret, I. Tan
|
|
2024 OP0039
|
INTERLEUKIN-6 (IL-6)/IL-6 RECEPTOR AND PERSISTENCE OF INFLAMMATION IN GIANT CELL ARTERITIS. EFFECTS OF IL-6 RECEPTOR BLOCKADE WITH TOCILIZUMAB,
R. Alba-Rovira, F. Kamberovic, M. Corbera-Bellalta, E. Planas-Rigol, M. A. Alba, S. Prieto-González, J. Hernández-Rodríguez, G. Espígol-Frigolé, M. C. Cid
|
|
2024 OP0174
|
AVACOPAN VERSUS PREDNISONE TAPER IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND EAR, NOSE, OR THROAT INVOLVEMENT,
R. Spiera, R. Lebovics, S. Bray, R. E. Gurlin, D. R. W. Jayne, P. A. Merkel
|
|
2024 POS0002
|
JANUS KINASE INHIBITORS ENHANCE PROSTANOID BIOSYNTHESIS IN HUMAN WHOLE BLOOD - IMPLICATIONS FOR SIDE-EFFECTS AND PREVENTION STRATEGIES,
S. Alabbasi, S. Tacconelli, M. De Vries, I. Gunnarsson, A. De Michele, P. DI Gregorio, P. Patrignani, H. Idborg, P. J. Jakobsson
|
|
2024 POS0053
|
CARDIOVASCULAR SAFETY OF COLCHICINE AND NSAID PROPHYLAXIS WITH URATE-LOWERING THERAPY INITIATION: TARGET TRIAL EMULATION (TTE) ANALYSES,
C. Yokose, N. Mccormick, N. Lu, A. Abhishek, A. Gaffo, Y. Zhang, H. Choi
|
|
2024 POS0180
|
TARGETING OXIDIZED MACROPHAGE MIGRATION INHIBITORY FACTOR (oxMIF) WITH ANTIBODY ON104: A PROMISING THERAPEUTIC APPROACH FOR RHEUMATOID ARTHRITIS,
C. Landlinger, M. Ferhat, G. Rossmüller, K. Mangano, F. Nicoletti, M. Thiele
|
|
2024 POS0246
|
DATA FROM THE ADVOCATE TRIAL ON 28 PATIENTS WITH ANCA-ASSOCIATED VASCULITIS WHO RECEIVED AVACOPAN WITHOUT CONCOMITANT GLUCOCORTICOID USE IN THE FIRST 29 DAYS,
J. H. Stone, D. R. W. Jayne, S. Bray, D. Trimpe, R. E. Gurlin, P. A. Merkel on behalf of the ADVOCATE Study Group
|
|
2024 POS0271
|
INFLIXIMAB FOR PARENCHYMAL NEURO-BEHÇET’S SYNDROME: A META-ANALYSIS,
W. Zheng, X. Wang, Y. Liu, Y. Ao, J. Wang, J. Liu, Y. Xu
|
|
2024 POS0353
|
TREATMENT PATTERNS ANALYSIS IN PATIENTS WITH RARE AUTOINFLAMMATORY DISEASES IN THE UNITED STATES,
N. Yasar, S. O’brien, K. Peres Da Costa, W. Toro, A. Patel, K. Akhras
|
|
2024 POS0360
|
INHIBITION OF CERAMIDE METABOLISM POTENTIALLY REDUCES INFLAMMATION AND BONE DESTRUCTION IN RHEUMATOID ARTHRITIS,
Z. Yang, H. Liang, P. Zhang, Q. Liang
|
|
2024 POS0361
|
PPARΒ/Δ TARGETING AS A POSSIBLE ROUTE TO CONTROL AUTOIMMUNE OVERREACTION: EVIDENCE FROM HUMAN IN VITRO STUDY,
M. Sottili, G. Buoncuore, G. La Spina, G. Farina, C. Alessandri, F. Ceccarelli, F. Conti, F. R. Spinelli, C. Crescioli
|
|
2024 POS0367
|
PHENOTYPES OF THE PATIENTS WITH MORE THAN ONE AUTOINFLAMMATORY GENE VARIANT: CLASSIFIED DISEASES AND MIXED AUTOINFLAMMATORY DISORDERS (MAID),
S. Amikishiyev, T. Kalayci, R. Deniz, L. Soltanova, Y. Yalçinkaya, B. Artim-Esen, M. Inanc, A. Şahin, A. Aday, S. S. Ekmekci, N. Abaci, S. Ozturk, S. Palanduz, A. Gül
|
|
2024 POS0385
|
ORAL SYSTEMIC ENZYME COMBINATION ALLEVIATES SYSTEMIC INFLAMMATION, CARTILAGE DEGRADATION, AND PAIN IN KNEE OSTEOARTHRITIS–A PROOF-OF-MECHANISM, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY,
Y. Henrotin, V. Badot, S. Lieten, D. Urbin-Choffray, C. Brabant, J. E. Dubuc, S. Rau, O. E. Johansen, M. Eynatten
|
|
2024 POS0394
|
AMINAPHTONE SHORT-TERM TREATMENT REDUCES TGF-BETA PLASMA LEVELS IN SYSTEMIC SCLEROSIS PATIENTS WITH SECONDARY RAYNAUD’S PHENOMENON,
A. Sulli, S. Soldano, E. Gotelli, A. Cere, R. Campitiello, E. Hysa, T. Vojinovic, S. Paolino, M. Cutolo
|
|
2024 POS0465
|
A NOVEL THERAPEUTICALLY ACTIVE ANTI-TNFR2 AGONISTIC ANTIBODY PROMOTES TREG PROLIFERATION AND INDUCTION OF TREG FUNCTIONAL MARKERS,
T. Miyazaki, M. Maiti, I. Amit, D. Hamel, Q. Wu, R. Pena, K. Brendza, T. Chang, V. Guo, S. Kivimae, Y. Ofran, J. Zalevsky
|
|
2024 POS0551
|
PHARMACODYNAMIC EFFECTS AND EXPLORATORY EFFICACY OF AFIMETORAN, A TLR7/8 INHIBITOR, IN PATIENTS WITH CUTANEOUS LUPUS ERYTHEMATOSUS,
F. Baribaud, J. Saini, S. Ignatenko, K. Chadwick, L. Zhu, H. Y. T. Bach, H. Karabeber, M. Dawes, M. Harrison, L. Carayannopoulos, G. Krishna, F. Hosein
|
|
2024 POS0722
|
PURIFIED MONOCLONAL RHEUMATOID FACTORS BIND FC CONTAINING TNF INHIBITORS IN VITRO BUT NOT THE FC-FREE TNF INHIBITOR, CERTOLIZUMAB PEGOL,
S. Bidgood, D. Kallenberg, A. Turner, J. O’neill, G. Odede, K. Mikula, J. Zydron, H. Hailu, E. Lukijanczuk, S. Cross, K. Tyson, S. Heywood, C. Cara, B. Lauwerys, B. Ufuktepe, D. Humphreys, A. Shock
|
|
2024 POS0984
|
COMPARISON OF ON-LABEL TREATMENT PERSISTENCE IN REAL-WORLD PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING GUSELKUMAB VERSUS SUBCUTANEOUS IL-17A INHIBITORS,
N. J. Shiff, P. J. Mease, R. Zhao, S. Ferrante, S. D. Chakravarty, J. A. Walsh
|
|
2024 POS1195
|
A COMPARATIVE COHORT STUDY OF FAMILIAL MEDITERRANEAN FEVER OUTCOMES: ADDRESSING THE ROLE OF DEMOGRAPHIC DIFFERENCES IN UNDERSTANDING THE NATURE OF THE DISEASE,
B. H. Egeli, K. Marzan, T. Stein, M. Heshin-Bekenstein
|
|
2024 POS1253
|
LIDOCAINE-INDUCED TEAR PRODUCTION IN SJOGREN’S DISEASE: BROADENING THE HORIZON FOR TREATMENT OF OCULAR DRYNESS?,
D. Rijnenberg, E. Van der Heijden, H. Leavis, J. Van Roon
|
|
2024 POS1283
|
RISK FACTORS FOR FLARES IN ANTI-SYNTHETASE SYNDROME: CLINICAL FEATURES, AUTOANTIBODIES, AND TREATMENT,
A. Hasegawa, K. Kurasawa, A. Kikuchi, S. Komatsu, Y. Aizawa, A. Shimizu, Y. Yoshida, T. Hiyama, T. Miyao, A. Tanaka, S. Arai, R. Maezawa, M. Arima, K. Ikeda
|
|
2024 POS1329
|
TOFACITINIB IN THE MANAGEMENT OF REFRACTORY ADULT-ONSET STILL’S DISEASE WITH SYSTEMIC AND ARTHRITIC PHASES: TWO CASE REPORTS,
S. Aguilera, M. J. Barrera, D. Rivera
|
|
|
[103]
|
Artificial Intelligence
|
|
|
| 2024 |
|
2024 AB0055
|
DISEASE PROFILES IN A BEHÇET’S DISEASE MONOCENTRIC COHORT - A NEURAL NETWORK ANALYSIS,
F. DI Cianni, V. Lorenzoni, N. Italiano, D. Marinello, M. Mosca, R. Talarico
|
|
2024 AB0139
|
WHAT TYPES OF FIBROMYALGIA AND CHRONIC PAIN PATIENTS BENEFIT FROM MULTIMODAL INPATIENT PAIN PROGRAMS?,
T. Hügle, T. Pretat, C. Lovejoy, P. Ming Azevedo
|
|
2024 AB0218
|
NATURAL LANGUAGE PROCESSING TOOLS APPLIED TO FREE-TEXT EMR ALLOW TO DISTINGUISH INFLAMMATORY ARTHRITIS FROM OTHER RHEUMATIC CONDITIONS,
A. Papatolo, B. Maizza, A. Bellone, S. DI Giorgio, G. Tettamanzi, M. C. Grondelli, N. Lambri, N. Luciano, E. Barone, D. Loiacono, C. Selmi
|
|
2024 AB0223
|
INTEGRATION OF ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY: EXPLORING REAL-WORLD DATA RETRIEVAL AND INITIAL FINDINGS FROM A MAJOR NON-ACADEMIC HOSPITAL,
D. Hens, P. Van Riel, M. Merkelbach, R. Simons, N. Cornelis, T. Jansen
|
|
2024 AB0226
|
USING MACHINE LEARNING METHODS TO PREDICT DISEASE ACTIVITY SCORE FROM ACCELEROMETERY SIGNAL,
P. Mielnik, A. Myhre Hjelle, A. Traseth, M. Fojcik, K. Tokarz
|
|
2024 AB0245
|
THE CLINICAL USEFULNESS OF DIFFERENT PHENOTYPIC CLUSTERS OF ANTI-MDA5 ANTIBODY-POSITIVE DERMATOMYOSITIS,
J. J. E. Koopman, M. Y. Choi
|
|
2024 AB0359
|
CLINICAL DETERMINANTS INFLUENCING THE DECISION FOR TOTAL KNEE REPLACEMENT IN THE CONTEXT OF OSTEOARTHRITIS: A PREDICTIVE MODEL,
H. Naranjo, N. Perez-Alvarez, F. Ojeda, S. Tassani, J. Noailly, J. Monfort, L. Tío
|
|
2024 AB0533
|
HIGH-CONFIDENCE ASSESSMENT OF RESPONSE TO THERAPIES IN RHEUMATOID ARTHRITIS,
N. Soloman, L. Zhang, M. C. Zielinski, S. Guardiano, J. Dines
|
|
2024 AB0543
|
MACHINE LEARNING IN THE PREDICTION OF TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW,
P. Munguía-Realpozo, C. Mendoza Pinto, I. Etchegaray-Morales, M. Sánchez-Tecuatl, I. D. Maya-Castro, R. Berra-Romani, F. J. Arellano-Avendaño, M. García-Carrasco
|
|
2024 AB0736
|
DEVELOPMENT AND APPLICATION OF EPITOPESCAN, A PYTHON3 TOOLSET FOR MUTATION TRACKING IN SARS-CoV-2 IMMUNOGENIC EPITOPES RESTRICTED BY THE RHEUMATOID ARTHRITIS SUSCEPTIBILITY ALLELE HLA-DRB1*04:01,
A. Kovalenko, S. Viatte
|
|
2024 AB0741
|
WHOLE BLOOD-BASED TRANSCRIPTOMIC BIOMARKERS FOR PREDICTING ADALIMUMAB TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS IDENTIFIED THROUGH MACHINE LEARNING,
C. F. Yap, N. Nair, K. Hyrich, A. G. Wilson, J. Isaacs, A. Morgan, A. Barton, D. Plant On Behalf of 3TR
|
|
2024 AB0759
|
USING MACHINE LEARNING TO PREDICT SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC THERAPIES,
F. Z. Aharrane, F. E. Abourazzak, T. Fatima Zahrae, A. Amar, I. Hmamouchi, I. El Bouchti, Z. Baba, F. Allali, R. Bahiri, A. Bezza, A. El Maghraoui, I. Ghozlani, H. Hassikou, T. Harzy, I. Linda, S. Janani, R. Niamane, R. Abouqal
|
|
2024 AB0800
|
DIAGNOSING SJOGREN’S SYNDROME: A MULTI-MODAL DEEP LEARNING APPROACH WITH HISTOPATHOLOGIC IMAGES AND CLINICAL DATA,
I. Brahim, A. Uguen, R. Zeghlache, V. Devauchelle-Pensec, D. Cornec
|
|
2024 AB0802
|
AI-ENABLED TISSUE CLASSIFIER FOR SJOGREN’S DISEASE SALIVARY GLAND IDENTIFIES KEY HISTOLOGICAL FEATURES IMPORTANT FOR UNDERSTANDING DISEASE MANIFESTATION,
M. C. Marlin, L. Bradshaw, K. Wright, A. Rasmussen, R. H. Scofield, L. Radfar, K. Grundahl, C. J. Lessard, A. D. Farris, J. M. Guthridge
|
|
2024 AB0837
|
“PRECISION UNVEILED: TUNISIAN INNOVATIONS IN AI-ASSISTED ULTRASONOGRAPHY FOR ENHANCED SJOGREN’S SYNDROME DIAGNOSIS”,
R. Bourguiba, A. Ben Aicha, N. Nouira, M. Charfi, K. Bouzaidi, S. Bellakhal, H. Fathallah
|
|
2024 AB0875
|
ARTIFICIAL INTELLIGENCE TO PREDICT DISEASE ACTIVITY USING A MULTIMODAL MODEL WITH MAGNETIC RESONANCE IMAGING AND LABORATORY RESULTS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS,
H. S. Cha, J. Lee, S. Lee, S. Kang, H. Kim, E. M. Koh
|
|
2024 AB0922
|
CLINICAL PHENOTYPES IN SPONDYLOARTHRITIS: CLUSTER ANALYSIS IN AN ARGENTINE COHORT,
J. M. Dapeña, M. Benegas, M. V. Martire, C. Airoldi
|
|
2024 AB0984
|
LONG-TERM OUTCOME IN SLE-PAH PATIENTS BASED ON AUTOANTIBODY CLUSTERING FROM A SINGLE CENTRE IN INDIA,
L. Rajasekhar, R. Baisya, N. Gollakota, P. K. Devarasetti
|
|
2024 AB0989
|
CHATGPT4’S PROFICIENCY IN ADDRESSING PATIENTS’ QUESTIONS ON SYSTEMIC LUPUS ERYTHEMATOSUS: A BLINDED COMPARATIVE STUDY WITH SPECIALISTS,
R. Mu, C. Xu, D. Xu, J. Zhao, R. Liu, Y. Dai, K. Sun, P. Wong, S. S. M. Lee, L. W. Koh, J. Wang, S. Xie, L. Zeng
|
|
2024 AB1055
|
MACHINE LEARNING MODELING FOR PREDICTION OF POTENTIAL RISK FACTORS ASSOCIATED WITH KIDNEY INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS,
S. Xie, Y. Jiang, B. Xie, F. Yuan, A. Chen, Z. Lin
|
|
2024 AB1065
|
A COMPOSITE BIOMARKER INCLUDING URINARY ALCAM HOLDS PROMISE IN LUPUS NEPHRITIS, ANALYSIS FROM A TERTIARY CARE CENTRE IN SOUTH INDIA,
S. B, A. V, R. Aithala, G. V, V. Shobha
|
|
2024 AB1067
|
VALIDATION OF MACHINE LEARNING ALGORITHM TO CHARACTERIZE DISEASE COMPLEXITY AND FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS,
S. L. Bosello, L. Lilli, C. Masciocchi, L. Antenucci, J. Lenkowicz, A. Ortolan, P. G. Cerasuolo, L. Lanzo, S. Piunno, G. Castellino, M. Gorini, S. Patarnello, M. A. D’agostino
|
|
2024 AB1123
|
MACHINE LEARNING MODELS FOR ANALYZING THE PROGNOSTIC FACTORS OF SLE PATIENTS WITH EBV INFECTION,
J. Tu, M. Fang, M. Huang, T. Zhou, J. Gui, L. Sun
|
|
2024 AB1127
|
IMPACT OF OVERWEIGHT AND OBESITY ON CLINICAL AND IMMUNOLOGICAL FEATURES IN SYSTEMIC LUPUS ERYTHEMATOSUS,
X. Zhang, R. Quinet, W. Davis, C. Keshavamurthy, J. Zakem, S. Ahrens, S. Shah, D. Reeves, S. Centala, A. Reese, S. Hayat, T. Leeth, S. Umer
|
|
2024 AB1138
|
APPLICATION OF MACHINE LEARNING METHODS TO PREDICT SF-36 MENTAL HEALTH DOMAIN FOR SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS,
E. Gaydukova
|
|
2024 AB1347
|
PERSPECTIVES OF ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY- RESULTS FROM A PROSPECTIVE SURVEY IN GERMANY,
M. T. Holzer, A. Meinecke, F. Mueller, I. Haase, H. Morf, T. Witte, H. Labinsky, P. Klemm, J. Knitza, M. Krusche
|
|
2024 AB1377
|
EXPLORING THE LANDSCAPE OF ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY: INSIGHTS, PERCEPTIONS, AND FUTURE CONSIDERATIONS FROM A SURVEY OF UNITED STATES RHEUMATOLOGY FELLOWS,
R. Purohit, S. Saineni, R. Mathai, R. Sambandan, R. Perez, N. Bhanusali
|
|
2024 AB1451
|
NEW APPROACHES TO THE STUDY OF SOCIAL DETERMINANTS OF HEALTH: DISCOVERY, EXTRACTION AND CHARACTERISATION OF MUSCULOSKELETAL PATIENTS’ OCCUPATIONS IN THE ELECTRONICAL MEDICAL RECORD USING DEEP LEARNING AND PRE-TRAINED LANGUAGE MODELS,
A. Madrid García, I. Pérez - Sancristóbal, L. León, L. Abasolo, A. Rodríguez González, B. Fernández-Gutiérrez, E. Menasalvas Ruiz, L. Rodriguez Rodriguez
|
|
2024 AB1453
|
PYROPTOTIC GENES AS PREDICTORS OF BONE RESORPTION AND MINERALIZATION IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS,
Z. Yang, M. MA, Y. Liang, Y. Wen, P. Zhang, R. Huang
|
|
2024 AB1455
|
EXPLORING THE RISK, CAUSALITY RELATIONSHIP AND MOLECULAR MECHANISM BETWEEN SYSTEMIC LUPUS ERYTHEMATOSUS AND THYROID CANCER: A META, MENDELIAN RANDOMIZATION AND TRANSCRIPTOME ANALYSES,
S. Liu, H. Chen, Q. Sun, Y. Liu, X. Yuan, D. Wang, L. Sun
|
|
2024 AB1462
|
COMPARATIVE ASSESSMENT OF THE ACCURACY AND SATISFACTION OF RESPONSES TO E-CONSULTATIONS IN RHEUMATOLOGY: CHAT-GPT VS SPECIALISTS (CORE-RC STUDY),
R. Mazzucchelli, P. Turrado-Crespí, N. Crespí-Villarías, J. L. Andréu Sánchez, J. Dorado, J. A. García-Vadillo, C. Carvajal, J. Quiros Donate, I. Sanchez, N. Puyo, R. Almodóvar, P. Zarco-Montejo, C. Pijoán-Moratalla, E. Pérez-Fernández
|
|
2024 AB1471
|
MACHINE-LEARNING BASED MODELS ASSIST THE IDENTIFICATION OF PULMONARY EMBOLISM IN AUTOIMMUNE DISEASES-A RETROSPECTIVE, MULTICENTER STUDY,
L. Dong
|
|
2024 AB1480
|
STRATIFICATION OF PATIENTS USING ADVANCED INTEGRATIVE MODELLING OF DATA ROUTINELY ACQUIRED FOR DIAGNOSING RHEUMATIC COMPLAINTS (SPIDeRR): A MULTICENTER EUROPEAN CONSORTIUM,
J. Desai, E. Van den Akker, J. Askling, B. Axnäs, A. Banos, L. Carmona, L. Christiansson, M. Hulsinga, D. De Jong, J. Knitza, H. Morf, F. Muehlensiepen, A. Pratt, G. Nagy, J. Newton, L. Rodriguez Rodriguez, D. Schiphof, S. Viatte, M. Villalobos Quesada, R. Knevel
|
|
2024 AB1488
|
IS THE FUTURE OF RHEUMATOLOGY HERE? A STUDY OF A PROPRIETARY RULE ENGINE AND ARTIFICIAL INTELLIGENCE GPT4 (AI GPT4) FOR INITIAL EVALUATION OF RHEUMATOLOGY CASES,
H. M. Badsha, B. Khan, G. Harifi, A. J, S. Raman
|
|
2024 AB1491
|
QUANTIFICATION OF LUNG INVOLVEMENT IN INFLAMMATORY RHEUMATIC DISEASE-INTERSTITIAL LUNG DISEASE (IRD-ILD): A COMPARATIVE STUDY BETWEEN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS USING AI-BASED HRCT ANALYSIS,
T. Hoffmann, U. Teichgräber, B. Lassen-Schmidt, D. Renz, L. B. Brüheim, M. Krämer, P. Oelzner, J. Böttcher, F. Güttler, G. Wolf, A. Pfeil
|
|
2024 AB1520
|
THE PERSPECTIVE OF DUTCH HEALTH CARE PROFESSIONALS ON THE USE OF ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY,
L. M. Verhoef, H. J. Bernelot Moens, N. Steinz, H. E. Vonkeman, R. Knevel
|
|
2024 AB1583-HPR
|
GENERATIVE AI-BASED KNOWLEDGE GRAPH AND TEXT NETWORK ANALYSIS FOR THE ILLUSTRATION AND DEVELOPMENT OF MHEALTH SELF-MANAGEMENT CONTENT,
M. Blanchard, V. Venerito, T. Hügle
|
|
2024 AB1602-HPR
|
A COMPARATIVE ANALYSIS OF MANUAL ALLOCATION VS. AUTOMATED AND AI-SUPPORTED APPROACHES FOR INITIAL APPOINTMENT ALLOCATION IN RHEUMATOLOGY,
S. Krämer, A. Floege, S. Handt, F. Juzek-Küpper, K. Vogt, T. Rauen
|
|
2024 AB1640-HPR
|
ENHANCING RHEUMATOLOGY RESEARCH THROUGH TRANSDISCIPLINARY COLLABORATION: THE VITAL ROLE OF STATISTICIANS AND DATA SCIENTISTS,
M. Najibi, A. Bengtsson
|
|
2024 AB1641-HPR
|
CHATGPT AMONG TUNISIAN PHYSICIANS: ARE RHEUMATOLOGISTS MORE ENGAGED?,
W. Lahmar, D. Ben Nessib, H. Ferjani, F. Majdoub, L. Kharrat, D. Kaffel, K. Maatallah, W. Hamdi
|
|
2024 OP0002-PARE
|
A LARGE LANGUAGE MODEL BASED APPROACH TO PROVIDING PERSONALISED HEALTH-RELATED INFORMATION FOR OSTEOPOROSIS PATIENTS,
A. Wilson, A. Adesina, Y. Jiao, K. Douglas
|
|
2024 OP0010
|
EVALUATION OF THE RISK OF PSORIATIC ARTHRITIS IN PATIENTS WITH PSORIASIS UNDERGOING BIOLOGICAL TREATMENT. GLOBAL POPULATION STUDY (TRINETX),
B. Joven-Ibáñez, R. Rivera, G. Hernandez, C. García-Donoso, J. L. Pablos Álvarez
|
|
2024 OP0018
|
DISSECTING EARLY RA PATIENT TRAJECTORIES THROUGH TIME-INDEPENDENT DISEASE STATE IDENTIFICATION IDENTIFIES DISTINCT PATTERNS DISSECTED BY INFLAMMATION IN BLOOD OR JOINTS,
N. Steinz, T. D. Maarseveen, A. Cope, J. Isaacs, A. Winkler, T. Huizinga, A. Yann, R. Knevel
|
|
2024 OP0111
|
QUIESCENT HUMAN BLOOD MONOCYTE STATES ARE PRE-COMMITTED TO AN INFLAMMATORY SYNOVIAL TRANSCRIPTIONAL PROGRAM,
E. Amies, M. Christofi, B. Mulhearn, L. Marshall, M. Sutcliffe, K. Hyrich, A. Morgan, A. G. Wilson, J. Isaacs, D. Plant, A. Barton, T. Hussell, S. Raychaudhuri, P. Martin, S. Viatte
|
|
2024 OP0112
|
DEVELOPMENT OF A DEEP LEARNING MODEL FOR AUTOMATED DETECTION OF CALCIUM PYROPHOSPHATE DEPOSITION ON HAND RADIOGRAPHS,
T. Hügle, E. Rosoux, T. Manigold, G. Fahrni, D. Markham, F. Becce
|
|
2024 OP0125
|
MACHINE LEARNING TO CHARACTERIZE BONE BIOMARKERS PROFILE IN RHEUMATOID ARTHRITIS,
G. Adami, A. Fassio, O. Viapiana, C. Benini, D. Gatti, M. Rossini
|
|
2024 OP0145
|
DISCOVERY AND VALIDATION OF A NEW CLASSIFICATION OF ANA-RMDS THAT BETTER PREDICT LONG TERM OUTCOMES COMPARED TO LEGACY DIAGNOSES,
J. Arnold, G. Barturen, S. Relton, L. M. Carter, M. Y. MD Yusof, Z. Wigston, D. Toro-Domínguez, M. Alarcon-Riquelme, E. M. Vital on behalf of PRECISESADS Clinical Consortium
|
|
2024 OP0146
|
ENHANCING CARDIOVASCULAR RISK PREDICTION IN RA PATIENTS WITH CARDIOTHORACIC RATIO DERIVED FROM DEEP LEARNING,
M. Fujisaki, S. Honda, K. Ikari, E. Tanaka, M. Harigai
|
|
2024 OP0158
|
A NOVEL APPROACH FOR MIXED-METHODS RESEARCH USING LANGUAGE LEARNING MODELS: A REPORT USING PATIENTS’ PERSPECTIVES ON BARRIERS TO HIP AND KNEE REPLACEMENT,
I. Mannstadt, S. Goodman, M. Rajan, S. Young, F. Wang, I. Navarro-Millan, B. Mehta
|
|
2024 OP0182
|
PREDICTION OF TREATMENT RESPONSE IN PATIENTS WITH ARTHRALGIA AT RISK FOR DEVELOPMENT OF RA, BY DEEP LEARNING FROM MRI SCANS OF THE WRIST, HAND AND FOOT,
T. Hassanzadeh, Y. Li, D. Shamonin, D. A. Ton, M. Reijnierse, A. H. M. Van der Helm – van Mil, B. Stoel
|
|
2024 OP0190
|
QUANTIFICATION OF TENOSYNOVITIS, SYNOVITIS AND BONE MARROW EDEMA IN RHEUMATOID ARTHRITIS FROM WRIST MRIs, BASED ON DEEP LEARNING,
D. Shamonin, Y. Li, T. Hassanzadeh, M. E. Bakker, D. A. Ton, M. Reijnierse, A. H. M. Van der Helm – van Mil, B. Stoel
|
|
2024 OP0194
|
COMPUTATIONAL SYSTEMS BIOLOGY APPROACH TO UNVEIL MOLECULAR INTERACTIONS IN SJÖGREN’S SYNDROME PATHOGENESIS,
S. E Silva-Saffar, J. E. Gottenberg, M. Bombardieri, D. Cornec, J. O. Pers, M. Alarcon-Riquelme, P. Moingeon, M. Barnes, S. Ng, W. F. Ng, X. Mariette, G. Nocturne, A. Niarakis
|
|
2024 OP0203
|
PREDICTING THE ONSET OF END-STAGE KNEE OSTEOARTHRITIS OVER TWO- AND FIVE-YEARS USING MACHINE LEARNING,
Z. Salis, J. Driban, T. Mcalindon
|
|
2024 OP0220
|
SCREENING TOOLS FROM PERIPHERAL BLOOD SMEARS TO DIFFERENTIATE VEXAS SYNDROME FROM DIFFERENTIAL DIAGNOSES: VACUOLES IN CIRCULATING IMMATURE MYELOID CELLS AND DEEP LEARNING ANALYSIS OF MATURE MYELOID CELLS IMAGE,
V. Lacombe, G. Urbanski, C. Lavigne, C. Ravaiau, F. Genevieve, F. Chabrun
|
|
2024 OP0227
|
COMPARISON OF LUNG ULTRASOUND B-LINES AND PLEURAL LINE ALTERATIONS WITH AUTOMATED QUANTITATIVE CT: IS IT POSSIBLE TO OVERCOME THE LIMITATIONS OF THE ULTRASOUND METHOD?,
D. Mohammad Reza Beigi, G. Pellegrino, N. Landini, M. Mattone, C. De Nardo, G. Paone, I. Bisconti, F. R. DI Ciommo, M. Cadar, S. Truglia, V. Panebianco, F. Conti, V. Riccieri
|
|
2024 OP0239
|
DECODING THE COMPLEXITY OF CHILDHOOD-ONSET SLE (cSLE) USING A HIGH-DIMENSIONAL APPROACH: ENHANCING THERAGNOSIS WITH AN IMMUNOLOGICAL-BASED DIAGNOSTIC MODEL REVEALING MECHANISTIC INSIGHTS,
K. Nay Yaung, J. G. Yeo, M. Wasser, S. L. Poh, K. L. Teh, L. Das, Y. X. Book, N. K. H. Khoo, Z. M. Y. Tay, R. Cheong, J. J. M. Wong, T. Arkachaisri, S. Albani
|
|
2024 POS0032
|
UTILIZING HIGH-DIMENSIONALITY MASS CYTOMETRY TO DECODE COMPLEX IMMUNOPATHOGENIC NETWORK FOR POTENTIAL THERAGNOSTIC APPLICATIONS IN EARLY SYSTEMIC SCLEROSIS,
M. Noviani, P. Kumar, V. R. Chellamuthu, A. Lajam, A. Chia, K. Nay Yaung, M. Wasser, J. G. Yeo, A. Low, S. Albani
|
|
2024 POS0160-HPR
|
IMPACT OF A SMARTPHONE DIGITAL THERAPEUTIC (DTx) APP WITH REAL-TIME FEEDBACK IN THE MANAGEMENT OF AXIAL SPONDYLOARTHRITIS (axSpA) THROUGH PHYSIOTHERAPY HOME-BASED EXERCISE PROGRAM: A PILOT STUDY,
G. Italiano, T. Nava, A. Carpino, M. Cavezza, G. Espedito, M. P. Ferraro, R. Fera, S. Marino, F. Martiniello, S. Ronzullo, M. L. Vella, A. M. Zottolo
|
|
2024 POS0165
|
MACHINE LEARNING-BASED APPROACHES TOWARDS STRATIFICATION OF DISEASE SEVERITY AND ORGAN DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE),
P. Garantziotis, D. Nikolopoulos, C. Adamichou, A. Fanouriakis, A. Repa, D. Boumpas, P. Sidiropoulos, G. K. Bertsias
|
|
2024 POS0190
|
POLYGENIC RISK SCORE ANALYSIS USING GRAPH CONVOLUTIONAL NETWORKS FOR PREDICTING AUTOIMMUNE DISEASE DEVELOPMENT,
S. Honda, K. Ikari, C. Terao, M. Harigai, Y. Kochi
|
|
2024 POS0236
|
HARNESSING THE POWER OF RADIOMICS TO PREDICT PERSISTENCE ON TNFi THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: A PROOF-OF-CONCEPT STUDY,
V. Venerito, S. Del Vescovo, A. Cito, M. Giannotta, C. Scioscia, G. Lopalco, F. Iannone
|
|
2024 POS0238
|
INVESTIGATING PERIPHERAL IMMUNOME DYSREGULATION IN KNEE OSTEOARTHRITIS: IMPLICATIONS FOR DISEASE CLASSIFICATION AND PATHOGENESIS,
A. Chia, A. Lajam, G. Ang, M. Wasser, Y. Y. Leung, S. Albani
|
|
2024 POS0273
|
A MACHINE LEARNING ALGORITHM BASED ON AUTOMATICALLY EXTRACTED IMAGE FEATURES AND CLINICAL DATA ON MORNING STIFFNESS CAN DISTINGUISH PSORIATIC ARTHRITIS PATIENTS FROM CONTROLS IN CLINICAL ROUTINE CARE,
M. Köhm, L. Zerweck, T. A. Bergmann, H. Kratz, D. Antweiler, S. Kugler, S. Tsiami, M. Polyzou, X. Baraliakos, S. Ohrndorf, A. Barton, L. C. Coates, S. R. Pennington, O. Fitzgerald, F. Behrens on behalf of HIPPOCRATES
|
|
2024 POS0388
|
INTEGRATED SOLUBLE PROTEOMICS AND AUTOREACTOMICS: PREDICTING RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS,
J. M. Guthridge, R. Lu, B. Jones, C. Guthridge, C. Arriens, J. Merrill, J. A. James
|
|
2024 POS0444
|
ARTIFICIAL INTELLIGENCE VERSUS RHEUMATOLOGIST IN DECISION MAKING IN THE TREATMENT OF RHEUMATOID ARTHRITIS. DO WE THINK ALIKE?,
O. Rusinovich Lovgach, E. Calvo-Aranda, A. I. Ramos-Lisbona, P. Cardoso-Peñafiel, P. Navarro Palomo, M. Machattou, M. Alonso de Francisco, C. Navarro Joven, A. Martínez Rodado, L. Ramos Ortiz de Zarate, M. Fernandez Castro, H. Godoy, B. García Magallón, J. Campos Esteban, C. Barbadillo, C. Isasi Zaragoza, J. Sanz, C. Merino Argumánez, M. Cantalejo Moreira, A. Diaz Oca, P. Navarro, J. L. Andréu Sánchez
|
|
2024 POS0451
|
DETECTION OF JOINT SWELLING IN RHEUMATOID ARTHRITIS THROUGH ANALYSIS OF DORSAL FINGER FOLDS IN SEQUENTIAL HAND PHOTOS: CHALLENGES IN A REAL-WORLD SETTING,
C. Koller, M. Blanchard, D. Brüschweiler, P. Hermann, T. Hügle
|
|
2024 POS0463
|
A NOVEL, ORAL, ALLOSTERIC INHIBITOR OF TYK2 DEMONSTRATES IN VITRO POTENCY, SELECTIVITY, AND IN VIVO EFFICACY IN MOUSE MODELS OF PSORIASIS,
R. Hussein, P. Tsuruda, S. Mortezaei, N. Ferdyan, C. Wegerski, K. Srinivasan, G. Hirst, N. Mozaffarian
|
|
2024 POS0465
|
A NOVEL THERAPEUTICALLY ACTIVE ANTI-TNFR2 AGONISTIC ANTIBODY PROMOTES TREG PROLIFERATION AND INDUCTION OF TREG FUNCTIONAL MARKERS,
T. Miyazaki, M. Maiti, I. Amit, D. Hamel, Q. Wu, R. Pena, K. Brendza, T. Chang, V. Guo, S. Kivimae, Y. Ofran, J. Zalevsky
|
|
2024 POS0468
|
USE OF A MOLECULAR SIGNAL RESPONSE CLASSIFIER TO PREDICT INADEQUATE RESPONSE TO TNFi RESULTS IN FEWER PATIENTS PRESCRIBED TNFi,
G. Karpouzas, L. Zhang, M. C. Zielinski, S. Guardiano, J. Dines
|
|
2024 POS0491
|
AUTOMATIC DETECTION AND LOCALIZATION OF SPINAL LESIONS ON [18F]FLUORIDE PET/CT IN SPONDYLOARTHRITIS PATIENTS,
W. R. P. Van der Heijden, G. J. C. Zwezerijnen, F. H. P. Van Velden, R. Boellaard, C. J. Van der Laken
|
|
2024 POS0493
|
RADIOMICS CAN DISCRIMINATE BETWEEN AXIAL SPONDYLOARTHRITIS AND AXIAL PSORIATIC ARTHRITIS: A MACHINE LEARNING ANALYSIS ON MRI RADIOMIC FEATURES OF BONE MARROW OEDEMA,
V. Venerito, S. Del Vescovo, C. Scioscia, M. Giannotta, M. G. Anelli, F. Cacciapaglia, F. Iannone, G. Lopalco
|
|
2024 POS0587
|
EMPLOYING MACHINE LEARNING TO PREDICT RA DIAGNOSIS FROM REFERRAL LETTERS BY THE GENERAL PRACTITIONER,
T. D. Maarseveen, H. K. Glas, J. Veris-Van Dieren, R. Knevel
|
|
2024 POS0589
|
EHR DEFINED BASELINE RA-SUBSETS CHARACTERISED BY LOCALISED JOINT INVOLVEMENT DIFFERENTIALLY ASSOCIATE WITH GENETIC RISK AND CLINICAL OUTCOMES BEYOND BASELINE,
T. D. Maarseveen, M. P. Maurits, S. Böhringer, N. Steinz, S. A. Bergstra, B. M. Boxma-De Klerk, A. H. M. Van der Helm – Van Mil, C. F. Allaart, M. J. T. Reinders, T. Huizinga, E. B. Van Den Akker, R. Knevel
|
|
2024 POS0607
|
LEVERAGING SINGLE CAMERA MOTION CAPTURING AS A DIGITAL BIOMARKER FOR DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS USING COMPUTER VISION: THE PROOF-OF-CONCEPT MEFISTO STUDY,
V. Venerito, T. Manigold, M. Capodiferro, D. Markham, M. Blanchard, F. Iannone, T. Hügle
|
|
2024 POS0629
|
IDENTIFICATION OF RA PHENOTYPES USING UNSUPERVISED CLUSTERING,
S. Steiger, H. Westerlind, D. DI Giuseppe, J. Askling
|
|
2024 POS0633
|
IMPACT OF GENETICS ON PREDICTING PERSISTENCE TO TREATMENT WITH METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS,
A. Öberg Sysojev, B. Delcoigne, T. Frisell, L. Alfredsson, L. Klareskog, E. Baecklund, L. Björkman, A. Kastbom, S. Rantapää Dahlqvist, C. Turesson, M. Boman, L. Padyukov, J. Askling, H. Westerlind
|
|
2024 POS0652
|
DIAGNOSING RHEUMATOID ARTHRITIS BY EXHALED BREATH PROFILING USING AN ELECTRONIC NOSE: AN EXPLORATIVE CASE-CONTROL STUDY,
D. Gerritsen, R. Scheps, C. Blaauwgeers, M. Hegeman, P. Ten Klooster, H. E. Vonkeman
|
|
2024 POS0657
|
MACHINE LEARNING-BASED PREDICTION OF TREATMENT RESPONSE TO ANTI-TUMOR NECROSIS FACTOR AND JANUS KINASE INHIBITOR THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS,
B. Y. Kim, J. Koo, J. Yeo, J. C. Lee, G. Choi, H. Choi, F. Kim, M. Kim
|
|
2024 POS0682
|
UNSUPERVISED MACHINE-LEARNING CLUSTERING ANALYSIS FOR CARDIOVASCULAR RISK ASSESSMENT IN RA PATIENTS IDENTIFIES SPECIFIC PHENOTYPES BEYOND THE SCORE-2 PREDICTION MODEL,
F. Cacciapaglia, V. Venerito, G. L. Erre, M. Piga, G. Sakellariou, O. Viapiana, E. Bartoloni, A. Manfredi, E. Gremese, F. R. Spinelli, F. Atzeni On Behalf of Cardiovascular Obesity and Rheumatic DISease Study Group of the Italian Society of Rheumatology
|
|
2024 POS0734
|
UNSUPERVISED MACHINE LEARNING IDENTIFIES DISTINCT SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT ENDOTYPES BASED ON B CELL PHENOTYPING AND AUTOANTIBODY PROFILES WITH DIFFERENTIAL RESPONSE TO BELIMUMAB,
R. Depascale, N. Cetrez, J. Lindblom, L. Iaccarino, A. Doria, D. Nikoloupolos, M. Gatto, I. Parodis
|
|
2024 POS0738
|
CHATGPT-4 FOR PATIENT EDUCATION IN LUPUS: A QUALITY AND EMPATHY ANALYSIS,
I. Haase, T. Xiong, A. Rissmann, J. Knitza, J. Greenfield, M. Krusche
|
|
2024 POS0749
|
RESPECTIVE PERFORMANCES OF CHATGPT AND GOOGLE FOR THE DIAGNOSIS OF RARE DISEASES IN RHEUMATOLOGY,
J. Lasnier-Siron
|
|
2024 POS0762
|
SEEKING FOR PREDICTORS OF INACTIVE DISEASE IN JUVENILE IDIOPATHIC ARTHRITIS WITH ARTIFICIAL INTELLIGENCE,
A. I. Rebollo Giménez, D. Cangelosi, F. Ridella, S. Orsi, E. Aldera, V. Natoli, S. Rosina, E. Naredo, A. Ravelli
|
|
2024 POS0824
|
ARTIFICIAL INTELLIGENCE (DEEP NEURAL NETWORK ANALYSIS) AS A SKIN OUTCOME: RESULTS OF AN OPEN-LABEL BELUMOSUDIL TRIAL IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS,
B. Gunes, L. Duran Camacho, S. Cowper, G. Panse, N. Page, E. Bundschuh, A. Williams, M. Carns, K. Aren, N. Pradhan, E. Bernstein, S. Fantus, E. Volkmann, H. Bukiri, C. Correia, F. Wilson, S. Mawe, J. M. Mahoney, R. Wang, M. Hinchcliff
|
|
2024 POS0828
|
AUTOMATED ANALYSIS OF NAILFOLD CAPILLARIES USING A LOW-COST USB MICROSCOPE - A ROUTE TO INCREASING UPTAKE OF NAILFOLD CAPILLAROSCOPY IN THE OUT-PATIENT CLINIC?,
M. Berks, P. Gurunath Bharathi, A. Murray, G. Dinsdale, J. Manning, A. L. Herrick, C. Taylor
|
|
2024 POS0904
|
UNLOCKING PRECISION IN CAPILLAROSCOPY: EXTERNAL VALIDATION OF THE CAPI-SCORE ALGORITHM FOR ACCURATE PATTERN IDENTIFICATION IN NAILFOLD VIDEOCAPILLAROSCOPY,
G. Lledó, L. Sáez-Comet, M. Freire Dapena, M. A. Mesa Navas, M. Martín Cascón, A. Guillén-Del-Castillo, E. Martínez Robles, J. A. Todoli, C. P. Simeón-Aznar, D. C. Varela, G. Maldonado, A. Marín Ballvé, N. Longares Ibáñez, B. D. C. Gracia Tello, E. Ramos Ibañez
|
|
2024 POS0907
|
THE SIGNIFICANCE OF ANALYSED MILLIMETERS IN INTERPRETING NAILFOLD CAPILLAROSCOPY IMAGES,
B. D. C. Gracia Tello, L. Sáez-Comet, G. Lledó, M. Freire Dapena, M. A. Mesa Navas, M. Martín Cascón, A. Guillén-Del-Castillo, E. Martínez Robles, C. P. Simeón-Aznar, A. Marín Ballvé, F. J. Orti Cuerva, A. Rodríguez Trigueros, N. Longares Ibáñez, E. Ramos Ibañez
|
|
2024 POS0951
|
AN EXPLAINABLE ARTIFICIAL INTELLIGENCE ALGORITHM FOR AUTOMATED GENERATION OF VAN DER HEIJDE SHARP SCORE IN PSORIATIC ARTHRITIS,
R. Janiczek, D. Govind, K. Broos, N. Fountoulakis, L. Noonan, S. Yamamoto, N. Zemlianskaia, C. S. Meyer, E. Scherer, M. Deman, P. Damasceno, P. S. Murphy, T. Rooney, E. C. Hsia, A. Beutler, K. Standish, S. S. F. Yip
|
|
2024 POS1014
|
USE OF AN INTERACTIVE ADAPTIVE-TRIAL AI SIMULATION TOOL TO INCREASE EFFICIENCY AND PROMOTE INFORMED DECISION MAKING WITHIN LUPUS CLINICAL TRIAL TEAMS, A CASE STUDY,
T. Ilan Ber, D. Goldstaub, O. Machluf, N. Shanwetter Levit, R. Cohen, Y. Racah, E. Berkman, R. Pryluk, M. B. Urowitz
|
|
2024 POS1021
|
UNSUPERVISED MACHINE-LEARNING ALGORITHM FOR THE IDENTIFICATION OF CLINICAL PHENOTYPES ACROSS PATIENTS INITIATING BELIMUMAB IN THE LUPUS ITALIAN REGISTRY (LIRE) OF THE ITALIAN SOCIETY FOR RHEUMATOLOGY,
M. Gatto, V. Venerito, D. Rozza, G. Landolfi, C. A. Scirè, G. D. Sebastiani, F. Conti, A. Doria on behalf of Centro Studi SIR
|
|
2024 POS1052
|
PREDICTING FIBROMYALGIA OUTCOME FROM A RHEUMATIC-SPECIFIC SURVEY,
D. Selani, L. Qin, F. Zegers, L. Klareskog, E. Steyerberg, S. Le Cessie, B. Axnäs, M. J. T. Reinders, E. B. Van den Akker, R. Knevel
|
|
2024 POS1054
|
MOST RHEUMATOID ARTHRITIS PATIENTS WITH 0 OR 1 TENDER AND SWOLLEN JOINT COUNT AND PATIENT GLOBAL ASSESSMENT GREATER THAN 3/10 HAVE POSITIVE SCREENING FOR FIBROMYALGIA, DEPRESSION, NECK PAIN, BACK PAIN FATIGUE AND JOINTS WITH LIMITED MOTION/DEFORMITY ON AN MDHAQ,
T. Pincus, R. Hunter, N. Rodwell
|
|
2024 POS1063
|
EXPLORING GENETIC AND IMMUNE CELL DYNAMICS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH EPSTEIN–BARR VIRUS INFECTION VIA COMBINED MICROARRAY AND SINGLE-CELL RNA SEQUENCING ANALYSES,
J. Gui, M. Fang, J. Tu, X. Chen, L. Sun
|
|
2024 POS1069
|
ARTIFICIAL INTELLIGENCE MODEL FOR SEGMENTATION AND SEVERITY SCORING OF OSTEOPHYTES IN HAND OSTEOARTHRITIS ON ULTRASOUND IMAGES,
B. Schultz Overgaard, A. Bossel Holst Christensen, L. Terslev, T. R. Savarimuthu, S. A. Just
|
|
2024 POS1085
|
UNDERSTANDING AGE AS A RISK FACTOR FOR COMPLICATIONS AFTER TOTAL KNEE ARTHROPLASTY: WHAT CAN WE LEARN FROM MACHINE LEARNING?,
B. Mehta, Y. Yuan, C. Heiting, K. Ho, S. Goodman, P. Sculco, F. Wang, S. Ibrahim, P. Cram, R. Caruna
|
|
2024 POS1142
|
DEVELOPMENT AND VALIDATION OF A RULE-BASED FRAMEWORK FOR AUTOMATED IDENTIFICATION OF LONGITUDINAL CLINICAL FEATURES ABOUT SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS FROM ELECTRONIC HEALTH RECORDS,
A. Ortolan, L. Lilli, S. L. Bosello, L. Antenucci, C. Masciocchi, J. Lenkowicz, P. Cerasuolo, L. Lanzo, S. Piunno, G. Castellino, M. Gorini, S. Patarnello, M. A. D’ Agostino
|
|
2024 POS1144
|
IDENTIFICATION OF PREDICTORS OF CARDIOVASCULAR EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A MACHINE LEARNING APPROACH,
D. Mauro, E. Gaggiano, A. Milone, M. Patrone, F. Riccio, G. Cuomo, S. Fasano, F. Ciccia
|
|
2024 POS1239
|
DEEP LEARNING BASED IMAGE RECOGNITION SYSTEM OF SALIVARY GLAND ULTRASOUND ASSISTED DIAGNOSIS OF PRIMARY SJOGREN ’S SYNDROME,
Z. Zhang, Y. Geng, X. Zhang
|
|
2024 POS1250
|
CLASSIFICATION OF SALIVARY GLAND BIOPSIES IN SJÖGREN’S SYNDROME BY A CONVOLUTIONAL NEURAL NETWORK USING AN AUTO-MACHINE LEARNING PLATFORM,
J. Álvarez Troncoso, E. Ruiz Bravo, C. Soto Abánades, A. Dumusc, Á. López Janeiro, T. Hügle
|
|
2024 POS1278
|
INTEGRATING LARGE LANGUAGE MODELS IN MEDICINE: A STUDY OF ANTHROPIC’S CLAUDE’S PERFORMANCE IN MDAAT SCORING FOR IDIOPATHIC INFLAMMATORY MYOPATHIES,
L. Gupta, V. Venerito, M. Fornaro, S. Sabbagh, S. Ghosh, H. Chinoy on behalf of MyoLLM Investigators Group
|
|
2024 POS1364
|
USE OF ARTIFICIAL INTELLIGENCE IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS: A SYSTEMATIC REVIEW,
D. Benavent, L. Carmona, J. F. Garcia Llorente, M. Montoro, S. Ramirez, T. Oton, E. Loza, A. Gómez-Centeno
|
|
2024 POS1376
|
AUTOMATIC SEGMENTATION-FREE INFLAMMATION SCORING IN RHEUMATOID ARTHRITIS FROM MRI USING DEEP LEARNING,
Y. LI, D. Shamonin, T. Hassanzadeh, D. A. Ton, M. Reijnierse, A. H. M. Van der Helm – van Mil, B. Stoel
|
|
2024 POS1380
|
TRANSFORMING RHEUMATOID ARTHRITIS CARE: A GROUNDBREAKING APPROACH TO PREDICTIVE TREATMENT OUTCOMES USING ARTIFICIAL INTELLIGENCE,
C. Ibañez, G. S. Rodríguez-Vargas, F. Rodriguez-Florido, P. Rodríguez-Linares, A. Rojas-Villarraga, P. Santos-Moreno
|
|
|
[69]
|
Atherosclerosis
|
|
|
| 2024 |
|
2024 AB0012
|
MIGRAINE IN PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: A POTENTIAL ROLE OF NAILFOLD CAPILLAROSCOPY FROM A PROSPECTIVE STUDY,
P. Triggianese, L. De Marco, I. Cristiano, M. Albanese, B. Sciacca, A. Bergamini, B. Kroegler, E. Greco, M. S. Chimenti
|
|
2024 AB0195
|
CARDIOVASCULAR EVENT IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS IN CASTILLA LA MANCHA: UTILITY OF CAROTID ULTRASOUND,
D. Velasco, M. A. Ramírez Huaranga, L. Jiménez Rodríguez, M. González Peñas, L. Martín de la Sierra López, M. Paulino Huertas, V. Salas Manzanedo, D. Castro-Corredor, M. D. Mínguez Sánchez, J. Anino-Fernández
|
|
2024 AB0213
|
THE CARDIOVASCULAR RISK OF JAK INHIBITORS IN TREATING RHEUMATIC DISEASES,
A. Kwan, E. Ingrid, M. Jiang, K. Lim
|
|
2024 AB0380
|
INHIBITION OF TOLL-LIKE RECEPTORS ALTERS MACROPHAGE CHOLESTEROL EFFLUX AND FOAM CELL FORMATION,
J. Kim, M. H. Ahn, H. A. Kim, J. W. Kim, C. H. Suh, J. Y. Jung
|
|
2024 AB0427
|
HIGHER GLUCOSE-TRIGLYCERIDE INDEX LEVELS WERE FOUND ASSOCIATED WITH PATIENTS WITH CAROTID PLAQUE AND PSORIATIC ARTHRITIS,
V. Gonzalez-Gonzalez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. R. Azpiri-Lopez
|
|
2024 AB0428
|
ASSOCIATIONS BETWEEN DIAGNOSIS DELAY, DISEASE ACTIVITY AND CARDIOVASCULAR RISK IN PSORIATIC ARTHRITIS,
A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez, D. A. Galarza-Delgado, I. J. Colunga-Pedraza, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. González-González
|
|
2024 AB0449
|
THE ROLE OF HOMOCYSTEINE IN THE DEVELOPMENT OF ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR DISEASES IN PATIENTS WITH PSORIATIC ARTHRITIS,
A. Bilukha, S. Smiyan, B. Koshak
|
|
2024 AB0451
|
COMPARING THE 2023 PREVENTTM AND THE 2013 AMERICAN COLLEGE OF CARDIOLOGY/AMERICAN HEART ASSOCIATION ALGORITHMS FOR DETECTION OF CAROTID PLAQUE IN PSORIATIC ARTHRITIS PATIENTS,
N. Guajardo-Jauregui, J. R. Azpiri-Lopez, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. González-González, A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez
|
|
2024 AB0454
|
LIPID ALTERATIONS AND THE IMPACT OF BIOLOGICS IN PSORIATIC ARTHRITIS MANAGEMENT,
A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez, D. A. Galarza-Delgado, I. J. Colunga-Pedraza, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. González-González
|
|
2024 AB0476
|
FIBROSIS-4 INDEX ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS IN PSORIATIC ARTHRITIS AND ITS RELATIONSHIP TO CARDIOVASCULAR RISK,
A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez, D. A. Galarza-Delgado, I. J. Colunga-Pedraza, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. González-González, P. Gamez-Siller
|
|
2024 AB0486
|
EVOLUTION OF SUBCLINICAL ATEROSCLEROSIS IN PATIENTS WITH PSORIATIC ARTHROPATHY,
L. Montolio-Chiva, I. Vázquez-Gómez, M. Robustillo-Villarino, J. Lacasa-Molina, C. Valera-Ribera, À. Martínez-Ferrer, E. Valls-Pascual, D. Ybáñez-García, C. Vergara-Dangond, I. Torner Hernández, A. Conesa, A. Lozano Saez, E. Flores-Fernández, M. A. Belmonte Serrano, J. J. Alegre-Sancho
|
|
2024 AB0493
|
DISCERNING THE MOST EFFECTIVE PREDICTOR OF CARDIOVASCULAR RISK FOR PATIENTS WITH PSORIATIC ARTHRITIS,
V. Gonzalez-Gonzalez, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, N. Guajardo-Jauregui, A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez
|
|
2024 AB0494
|
ROLE OF HEMATOLOGICAL INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS,
I. Vázquez-Gómez, L. Montolio-Chiva, J. Lacasa-Molina, L. Perea-Galera, A. Taberner-Cortés, M. Robustillo-Villarino, À. Martínez-Ferrer, E. Valls-Pascual, D. Ybáñez-García, C. Valera-Ribera, P. Andújar-Brazal, A. Mayo-Juanatey, P. León-Torralba, J. J. Alegre-Sancho
|
|
2024 AB0553
|
RELATIONSHIP BETWEEN ENDOTHELIAL FUNCTION AND QRISK3 IN RHEUMATOID ARTHRITIS,
A. Syngle, I. Verma, V. Sabarwal, K. Chauhan
|
|
2024 AB0562
|
THE EFFECTS OF TOFACITINIB IN SIMULTANEOUSLY IMPROVING GLYCAEMIC PARAMETERS AND INFLAMMATORY MARKERS IN RHEUMATOID ARTHRITIS PATIENTS WITH COMORBID TYPE 2 DIABETES. A PROOF-OF-CONCEPT, OPEN, PROSPECTIVE, CLINICAL STUDY,
P. Ruscitti, C. Di Muzio, I. Di Cola, A. Shariat Panahi, F. Sensini, F. Ursini, A. Iagnocco, R. Giacomelli, P. Cipriani
|
|
2024 AB0564
|
COMPARATIVE ANALYSIS OF SERUM URIC ACID LEVELS VERSUS URIC ACID/CREATININE RATIO IN PATIENTS WITH CAROTID PLAQUE,
A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez, D. A. Galarza-Delgado, I. J. Colunga-Pedraza, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. González-González
|
|
2024 AB0576
|
PERCUTANEOUS CORONARY INTERVENTION (PCI) IN PATIENTS WITH RHEUMATOID ARTHRITIS(RA): A SYSTEMATIC REVIEW AND META-ANALYSIS,
S. Piplani, A. Kostojchin, S. Kong, A. Sharma, D. Brown, V. Jelic, S. Chaturvedi, V. R. Bejugam, T. Simpson, W. Xiao, A. Sharma, M. Radulovic
|
|
2024 AB0624
|
NON-INVASIVE MEASUREMENT OF ENDOTHELIAL DYSFUNCTION (PERIFLUX) IN PATIENTS WITH RHEUMATOID ARTHRITIS,
S. Dans-Caballero, M. L. Ladehesa-Pineda, M. C. Ábalos-Aguilera, P. Ruiz Limón, C. Perez-Sanchez, A. Escudero-Contreras
|
|
2024 AB0632
|
EVALUATION OF NOVEL CARDIOVASCULAR RISK CALCULATORS IN PATIENTS WITH RHEUMATOID ARTHRITIS,
V. Gonzalez-Gonzalez, D. A. Galarza-Delgado, I. J. Colunga-Pedraza, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, N. Guajardo-Jauregui, A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez
|
|
2024 AB0659
|
ASSOCIATION OF PLASMA ATHEROGENIC INDEX WITH CAROTID INTIMA-MEDIA HYPERPLASIA IN PATIENTS WITH RHEUMATOID ARTHRITIS,
V. Gonzalez-Gonzalez, D. A. Galarza-Delgado, I. J. Colunga-Pedraza, J. R. Azpiri-Lopez, R. I. Arvizu-Rivera, J. A. Cardenas-de la Garza, M. F. Elizondo-Benitez, A. L. Guajardo-Aldaco
|
|
2024 AB0675
|
NON-INVASIVE ASSESSMENT OF MICRO- AND MACROVASCULAR FUNCTION AFTER INITIATION OF JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS,
P. Anyfanti, E. Angeloudi, E. Pagkopoulou, E. Bekiari, M. Doumas, P. Avgerou, K. Defteraiou, G. Kitas, T. Dimitroulas
|
|
2024 AB0677
|
C-REACTIVE PROTEIN AT RHEUMATOID ARTHRITIS ONSET IS THE FOREMOST CAUSE FOR A CONTINUING SUBCLINICAL ATHEROSCLEROSIS PROGRESSION,
H. Hannawi, S. Hannawi, M. Al-Salmi
|
|
2024 AB0698
|
HEMATOLOGICAL INDICES IN RHEUMATOID ARTHRITIS: USE AS A PREDICTOR OF SUBCLINICAL ATEROSCLEROSIS, CARDIOVASCULAR EVENTS AND DEATH,
C. Valera-Ribera, P. León-Torralba, L. Perea-Galera, A. Taberner-Cortés, J. Lacasa-Molina, A. Mayo-Juanatey, P. Andújar-Brazal, I. Vázquez-Gómez, E. Valls-Pascual, À. Martínez-Ferrer, D. Ybáñez-García, J. J. Alegre-Sancho, M. Robustillo-Villarino
|
|
2024 AB0755
|
DIFFERENTIAL EFFECTS OF HDL-MODULATING AGENTS IN ARTHRITIS AND HDL PROPERTIES IN MOUSE MODELS OF EXPERIMENTAL ARTHRITIS,
E. Sevdali, E. Neofotistou Themeli, T. Chanis, E. Thymiakou, A. G. Dedemadi, E. Drakos, D. Kardassis, A. Chroni, P. Sidiropoulos
|
|
2024 AB0806
|
HUMORAL RESPONSES AGAINST HDL ARE LINKED TO UNFAVORABLE LIPOPROTEIN TRAITS AND LIPID SPECIES IN PRIMARY SJÖGREN SYNDROME,
J. Rodríguez-Carrio, S. Suárez, P. López, Á. I. Pérez-Álvarez, L. Caminal-Montero, A. Suárez
|
|
2024 AB0830
|
MICRORNAS AS POTENTIAL BIOMARKERS FOR SUBCLINICAL ATHEROSCLEROSIS IN PRIMARY SJÖGREN’S SYNDROME,
N. Zehrfeld, M. Abelmann, S. Benz, T. Seeliger, F. Engelke, T. Skripuletz, C. Baer, T. Thum, T. Witte, K. Sonnenschein, D. Ernst, A. A. Derda
|
|
2024 AB0841
|
HOMOCYSTEINE AND CAROTID INTIMA-MEDIA THICKNESS IN PRIMARY SJÖGREN’S SYNDROME PATIENTS,
D. Perković, M. Janković Danolić, M. Petrić, I. Barišić, K. Gugo, J. Božić
|
|
2024 AB0880
|
PROGNOSTIC SIGNIFICANCE OF DISEASE DURATION, AGE, AND PERSISTENT INFLAMMATION IN AORTIC VALVE DEGENERATIVE LESIONS AMONG PATIENTS WITH SPONDYLOARTHRITIS,
H. S. Park, A. Laiz, P. Moya Alvarado, L. Sainz Comas, A. García-Alija, A. Casals Urquiza, C. Díaz-Torné, B. P. Magallares, I. Castellví, S. P. Fernandez-Sanchez, J. Bernardez, H. Codes, J. L. Tandaipan, C. Pitarch, A. Garcia Guillen, C. Marco Pascual, A. Lopez-Ferrer, L. Puig, H. Corominas
|
|
2024 AB0910
|
VASCULAR EFFECTS OF ACHIEVING LOW DISEASE ACTIVITY IN AXIAL SPONDYLOARTHRITIS - A 2-YEAR PROSPECTIVE COHORT STUDY,
H. Meng, S. L. Lau, I. T. Cheng, B. P. Yan, A. P. W. Lee, H. So, L. S. Tam
|
|
2024 AB1009
|
NOVEL MARKERS OF MICRO- AND MACROVASCULAR DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM THE SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED CARDIOVASCULAR RISK (LUPCARD) COHORT,
K. Triantafyllias, F. Tietze, A. Schwarting
|
|
2024 AB1021
|
BIOMARKERS OF DYSFUNCTIONAL HDL IN LUPUS NEPHRITIS AND ITS ASSOCIATION WITH SUBCLINICAL ATHEROSCLEROSIS,
S. Zarali, E. Cingoz, S. Cinar, D. Baykiz, A. Poyanli, A. K. Bilge, Y. Yalcinkaya, A. Gul, M. Inanc, B. Artim Esen
|
|
2024 AB1031
|
PATIENT SATISFACTION OF SUBCUTANEOUS BELIMUMAB AND IMPACT ON DISEASE ACTIVITY AND LUPUS NEPHRITIS IN LONG-LASTING SYSTEMIC LUPUS ERYTHEMATOSUS,
T. Shirai, M. Yamato, Y. Ishii, H. Sato, T. Ishii, H. Fujii
|
|
2024 AB1035
|
CARDIOVASCULAR RISK IN SYSTEMIC LUPUS ERYTHEMATOSUS: CAROTID ULTRASONOGRAPHY IS USEFUL FOR THE RE-STRATIFICATION OF CARDIOVASCULAR RISK DETERMINED BY SCORE2,
C. Corrales-Selaya, L. Riancho Zarrabeitia, C. Bejerano, V. Portilla González, R. Blanco, V. Martinez Taboada, A. Corrales Martinez
|
|
2024 AB1060
|
ASSOCIATION BETWEEN TRIGLYCERIDE-GLUCOSE INDEX AND CAROTID ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CROSS-SECTIONAL STUDY,
Z. Zhang, W. Xie
|
|
2024 AB1184
|
OSCILLOMETRIC, GREYSCALE- AND NOVEL POWER-DOPPLER-ULTRASOUND INDICES OF CARDIOVASCULAR AND CEREBROVASCULAR RISK IN PATIENTS WITH SYSTEMIC SCLEROSIS: DATA FROM THE SCLEROCARD COHORT,
K. Triantafyllias, A. Raetsch, A. Schwarting
|
|
2024 AB1227
|
SUBCLINCAL ATHEROSCLEROSIS AND CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THE GENERAL POPULATION,
S. Oreska, H. Štorkánová, A. Pekáčová, J. Kudlicka, V. Tuka, O. Mikeš, Z. Krupičková, M. Satny, E. Chytilova, J. Kvasnicka, M. Špiritović, B. Heřmánková, P. Česák, M. Rybar, K. Pavelka, L. Šenolt, R. Bečvář, J. Vencovský, M. Vrablik, M. Tomčík
|
|
2024 AB1233
|
ROLE OF HEMATOLOGICAL INDICES IN SYSTEMIC SCLEROSIS: USE AS A PREDICTOR OF SUBCLINICAL VASCULAR DAMAGE, CARDIOVASCULAR EVENTS AND DEATH,
C. Valera-Ribera, L. Perea-Galera, J. Lacasa-Molina, A. Taberner-Cortés, À. Martínez-Ferrer, E. Valls-Pascual, I. Vázquez-Gómez, P. León-Torralba, P. Andújar-Brazal, A. Mayo-Juanatey, M. Robustillo-Villarino, D. Ybáñez-García, J. J. Alegre-Sancho
|
|
2024 AB1268
|
SUBCLINICAL ATHEROSCLEROSIS AND LIPID PROFILE IN PATIENTS WITH WEGENER’S GRANULOMATOSIS: A META-ANALYSIS,
R. Yadav
|
|
2024 AB1305
|
NON-INVASIVE VASCULAR BIOMARKERS IDENTIFY SUBCLINICAL VASCULAR DAMAGE IN PRIMARY SYSTEMIC VASCULITIS,
O. D. Argyropoulou, A. A. Argyris, E. K. Aissopou, D. Mouziouras, G. Charalampopoulos, C. P. Mavragani, N. Tentolouris, P. P. Sfikakis, P. G. Vlachoyiannopoulos, A. D. Protogerou
|
|
2024 AB1330
|
PREVALENCE OF CAROTID ATHEROSCLEROSIS IN PATIENTS WITH GIANT CELL ARTERITIS,
J. Fernandes Serodio, C. Saca, F. Batista, F. Seguro Paula, S. Oliveira, J. Delgado Alves
|
|
2024 AB1468
|
ATTAINMENT OF GUIDELINE-RECOMMENDED CHOLESTEROL GOALS IN CARDIOVASCULAR PREVENTION - RESULTS FROM A PREVENTIVE CARDIO-RHEUMA CLINIC IN NORWAY,
E. J. P. Sollerud, E. Ikdahl, J. Sexton, A. Eirheim, A. G. Semb On Behalf of Preventive Cardio-Rheuma Clinic, REMEDY Centre for Treatment of Rheumatic and Musculoskeletal Diseases
|
|
2024 AB1644-PARE
|
EVALUATION OF MODIFIABLE CARDIOVASCULAR RISK FACTORS IN PRIMARY SJOGREN SYNDROME,
A. Dellal, N. Olivier, K. K. Irène, F. K. Doryne, H. Ons, R. Niariantsoa, O. Fain, J. Sellam, A. Mekinian
|
|
2024 OP0004
|
AGE-ASSOCIATED B-CELLS ARE EXPANDED IN EARLY RHEUMATOID ARTHRITIS LINKED TO ATHEROSCLEROSIS AND IMMUNE CIRCUITS: A POTENTIAL ROLE AS A BIOMARKER FOR RISK STRATIFICATION,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2024 OP0189
|
MOLECULAR MECHANISMS AND IMMUNE CELL PATTERNS IN PERIPHERAL BLOOD ASSOCIATED TO CORONARY ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS,
R. Martinez-Canales, E. Rojas Gutiérrez, C. Elizondo Solis, N. Macias-Segura, M. Salinas Carmona
|
|
2024 OP0215
|
COMPARISON OF THE DIAGNOSTIC ACCURACY OF TEMPORAL ARTERY ULTRASOUND AND CRANIAL T1-BLACK BLOOD MRI FOR THE DIAGNOSIS OF GCA,
L. Seitz, S. Bucher, B. Maurer, F. Wagner, F. Lötscher, P. Seitz
|
|
2024 POS0113
|
CARDIOVASCULAR RISK RECLASSIFICATION ACCORDING TO THE 2023 PREVENTTM ALGORITHM AND CAROTID ULTRASOUND IN RHEUMATOID ARTHRITIS PATIENTS,
N. Guajardo-Jauregui, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. Gonzalez-Gonzalez, M. F. Elizondo-Benitez, A. L. Guajardo-Aldaco
|
|
2024 POS0133
|
POOR PERFORMANCE OF VALIDATED CARDIOVASCULAR RISK SCORES IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS - FIRST EVALUATION OF A GLOBAL US/UK COHORT,
C. Ciurtin, J. Peng, Y. Gao, M. Niwa, S. Ardoin, L. Schanberg, L. Lewandowski, E. Jury, G. Robinson
|
|
2024 POS0164
|
ARTERIOSCLEROSIS AND CREATININE AT REPEAT RENAL BIOPSY CAN PREDICT THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH LUPUS NEPHRITIS: -A TEN-YEAR FOLLOW-UP DATA,
I. I. K, R. Goel, J. Mathew, V. G. David, S. Roy, S. Alexander, S. Varughese, A. J. Mathew
|
|
2024 POS0178
|
PROSPECTIVE EVALUATION OF CAROTID ATHEROSCLEROSIS, URATE DEPOSITS AND INFLAMMATION AFTER ONE YEAR OF TREATMENT IN NEWLY DIAGNOSED GOUT,
M. Andrés, C. Rodríguez, I. Calabuig, A. Martínez-Sanchis
|
|
2024 POS0342
|
ANGIOGENIC T-CELL DEPLETION IS A VERY EARLY EVENT ALONG ARTHRITIS DEVELOPMENT LINKED TO IMPAIRED VASCULAR REPAIR AND SUBCLINICAL VASCULAR STIFFNESS,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2024 POS0567
|
ASSOCIATION OF PERIPHERAL AND CARDIOVASCULAR MONOSODIUM URATE DEPOSITS IN GOUT AND HYPERURICEMIA,
J. Held, C. Schwabl, D. Haschka, G. Feuchtner, G. Widmann, A. Klauser, C. Duftner, G. Weiss
|
|
2024 POS0598
|
AGE, SEROPOSITIVITY AND INFLAMMATION DETERMINE RISK VERSUS BENEFIT OF ENDOGENOUS ESTROGENS ON CORONARY ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS,
G. Karpouzas, B. Papotti, S. Ormseth, M. Palumbo, E. Hernandez, M. Budoff, N. Ronda
|
|
2024 POS0646
|
EFFECT OF OLOKIZUMAB ON THE NEUTROPHIL-LYMPOCYTE RATIO IN PATIENTS WITH RHEUMATOID ARTHRITIS,
E. Feist, A. Egorova, E. Alekseev
|
|
2024 POS0649
|
LONG-TERM CHANGES IN CORONARY CALCIUM SCORE LEVELS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS: A COHORT STUDY,
C. Corrales-Selaya, V. Portilla González, J. A. Parra Blanco, N. Vegas Revenga, R. Blanco, M. Á. González-Gay, I. Ferraz-Amaro, A. Corrales Martinez
|
|
2024 POS0667
|
VARIATIONS IN MACROPHAGE CHOLESTEROL LOADING OVER TIME ARE LINKED TO DYNAMIC CHANGES IN CORONARY ATHEROSCLEROSIS BURDEN IN RHEUMATOID ARTHRITIS,
G. Karpouzas, B. Papotti, S. Ormseth, M. Palumbo, E. Hernandez, M. P. Adorni, F. Zimetti, M. Budoff, N. Ronda
|
|
2024 POS0714
|
MYOCARDITIS AND MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) IN PATIENTS WITH MELANOMA RECEIVING IMMUNE CHECKPOINT INHIBITORS,
M. Suarez-Almazor, J. Ruiz, B. Zhao, N. Palaskas, A. Deswal, H. Zhao, J. McQuade
|
|
2024 POS0739
|
RENIN-ANGIOTENSIN SYSTEM BLOCKADE SIGNIFICANTLY REDUCES FUTURE CARDIOVASCULAR RISK IN LUPUS NEPHRITIS,
S. Garg, B. Astor, S. S. Lim, A. Raval, M. Buechel, W. Zhong, S. Panzer, T. Singh, B. H. Rovin, C. Bartels
|
|
2024 POS0846
|
THE EVALUATION OF LOWER EXTREMITIES ARTERIAL DISEASE IN SYSTEMIC SCLEROSIS PATIENTS THROUGH RHEUMATOLOGIST-VASCULAR SURGEON MULTIDISCIPLINARY MANAGEMENT: PRELIMINARY DATA FROM AN ITALIAN SINGLE CENTRE STUDY,
M. G. Lazzaroni, P. Baggi, L. Moschetti, E. Pedretti, C. Barison, E. Manzoni, F. Franceschini, S. Bonardelli, P. Airo’
|
|
2024 POS0851
|
USE OF NAILFOLD CAPILLAROSCOPY AS A PREDICTOR OF CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS,
C. Valera-Ribera, J. Lacasa-Molina, L. Perea-Galera, A. Taberner-Cortés, P. León-Torralba, A. Mayo-Juanatey, P. Andújar-Brazal, I. Vázquez-Gómez, D. Ybáñez-García, À. Martínez-Ferrer, E. Valls-Pascual, M. Robustillo-Villarino, J. J. Alegre-Sancho
|
|
2024 POS0971
|
SMALL DENSE LOW-DENSITY LIPOPROTEIN AS A BIOMARKER OF SUBCLINICAL ATHEROSCLEROSIS IN PSORIATIC ARTHRITIS PATIENTS,
N. Guajardo-Jauregui, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, I. J. Colunga-Pedraza, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera
|
|
2024 POS1022
|
LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC)-FRAILTY INDEX (SLICC-FI) MAY SERVE AS A VALUABLE TOOL FOR EARLY DETECTION OF SUBCLINICAL CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE),
M. Pappa, K. Keramiotou, P. P. Sfikakis, M. G. Tektonidou
|
|
2024 POS1050
|
SCORE AND SCORE2 COMPARISON IN CARDIOVASCULAR RISK ESTIMATION IN RHEUMATOID ARTHRITIS PATIENTS: A CROSS-SECTIONAL STUDY INCLUDING CAROTID ULTRASOUND,
C. Campos Fernández, P. Martinez Calabuig, R. González-Mazarío, J. J. Fragío Gil, J. A. Román Ivorra
|
|
2024 POS1092
|
CLINICAL AND MOLECULAR CARDIOVASCULAR ALTERATIONS ASSOCIATED WITH PERSISTENT HIGH LEVELS OF C-REACTIVE PROTEIN IN AXIAL SPONDYLOARTHRITIS PATIENTS,
L. Cuesta-López, I. Arias-de la Rosa, M. L. Ladehesa-Pineda, M. Ruiz-Ponce, A. Barranco, M. Á. Puche-Larrubia, C. Perez-Sanchez, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, P. Ortiz-Buitrago, C. Lopez-Pedrera, A. Escudero-Contreras, E. Collantes-Estevez, C. López-Medina, N. Barbarroja
|
|
2024 POS1108
|
SUBCLINICAL ATHEROSCLEROSIS IS ASSOCIATED WITH FUTURE CARDIOVASCULAR EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AT APPARENT LOW RISK FOR CARDIOVASCULAR DISEASE: A LONGITUDINAL PROSPECTIVE STUDY,
K. Sacre, A. Mageau, B. Escoubet, F. Arnoult, M. P. Chauveheid, T. Papo
|
|
2024 POS1123
|
ACCUMULATION OF MICROVASCULAR TARGET ORGAN DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK,
N. Koletsos, A. Triantafyllou, A. Stoimeni, P. Anyfanti, A. Lazaridis, N. G. Papadopoulos, S. Aslanidis, S. Douma, E. Gkaliagkousi
|
|
2024 POS1137
|
PREDICTORS OF ATHEROSCLEROTIC PLAQUE PROGRESSION AND CARDIOVASCULAR EVENTS DURING A 10-YEAR FOLLOW-UP IN SYSTEMIC LUPUS ERYTHEMATOSUS VERSUS HEALTHY CONTROLS: THE IMPACT OF SUSTAINED REMISSION, CARDIOVASCULAR RISK FACTOR TARGET ATTAINMENT AND ANTIPHOSPHOLIPID SYNDROME,
N. Papazoglou, P. P. Sfikakis, M. G. Tektonidou
|
|
2024 POS1226
|
REDUCED EXPRESSION OF GPR55 ON B-CELLS IN EARLY RHEUMATOID ARTHRITIS PATIENTS: A CANDIDATE MODULATOR OF IMMUNE RESPONSES IN ATHEROSCLEROSIS,
D. Miranda-Prieto, M. Alperi-López, J. Rodríguez-Carrio, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez
|
|
2024 POS1319
|
PERSONALIZED LIPIDOMIC AND PROTEOMIC PROFILES IDENTIFY APS PATIENTS WITH DISTINCTIVE ATHEROTHROMBOTIC RISK,
B. Vellón-García, C. Perez-Sanchez, M. Á. Aguirre-Zamorano, S. Corrales-Díaz Flores, I. Sanchez-Pareja, L. Muñoz-Barrera, T. Cerdó, L. Pérez-Sánchez, P. Ortiz-Buitrago, C. Merlo-Ruiz, D. Ruiz-Vilchez, M. D. C. Abalos-Aguilera, M. L. Ladehesa-Pineda, C. López-Medina, N. Barbarroja, A. Escudero-Contreras, R. Ortega-Castro, J. M. Villalba, C. Lopez-Pedrera
|
|
2024 POS1379
|
RESIDUAL INFLAMMATORY RISK (RIR) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN REMISSION – DO WE NEED TO DO MORE FOR THE PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)?,
A. Malaviya, B. Bondge
|
|
